Chlamydia pneumoniae

species of bacterium

DBpedia resource is: http://dbpedia.org/resource/Chlamydia_pneumoniae

Abstract is: Chlamydia pneumoniae is a species of Chlamydia, an obligate intracellular bacterium that infects humans and is a major cause of pneumonia. It was known as the Taiwan acute respiratory agent (TWAR) from the names of the two original isolates – Taiwan (TW-183) and an acute respiratory isolate designated AR-39. Briefly, it was known as Chlamydophila pneumoniae, and that name is used as an alternate in some sources. In some cases, to avoid confusion, both names are given. Chlamydia pneumoniae has a complex life cycle and must infect another cell to reproduce; thus, it is classified as an obligate intracellular pathogen. The full genome sequence for C. pneumoniae was published in 1999. It also infects and causes disease in koalas, emerald tree boas (Corallus caninus), iguanas, chameleons, frogs, and turtles. The first known case of infection with C. pneumoniae was a case of conjunctivitis in Taiwan in 1950. There are no known cases of C. pneumoniae in human history before 1950. This atypical bacterium commonly causes pharyngitis, bronchitis, coronary artery disease and atypical pneumonia in addition to several other possible diseases.

Chlamydia pneumoniae is …
instance of (P31):
taxonQ16521

External links are
P846GBIF taxon ID5428223
P5055IRMNG ID10534147
P815ITIS TSN968259
P1991LPSN URLhttps://lpsn.dsmz.de/species/chlamydia-pneumoniae
P685NCBI taxonomy ID83558
P11143WikiProjectMed IDChlamydia pneumoniae

P1542has effectChlamydia pneumoniae infectionQ11299062
P171parent taxonChlamydiaQ846309
P1813short nameC. pneumoniae
P225taxon nameChlamydia pneumoniae
P105taxon rankspeciesQ7432
P10video3D model of EGFR-YFP surrounding internalized C. pneumoniae EBs (Related to Figure 3D). Images taken from the boxed area of Figure 3D were imported into ImageJ software to calculate a 3D model of all focal planes based on a maximal intensity projection. The movie was generated by 360° rotation of the model.
License: CC BY 2.5
Artists: Molleken K, Becker E, Hegemann J
This work is copyrighted.
Attribution is required.

Reverse relations

host (P2975)
Q199458Chelonia mydas
Q215376green iguana

main subject (P921)
Q618228431103-197 Chlamydia pneumoniae-heat shock protein 60 induces a highly specific persistent immune response in patients with unstable angina independently from IgG and IgA seropositivity
Q1154373251271 Chronic chlamydia pneumoniae infection and stroke in Cameroon: a case-control study
Q941345952221. Chlamydia pneumoniae (Cpn) Induces IFN-γ Responses in Peripheral Blood Mononuclear Cells (PBMC) from Pediatric and Adult Asthma Patients: Effects of Age and Inhaled Corticosteroid Use
Q3786256560-kDa heat shock protein of Chlamydia pneumoniae is a target of T-cell immune response
Q3786298560-kDa heat shock protein of Chlamydia pneumoniae promotes a T helper type 1 immune response through IL-12/IL-23 production in monocyte-derived dendritic cells.
Q37887420: Risk factors for seropositivity and association with coronary heart disease
Q37871114A 22-year-old woman with fulminant Chlamydia pneumoniae pneumonia.
Q37865011A 6 week course of azithromycin treatment has no beneficial effect on atherosclerotic lesion development in apolipoprotein E-deficient mice chronically infected with Chlamydia pneumoniae
Q37865026A CD8+ T cell heptaepitope minigene vaccine induces protective immunity against Chlamydia pneumoniae
Q90662703A Chlamydia pneumoniae adhesin induces phosphatidylserine exposure on host cells
Q37879971A Chlamydia pneumoniae component that induces macrophage foam cell formation is chlamydial lipopolysaccharide
Q37870819A Chlamydia pneumoniae infection model using established human lymphocyte cell lines
Q37873820A Chlamydia pneumoniae-specific peptide induces experimental autoimmune encephalomyelitis in rats
Q37868503A Prospective Study of Chlamydia pneumoniae Antibodies in Children Between 7 months and 8 years of Age
Q37889220A case of adult Chlamydia pneumoniae pneumonia diagnosed from a culture method
Q37839216A case of interstitial pneumonia, myocarditis and severe sepsis caused by Chlamydia pneumoniae.
Q37888216A case of pediatric Chlamydia pneumoniae infection and properties of the isolate
Q37896796A case of pneumonia caused by Chlamydia pneumoniae, strain TWAR
Q37869652A case of pneumonia due to coinfection by Mycoplasma pneumoniae and Chlamydia pneumoniae
Q37868076A case of severe Chlamydia pneumoniae pneumonia requiring mechanical ventilation and complicated with disseminated intravascular coagulation
Q37890219A case of severe interstitial pneumonia probably due to Chlamydia pneumoniae
Q37874025A case of splenic abscess due to Chlamydia pneumoniae
Q37873704A case presenting severe respiratory failure with high antibody titers to Chlamydia pneumoniae
Q37887958A child with iritis due to Chlamydia pneumoniae infection
Q37899165A clinical and epidemiological study of "ornithosis" caused by Chlamydia psittaci and Chlamydia pneumoniae (strain TWAR).
Q37849190A combination of secondhand cigarette smoke and Chlamydia pneumoniae accelerates atherosclerosis
Q37853972A comparative study of RNA and DNA as internal gene expression controls early in the developmental cycle of Chlamydia pneumoniae
Q37892824A family outbreak of Chlamydia pneumoniae infection
Q37869625A lack of serologic evidence of transmission of Chlamydia pneumoniae by transfusion of buffy coat‐depleted RBCs
Q37838093A meta-analysis of the association between Chlamydia pneumoniae infection and lung cancer risk
Q37858418A method for HLA genotyping using the specific cleavage of DNA-rN1-DNA/DNA with RNase HII from Chlamydia pneumoniae
Q37884466A microcarrier culture method for the production of large quantities of viable Chlamydia pneumoniae
Q33596734A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis
Q37875196A new DIG-PCR-EIA method for the detection of Chlamydia pneumoniae DNA in clinical samples
Q37866736A new microimmunofluorescence test for the detection of Chlamydia pneumoniae specific antibodies
Q37885832A new primer pair for detection of Chlamydia pneumoniae by polymerase chain reaction
Q37896793A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR.
Q37882795A novel method for isolation of Chlamydia pneumoniae by treatment with trypsin or EDTA.
Q33889181A novel superfamily of predicted cysteine proteases from eukaryotes, viruses and Chlamydia pneumoniae
Q37871087A patient with adult Still's disease with an increased Chlamydia pneumoniae antibody titer
Q37850074A pilot study on the association between double positive Chlamydia pneumoniae serology and serum lipid indices alterations in obese adult females
Q89478117A platform for studying the transfer of Chlamydia pneumoniae infection between respiratory epithelium and phagocytes
Q35588641A population based seroepidemiological survey of Chlamydia pneumoniae infections in schoolchildren
Q37882360A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age.
Q37852005A potential role of Chlamydia pneumoniae in the pathogenesis of periodontal disease in adolescents and adults
Q37866674A prediction model for community-acquired Chlamydia pneumoniae pneumonia in hospitalized patients
Q37875154A preliminary evaluation of a new enzyme immunoassay to detect Chlamydia pneumoniae-specific antibodies
Q37867101A prospective study of Chlamydia pneumoniae infection and risk of MS in two US cohorts
Q34082096A protein secreted by the respiratory pathogen Chlamydia pneumoniae impairs IL-17 signalling via interaction with human Act1
Q37863557A randomized trial in patients undergoing percutaneous coronary angioplasty: roxithromycin does not reduce clinical restenosis but angioplasty increases antibody concentrations against Chlamydia pneumoniae
Q37890925A report of 4 cases from whom Chlamydia pneumoniae was isolated
Q58601477A retrospective seroepidemiologic survey of Chlamydia pneumoniae infection in patients in Beijing between 2008 and 2017
Q101049331A retrospective survey of Chlamydia pneumoniae infection rates in paediatric patients from a single centre in Wuxi, China
Q37885237A reverse transcriptase-PCR based assay for in-vitro antibiotic susceptibility testing of Chlamydia pneumoniae
Q33594484A review of Chlamydia pneumoniae and atherosclerosis.
Q37896100A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR.
Q37890729A seroepidemiologic study of Chlamydia pneumoniae in Rhode Island. Evidence of serologic cross-reactivity
Q37885733A seroepidemiologic study of Chlamydia pneumoniae, Chlamydia trachomatis and Chlamydia psittaci in different populations on the mainland of China
Q37868210A severe case of Chlamydia pneumoniae pneumonia
Q37858539A simultaneous detection of Chlamydia pneumoniae and Chlamydia trachomatis DNA by real-time PCR
Q35341808A single infection with Chlamydia pneumoniae is sufficient to exacerbate atherosclerosis in ApoE deficient mice
Q33264901A study on immunopathogenetic mechanisms of atherosclerotic process caused by chronic infection of Chlamydia pneumoniae in rats (Ratus novergicus).
Q37853444A systemic network for Chlamydia pneumoniae entry into human cells
Q37867499A thermostable manganese-containing superoxide dismutase from pathogen Chlamydia pneumoniae
Q37846516ABC-cassette transporter 1 (ABCA1) expression in epithelial cells in Chlamydia pneumoniae infection
Q37840971AP-1 Transcription Factor Serves as a Molecular Switch between Chlamydia pneumoniae Replication and Persistence
Q115335507ASSOCIATION OF CHLAMYDIA PNEUMONIAE INFECTION WITH OTITIS MEDIA WITH EFFUSION
Q37858489Absence of Chlamydia pneumoniae and signs of atherosclerotic cardiovascular disease in adolescents with systemic lupus erythematosus
Q37868777Absence of Chlamydia pneumoniae in brain of vascular dementia patients
Q37871487Absence of Chlamydia pneumoniae in surgical specimens of coronary and carotid arteries by polymerase chain reaction
Q37881116Absence of Porphyromonas asaccharolytica, Bacteroides fragilis and Chlamydia pneumoniae in human subgingival plaque
Q37877073Acellular components of Chlamydia pneumoniae stimulate cytokine production in human blood mononuclear cells
Q37873346Acepromazine modulates cell differentiation: in vitro experiments on monocytes stimulated by Chlamydia pneumoniae toxins
Q34003385Acquired immunity to Chlamydia pneumoniae is dependent on gamma interferon in two mouse strains that initially differ in this respect after primary challenge
Q37833680Acquisition of Rab11 and Rab11-Fip2-A novel strategy for Chlamydia pneumoniae early survival.
Q33925828Activity of gemifloxacin and other new quinolones against Chlamydia pneumoniae: a review
Q37878072Activity of grepafloxacin and other fluoroquinones and newer macrolides against recent clinical isolates of Chlamydia pneumoniae
Q33770135Activity of quinolones against Chlamydia pneumoniae
Q37867383Acute Chlamydia pneumoniae and Mycoplasma pneumoniae infections in community-acquired pneumonia and exacerbations of COPD or asthma: therapeutic considerations.
Q37869181Acute Chlamydia pneumoniae infection causes coronary endothelial dysfunction in pigs
Q37855741Acute Chlamydia pneumoniae infection in the pathogenesis of autoimmune diseases
Q37863763Acute Chlamydia pneumoniae infection with heat-shock-protein-60-related response in patients with acute coronary syndrome
Q37858533Acute Chlamydia pneumoniae infections in asthmatic and non-asthmatic military conscripts during a non-epidemic period
Q37854858Acute Chlamydia pneumoniae reinfection accelerates the development of insulin resistance and diabetes in obese C57BL/6 mice
Q128476111Acute Fulminant Chlamydia pneumoniae Myocarditis Treated with Mechanical Circulatory Support in a Female Adult: A Case Report
Q37067678Acute Glomerulonephritis in a Child with Chlamydia pneumoniae Infection: A Case Report
Q37894266Acute Upper Resiratory Tract Infections Associated with Chlamydia pneumoniae
Q37850407Acute and chronic Chlamydia pneumoniae infection and inflammatory markers in coronary artery disease patients.
Q37852371Acute and chronic Chlamydia pneumoniae infection in pregnancy complicated with preeclampsia.
Q37875794Acute coronary syndrome associated with Chlamydia pneumoniae pneumonia in two cases
Q37888018Acute exacerbations of asthma in adults: role of Chlamydia pneumoniae infection
Q37861627Acute generalized exanthematous pustulosis: first case associated with a Chlamydia pneumoniae infection
Q73319382Acute glomerulonephritis associated with pneumonia: a possible Chlamydia pneumoniae etiology?
Q37891752Acute lower respiratory tract infection associated with Chlamydia pneumoniae in Germany
Q37856423Acute pericarditis as an organic manifestation of the acute infection Chlamydia pneumoniae
Q37872068Acute polyradiculoneuropathy after Chlamydia pneumoniae infection
Q37878175Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection
Q37852889Acute renal failure following Chlamydia pneumoniae pneumonia in a child
Q37877187Acute respiratory Chlamydia pneumoniae infections in adults. Value of direct gene amplification diagnosis
Q36715394Acute respiratory infection due to Chlamydia pneumoniae: current status of diagnostic methods
Q37893849Acute respiratory infections by Chlamydia pneumoniae
Q33360207Acute thrombotic thrombocytopenic purpura following doxycycline treatment of Chlamydia pneumoniae infection in a patient with dermatomyositis
Q37873236Acute-phase proteins and Chlamydia pneumoniae infection: which one is more important in acute coronary syndrome?
Q37869013Acute-phase response of human hepatocytes after infection with Chlamydia pneumoniae and cytomegalovirus.
Q37870760Adjuvant modulation of the immune responses and the outcome of infection with Chlamydia pneumoniae
Q37861716Adult calcific aortic stenosis and Chlamydia pneumoniae: the role of Chlamydia infection in valvular calcification.
Q37885000Adult respiratory distress syndrome due to Chlamydia pneumoniae in a young adult.
Q37888887Advance in the study of Chlamydia pneumoniae
Q35917262Advances in the management of Chlamydia pneumoniae infections
Q37889685Age specific prevalence of antibodies against Chlamydia pneumoniae in Iceland
Q37120590Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor
Q37855855Airflow limitation, asthma, and Chlamydia pneumoniae-specific heat shock protein 60.
Q37857345Amalgamation of Chlamydia pneumoniae inclusions with lipid droplets in foam cells in human atherosclerotic plaque
Q30582874AmiA is a penicillin target enzyme with dual activity in the intracellular pathogen Chlamydia pneumoniae
Q37183656Amino acid requirements for growth of Chlamydia pneumoniae in cell cultures: growth enhancement by lysine or methionine depletion
Q36046741Amphipathic β2,2-Amino Acid Derivatives Suppress Infectivity and Disrupt the Intracellular Replication Cycle of Chlamydia pneumoniae
Q36402455Amphiphysin IIm is required for survival of Chlamydia pneumoniae in macrophages
Q37868355An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients.
Q37874374An association between an antibody against Chlamydia pneumoniae and common carotid atherosclerosis.
Q37868954An association between an antibody against Chlamydia pneumoniae and ischemic stroke in elderly Japanese
Q37872408An association between chronic infection with Chlamydia pneumoniae and lung cancer. A prospective 2-year study
Q43429551An association of an antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan
Q36328854An engineered L-arginine sensor of Chlamydia pneumoniae enables arginine-adjustable transcription control in mammalian cells and mice
Q37878794An epidemic of a pertussis-like illness caused by Chlamydia pneumoniae
Q37890430An epidemic of infections due to Chlamydia pneumoniae in military conscripts
Q37862349An epidemic outbreak of respiratory infection caused by Chlamydia pneumoniae in medical workers
Q37848175An experimental model for induction of lung cancer in rats by Chlamydia pneumoniae
Q37886904An immunofluorescence assay in microwell plate (IFA) for detecting serum antibodies to Chlamydia pneumoniae
Q32041459An immunogenic epitope of Chlamydia pneumoniae from a random phage display peptide library is reactive with both monoclonal antibody and patients sera.
Q37845555An improved method on isolation and serial passage of Chlamydia pneumoniae from human peripheral blood mononuclear cells.
Q43422119An increased rate of seropositivity for immunoglobulin G antibodies to Chlamydia pneumoniae
Q34299315An infectious basis for multiple sclerosis: perspectives on the role of Chlamydia pneumoniae and other agents
Q37893837An isolation procedure of Chlamydia pneumoniae and Chlamydia trachomatis
Q37871587An open, comparative pilot study of thiamphenicol glycinate hydrochloride vs clarithromycin in the treatment of acute lower respiratory tract infections due to Chlamydia pneumoniae
Q37891729An unusual manifestation of Chlamydia pneumoniae infection: meningitis, hepatitis, iritis and atypical erythema nodosum
Q37872423Analysis of Chlamydia pneumoniae growth in cells by reverse transcription-PCR targeted to bacterial gene transcripts
Q37851467Analysis of Chlamydia pneumoniae infection in mononuclear cells by reverse transcription-PCR targeted to chlamydial gene transcripts
Q37863995Analysis of Chlamydia pneumoniae-specific oligoclonal bands in multiple sclerosis and other neurologic diseases
Q37866515Analysis of altered protein expression patterns of Chlamydia pneumoniae by an integrated proteome-works system
Q37848394Analysis of gene expression in penicillin G induced persistence of Chlamydia pneumoniae
Q92007945Analysis of humoral immune responses to recombinant Chlamydia pneumoniae antigens
Q33997961Analysis of the humoral immune response to Chlamydia pneumoniae by immunoblotting and immunoprecipitation.
Q37872721Analysis of the serological response to Chlamydia pneumoniae in patients with ischemic heart disease by recombinant MOMP-ELISA.
Q33968165Analytical sensitivity, reproducibility of results, and clinical performance of five PCR assays for detecting Chlamydia pneumoniae DNA in peripheral blood mononuclear cells
Q37879491Animal models for Chlamydia pneumoniae infection
Q41564445Animal models for Chlamydia pneumoniae infection
Q37882844Anti-Chlamydia pneumoniae antibodies and production of interleukin 6 in acute myocardial infarct
Q37869913Anti-Chlamydia pneumoniae heat shock protein 10 antibodies in asthmatic adults
Q37855789Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (
Q37876362Antibiotic susceptibility of Chlamydia pneumoniae
Q37865020Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome
Q43429735Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events
Q37872609Antibiotics against Chlamydia pneumoniae and prognosis after acute myocardial infarction
Q33935083Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis
Q43423795Antibodies against Chlamydia pneumoniae and their relation to lymphocyte population levels
Q43422473Antibodies against Chlamydia pneumoniae in stable angina and interleukin-6 levels
Q37873783Antibodies against Chlamydia pneumoniae predict the need for elective surgical intervention on small abdominal aortic aneurysms
Q37882900Antibodies against Chlamydia pneumoniae, cytomegalovirus, enteroviruses and respiratory syncytial virus in patients with polymyalgia rheumatica.
Q37872816Antibodies anti-Chlamydia pneumoniae and anti-Mycoplasma pneumoniae in patients with negative serology for hantavirus. Retrospective study
Q33941659Antibodies to 60-kilodalton heat shock protein and outer membrane protein 2 of Chlamydia pneumoniae in patients with coronary heart disease
Q37874993Antibodies to Chlamydia pneumoniae and clinical course in patients with unstable angina pectoris
Q37868802Antibodies to Chlamydia pneumoniae and haemostatic factors in acute coronary syndrome without ST segment elevation.
Q37855045Antibodies to Chlamydia pneumoniae are associated with increased intima media thickness in asymptomatic Indian individuals
Q127098084Antibodies to Chlamydia pneumoniae are related to the intima-media thickness in the carotid artery and to an atherogenetic fatty acid profile
Q37862917Antibodies to Chlamydia pneumoniae in blood serum of patients with ischemic heart disease and presence of complicated lesions in coronary arteries
Q37880449Antibodies to Chlamydia pneumoniae in healthy children from Bari, south Italy
Q37873576Antibodies to Chlamydia pneumoniae in young Swedish orienteers
Q43430065Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease
Q44025823Antibodies to cytomegalovirus or Chlamydia pneumoniae and coronary heart disease.
Q37871483Antibodies to neuron-specific antigens in children with autism: possible cross-reaction with encephalitogenic proteins from milk, Chlamydia pneumoniae and Streptococcus group A.
Q37866484Antibody levels against Chlamydia pneumoniae and outcome of roxithromycin therapy in patients with acute myocardial infarction. Results from a sub-study of the randomised Antibiotic Therapy in Acute Myocardial Infarction (ANTIBIO) trial
Q37881439Antibody response to Chlamydia pneumoniae infection in children with respiratory illness
Q37876498Antibody response to the 60-kDa heat-shock protein of Chlamydia pneumoniae in patients with coronary artery disease
Q37892043Antigenic Characterization of Chlamydia pneumoniae Isolated in Hiroshima, Japan
Q37883393Antigenic and molecular analyses of different Chlamydia pneumoniae strains.
Q37894749Antigenic variation among strains of Chlamydia pneumoniae.
Q37849908Antigens of persistent Chlamydia pneumoniae within coronary atheroma from patients undergoing heart transplantation
Q37874398Antimicrobial activity of thiamphenicol-glycinate-acetylcysteinate and other drugs against Chlamydia pneumoniae
Q37846046Antimicrobial effect of natural polyphenols with or without antibiotics on Chlamydia pneumoniae infection in vitro.
Q37888465Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae
Q33726287Antimicrobial therapy for Chlamydia pneumoniae: its potential role in atherosclerosis and asthma
Q43419753Antiphospholipid antibodies induced by Chlamydia pneumoniae infections
Q37544269Application of DNA chip scanning technology for automatic detection of Chlamydia trachomatis and Chlamydia pneumoniae inclusions.
Q37889844Application of PCR for isolation of Chlamydia pneumoniae
Q37873191Application of blood-based polymerase chain reaction for detection of Chlamydia pneumoniae in acute respiratory tract infections
Q37859290Application of the recombinant protein MOMP(VD2-VD3) from Chlamydia pneumoniae in sero diagnosis
Q37869358Are anti-Chlamydia pneumoniae antibodies prognosis indicators for peripartum cardiomyopathy?
Q37875724Are morphological or functional changes in the carotid artery wall associated with Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, or herpes simplex virus infection?
Q37861345Arterial stiffness and Chlamydia pneumoniae infection in coronary artery disease. Is there a link?
Q37880719Arteriosclerosis as a sequela of chronic Chlamydia pneumoniae infection
Q37880818Arteriosclerosis caused by infection? A possible link between Chlamydia pneumoniae and atherosclerosis
Q37882091Arteriosclerosis--a Chlamydia pneumoniae infection
Q43429963Arteriosclerosis--a Chlamydia pneumoniae infection?
Q28195798Aspirin inhibits Chlamydia pneumoniae-induced NF-κB activation, cyclo-oxygenase-2 expression and prostaglandin E2 synthesis and attenuates chlamydial growth
Q28193411Aspirin inhibits Chlamydia pneumoniae-induced nuclear factor-kappa B activation, cytokine expression, and bacterial development in human endothelial cells
Q37854565Assay of Chlamydia pneumoniae-specific IgM antibodies by ELISA method--reduction of non-specific reaction and resetting of serological criteria by measuring IgM antibodies--.
Q37883761Assay of antibiotic susceptibility of Chlamydia pneumoniae.
Q37884610Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 1. Evaluation of ELISA kit using outer membrane complex
Q37884606Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 2. studies on clinical usefulness and serological diagnostic standards
Q37878182Assay of specific anti-Chlamydia pneumoniae antibodies by ELISA method. 3. Setting of serological criteria
Q92661162Assaying Chlamydia pneumoniae Persistence in Monocyte-Derived Macrophages Identifies Dibenzocyclooctadiene Lignans as Phenotypic Switchers
Q90799663Assessment of evidence for or against contributions of Chlamydia pneumoniae infections to Alzheimer's disease etiology
Q37872175Assessment of polymerase chain reaction and serology for detection of chlamydia pneumoniae in patients with acute respiratory tract infection.
Q37883028Assessment of sputum culture and serology for detection of chlamydia pneumoniae in patients with symptomatic acute respiratory tract infection
Q62865992Association Between Chlamydia pneumoniae Antibodies and Lung Cancer: A Meta-Analysis
Q37836568Association Between Chlamydia pneumoniae and Migraine: A Study from a Tertiary Center in India
Q37875109Association between C-reactive protein, anti-Chlamydia pneumoniae antibodies, and vascular function in healthy adults
Q36259587Association between Chlamydia pneumoniae IgG antibodies and migraine
Q34406483Association between Chlamydia pneumoniae and acute myocardial infarction in young men in the United States military: the importance of timing of exposure measurement
Q74181404Association between Chlamydia pneumoniae and atherosclerotic lesions
Q37872430Association between Chlamydia pneumoniae antibodies and intimal calcification in femoral arteries of nondiabetic patients
Q36225330Association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex.
Q30732782Association between Sézary T cell-activating factor, Chlamydia pneumoniae, and cutaneous T cell lymphoma
Q37864810Association between angiographic evidence of coronary artery disease and seropositivity for Helicobacter pylori and Chlamydia pneumoniae infection.
Q33183960Association between cardiovascular disease and anti-Chlamydia pneumoniae antibodies
Q37864201Association between carotid atherosclerosis, inflammatory markers and Chlamydia pneumoniae infection
Q37873296Association between infection with Helicobacter pylori and Chlamydia pneumoniae and risk of ischemic stroke subtypes: Results from a population-based case-control study
Q74329563Association between past infection with Chlamydia pneumoniae and body mass index, low-density lipoprotein particle size and fasting insulin
Q37872032Association between seropositivity to Chlamydia pneumoniae and acute ischaemic stroke
Q37869140Association of CD14 promoter gene polymorphism and Chlamydia pneumoniae infection
Q34121913Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma
Q60395859Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma
Q36504586Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma
Q28833753Association of Chlamydia pneumoniae Infection With Atherosclerotic Plaque Formation
Q43418518Association of Chlamydia pneumoniae and Helicobacter pylori infection with angiographically demonstrated coronary artery disease
Q37885075Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland
Q43425344Association of Chlamydia pneumoniae and multiple sclerosis: stage two?
Q37868121Association of Chlamydia pneumoniae antibody with the cholesterol-lowering effect of statins
Q37875232Association of Chlamydia pneumoniae immunoglobulin A seropositivity and risk of lung cancer.
Q40041033Association of Chlamydia pneumoniae immunoglobulin G antibodies with the risk of lung cancer among non-smoking women in Liaoning, China
Q37861976Association of Chlamydia pneumoniae infection and carotid intima-media wall thickness in Japanese Americans
Q36422568Association of Chlamydia pneumoniae infection with HLA-B*35 in patients with coronary artery disease
Q37877118Association of Chlamydia pneumoniae infection with diabetic nephropathy
Q37891758Association of Chlamydia pneumoniae infection with otitis media with effusion
Q37850845Association of Chlamydia pneumoniae serology and ischemic stroke
Q35586480Association of Chlamydia pneumoniae with central nervous system disease
Q127475183Association of Chlamydia pneumoniae with chronic human diseases
Q43429503Association of Chlamydia pneumoniae with chronic juvenile arthritis
Q37871349Association of Chlamydia pneumoniae with coronary artery disease and its progression is dependent on the modifying effect of mannose-binding lectin.
Q37879810Association of Chlamydia pneumoniae with otitis media in children
Q34420129Association of HLA-DRB3*0202 and serum IgG antibodies to Chlamydia pneumoniae with essential hypertension in a highly homogeneous population from Majorca (Balearic Islands, Spain).
Q37886448Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
Q37884580Association of Positive Chlamydia trachomatis and Chlamydia pneumoniae Immunoglobulin G Titers with Increasing Age
Q37892814Association of Prior Infection With Chlamydia pneumoniae and Angiographically Demonstrated Coronary Artery Disease
Q33602983Association of carotid plaque Lp-PLA(2) with macrophages and Chlamydia pneumoniae infection among patients at risk for stroke
Q126553522Association of chlamydia pneumoniae infection with diabetes mellitus in patients with coronary artery disease
Q37879436Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese.
Q24791856Association of circulating Chlamydia pneumoniae DNA with cardiovascular disease: a systematic review
Q37857193Association of hyperhomocysteinemia and Chlamydia pneumoniae infection with carotid atherosclerosis and coronary artery disease in Japanese patients
Q37866640Association of peripheral mononuclear cells containing Chlamydia pneumoniae DNA with acute coronary syndrome and stable coronary artery disease in Japanese subjects
Q37150725Association of plasma circulatory markers, Chlamydia pneumoniae, and high sensitive C-reactive protein in coronary artery disease patients of India
Q37882038Association of positive Chlamydia trachomatis and Chlamydia pneumoniae immunoglobulin-gamma titers with increasing age.
Q37865490Association of raised titres of antibodies to Chlamydia pneumoniae with a history of pre-eclampsia
Q37874837Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease
Q37877190Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease
Q43428213Association of seropositivity for Chlamydia pneumoniae and coronary artery disease in heterozygous familial hypercholesterolaemia
Q37883320Asthma and Chlamydia pneumoniae. A future prospect for macrolides in general and roxithromycin in particular?
Q37878633Asthma, atopy and Chlamydia pneumoniae antibodies in adults
Q37859589Asthmatic persons are prone to the persistence of Chlamydia pneumoniae antibodies
Q64264567Astrocytes infected with Chlamydia pneumoniae demonstrate altered expression and activity of secretases involved in the generation of β-amyloid found in Alzheimer disease
Q37866051Asymptomatic carotid atherosclerosis is associated with circulating chlamydia pneumoniae DNA in younger normotensive subjects in a general population survey
Q43425332Asymptomatic respiratory infection with Chlamydia pneumoniae : what does it mean?
Q37243062Asymptomatic respiratory tract infection with Chlamydia pneumoniae TWAR
Q37876467Atherogenetically relevant cells support continuous growth of Chlamydia pneumoniae
Q37868568Atherogenic effects of chlamydia pneumoniae: refuting the innocent bystander hypothesis
Q37870277Atherosclerosis and Chlamydia pneumoniae
Q33926255Atherosclerosis and infection due to Chlamydia pneumoniae or cytomegalovirus: weighing the evidence
Q37866637Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?
Q37882083Atherosclerosis due to chronic arteritis caused by Chlamydia pneumoniae: a tentative hypothesis
Q34766537Atherosclerosis in dialysis patients: does Chlamydia pneumoniae infection contribute to cardiovascular damage?
Q33772514Atherosclerosis, inflammation and Chlamydia pneumoniae
Q37878654Atherosclerosis--a chronic infectious disease caused by Chlamydia pneumoniae
Q43423054Atherosclerosis: lipid infiltration or Chlamydia pneumoniae infection?
Q37890581Atypical pneumonia due to Chlamydia pneumoniae: a case report.
Q37871369Autoantibodies and anti-factor VIII and Chlamydia pneumoniae infection
Q37872383Autoimmunity to human heat shock protein 60, Chlamydia pneumoniae infection, and inflammation in predicting coronary risk
Q96223012Azithromycin decreases Chlamydia pneumoniae-mediated Interleukin-4 responses but not Immunoglobulin E responses
Q37888769Azithromycin in the treatment of pneumonia caused by Chlamydia pneumoniae: report of a case
Q37866763Azithromycin inhibits interleukin-6 but not fibrinogen production in hepatocytes infected with cytomegalovirus and chlamydia pneumoniae.
Q37864081Azithromycin reduces Chlamydia pneumoniae-induced attenuation of eNOS and cGMP production by endothelial cells.
Q37867723Azithromycin therapy in patients with chronic Chlamydia pneumoniae infection and coronary heart disease: immediate and long-term effects on inflammation, coagulation, and lipid status in a double-blind, placebo-controlled study
Q43429072Azithromycin, Chlamydia pneumoniae, and intimal thickening
Q33935003Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
Q37869893Bacterial flora from bronchoalveolar lavage and occurrence of class IgG and IgA antibodies to Chlamydia pneumoniae in patients with chronic obstructive pulmonary disease (COPD)
Q37877649Baseline IgG antibody titers to Chlamydia pneumoniae, Helicobacter pylori, herpes simplex virus, and cytomegalovirus and the risk for cardiovascular disease in women
Q37879261Basic and clinical study of Chlamydia pneumoniae infections
Q37841601Berberine inhibits Chlamydia pneumoniae infection-induced vascular smooth muscle cell migration through downregulating MMP3 and MMP9 via PI3K.
Q37850932Bilateral hilar lymphadenopathy due to Chlamydia pneumoniae infection
Q37873741Bilateral pleural effusion and a subsegmental infiltrate due to Chlamydia pneumoniae in a mechanically ventilated patient
Q27684803Biochemical and Structural Insights into Microtubule Perturbation by CopN from Chlamydia pneumoniae
Q37835765Biophysical and Biochemical Outcomes of Chlamydia pneumoniae Infection Promotes Pro-atherogenic Matrix Microenvironment
Q27302171Biophysical regulation of Chlamydia pneumoniae-infected monocyte recruitment to atherosclerotic foci
Q37877796Bordetella pertussis, Bordetella parapertussis, Mycoplasma pneumoniae, Chlamydia pneumoniae and persistent cough in children
Q37860951Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.
Q34104428Bronchial Chlamydia pneumoniae infection, markers of allergic inflammation and lung function in children
Q37862568Bronchial asthma and Chlamydia pneumoniae antibodies in children aged 4-8 years in Olomouc district
Q37881156Bronchial asthma from Chlamydia pneumoniae? Epidemiology, risk factors and practical consequence for therapy
Q37881607Bronchitis and alveolitis in the course of Chlamydia pneumoniae infection
Q35113951C-reactive protein and anti-Chlamydia pneumoniae antibodies as risk factors of cardiovascular death in incident patients on peritoneal dialysis.
Q37874536C-reactive protein and chronic Chlamydia pneumoniae infection--long-term predictors for cardiovascular disease and survival in patients on peritoneal dialysis
Q37872961C-reactive protein levels and viable Chlamydia pneumoniae in carotid artery atherosclerosis
Q37870054C-reactive protein, Helicobacter pylori, Chlamydia pneumoniae, cytomegalovirus and risk for myocardial infarction
Q37867040CD14 promoter polymorphism -159C>T is associated with susceptibility to chronic Chlamydia pneumoniae infection in peripheral blood monocytes
Q37859108CD8+ T cell protective immunity against Chlamydia pneumoniae includes an H2-M3-restricted response that is largely CD4+ T cell-independent
Q36794140CD8+ T cells mediate Chlamydia pneumoniae-induced atherosclerosis in mice
Q115380914CHLAMYDIA PNEUMONIAE IN ACUTE OTITIS MEDIA. † 988
Q43423185CNS infection with Chlamydia pneumoniae complicated by multiple strokes
Q35198182Calcium, ARMS2 genotype, and Chlamydia pneumoniae infection in early age-related macular degeneration: a multivariate analysis from the Nagahama study
Q34479396Can acute Chlamydia pneumoniae respiratory tract infection initiate chronic asthma?
Q37877470Can an antibiotic (macrolide) prevent Chlamydia pneumoniae-induced atherosclerosis in a rabbit model?
Q37879600Can degenerative aortic valve stenosis be related to persistent Chlamydia pneumoniae infection?
Q37874641Cardiac allograft vasculopathy in heart transplant recipients: a bacteriosclerosis by chlamydia pneumoniae?
Q37867726Cardiac heart disease in the era of sucrose polyester, Helicobacter pylori and Chlamydia pneumoniae
Q37881987Cardiovascular disease risk from prior Chlamydia pneumoniae infection can be related to certain antigens recognized in the immunoblot profile
Q37875238Cardiovascular infection by Chlamydia pneumoniae is not related to apolipoprotein E genotype
Q104745927Case Report: Refractory Acute Respiratory Distress Syndrome Supported by Extracorporeal Membrane Oxygenation due to Coinfection with Chlamydia pneumoniae and Leptospirosis in Reunion Island
Q37894490Case report: Chlamydia pneumoniae pneumonia in an HIV-infected man.
Q37890811Case report: acute postoperative respiratory failure caused by Chlamydia pneumoniae and diagnosed by bronchoalveolar lavage.
Q33952490Caspase-1 dependent IL-1β secretion is critical for host defense in a mouse model of Chlamydia pneumoniae lung infection
Q37883753Cell mediated immunity to Chlamydia pneumoniae.
Q91210836Cell-mediated immune response associated with Chlamydia pneumoniae infection in atherosclerotic patients
Q34005391Cell-mediated immune response during primary Chlamydia pneumoniae infection
Q33597752Cell-mediated immunity to Chlamydia pneumoniae measured as lymphocyte blast transformation in vitro.
Q37870284Cell-to-cell contact of human monocytes with infected arterial smooth-muscle cells enhances growth of Chlamydia pneumoniae
Q37878008Cellular oxidation of low-density lipoprotein by Chlamydia pneumoniae
Q37866587Cerebrospinal fluid molecular demonstration of Chlamydia pneumoniae DNA is associated to clinical and brain magnetic resonance imaging activity in a subset of patients with relapsing-remitting multiple sclerosis
Q37866972Changes in antibody titers against Chlamydia pneumoniae after coronary angioplasty
Q125998213Changing of infectious disease.4.Changing of chlamydia respiratory tract infection.Especially on actual conditions of Chlamydia pneumoniae respiratory tract infection in Japapn.
Q37872211Characterisation of 20-kDa lectin-spermagglutinin from Arum maculatum that prevents Chlamydia pneumoniae infection of L-929 fibroblast cells.
Q37840790Characterisation of Chlamydia pneumoniae and other novel chlamydial infections in captive snakes
Q37857565Characterization and intracellular localization of putative Chlamydia pneumoniae effector proteins
Q37874935Characterization and intracellular trafficking pattern of vacuoles containing Chlamydia pneumoniae in human epithelial cells
Q37883175Characterization of Chlamydia pneumoniae antigens using human T cell clones
Q37873100Characterization of Chlamydia pneumoniae persistence in HEp-2 cells treated with gamma interferon.
Q37072769Characterization of Chlamydia pneumoniae species-specific proteins immunodominant in humans
Q37889709Characterization of a Chlamydia pneumoniae strain isolated from a 57-year-old man.
Q33758389Characterization of a neutralizing monoclonal antibody directed at the lipopolysaccharide of Chlamydia pneumoniae.
Q37881299Characterization of a strain of Chlamydia pneumoniae isolated from a coronary atheroma by analysis of the omp1 gene and biological activity in human endothelial cells
Q37873267Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells
Q35700382Characterization of antiapoptotic activities of Chlamydia pneumoniae in infected cells
Q33284727Characterization of hypothetical proteins Cpn0146, 0147, 0284 & 0285 that are predicted to be in the Chlamydia pneumoniae inclusion membrane
Q37877285Characterization of low-density lipoprotein uptake by murine macrophages exposed to Chlamydia pneumoniae
Q37844761Characterization of serine hydroxymethyltransferase GlyA as a potential source of D-alanine in Chlamydia pneumoniae.
Q37869147Characterization of the first Korean isolate of a Chlamydia pneumoniae strain.
Q37860360Characterization of the hypothetical protein Cpn1027, a newly identified inclusion membrane protein unique to Chlamydia pneumoniae
Q37878729Characterization of the koala biovar of Chlamydia pneumoniae at four gene loci--ompAVD4, ompB, 16S rRNA, groESL spacer region
Q35513577Characterization of the murine antibody response to peptides representing the variable domains of the major outer membrane protein of Chlamydia pneumoniae
Q37875097Chest radiograph of atypical pneumonia: comparison among Chlamydia pneumoniae. Pneumonia, ornithosis, and Mycoplasma pneumoniae pneumonia
Q35954456Chlamydia Outer Protein (Cop) B from Chlamydia pneumoniae possesses characteristic features of a type III secretion (T3S) translocator protein
Q37850728Chlamydia Pneumoniae CdsL Regulates CdsN ATPase Activity, and Disruption with a Peptide Mimetic Prevents Bacterial Invasion
Q37840244Chlamydia Pneumoniae and Immunoinflammatory Reactions in an Unstable Atherosclerotic Plaque in Humans
Q36272565Chlamydia pneumoniae
Q72190879Chlamydia pneumoniae
Q72523970Chlamydia pneumoniae
Q74649305Chlamydia pneumoniae
Q78554678Chlamydia pneumoniae
Q37866118Chlamydia pneumoniae (C. pneumoniae) infection upregulates atherosclerosis-related gene expression in human umbilical vein endothelial cells (HUVECs).
Q37886058Chlamydia pneumoniae (TWAR) in atherosclerosis of the carotid artery
Q34086738Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old)
Q43435592Chlamydia pneumoniae (TWAR) in neonates
Q37885974Chlamydia pneumoniae (TWAR) infection in Tanzanian children
Q37888569Chlamydia pneumoniae (TWAR) infections in children.
Q37894824Chlamydia pneumoniae (TWAR)--a common cause of respiratory tract infections
Q35367697Chlamydia pneumoniae (TWAR).
Q37889646Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis
Q43433683Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis
Q37894361Chlamydia pneumoniae (strain TWAR) isolated from two symptom-free children during evaluation for possible sexual assault
Q43413871Chlamydia pneumoniae - causal pathogen or fortuitous witness of atherosclerosis progression?
Q37863667Chlamydia pneumoniae AP endonuclease IV could cleave AP sites of double- and single-stranded DNA.
Q37835726Chlamydia pneumoniae CPj0783 interaction with Huntingtin-protein14.
Q37838361Chlamydia pneumoniae Clinical Isolate from Gingival Crevicular Fluid: A Potential Atherogenic Strain
Q35193819Chlamydia pneumoniae CopD translocator protein plays a critical role in type III secretion (T3S) and infection
Q37877400Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection
Q37875681Chlamydia pneumoniae DNA in non-coronary atherosclerotic plaques and circulating leukocytes
Q37869411Chlamydia pneumoniae DNA in patients with symptomatic carotid atherosclerotic disease
Q37870489Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in dialysis patients, renal transplant recipients and healthy controls
Q28182623Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and patients with diabetes mellitus, acute coronary syndrome, stroke, and arterial hypertension
Q37874784Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in peritoneal dialysis patients.
Q37872267Chlamydia pneumoniae DNA in peripheral venous blood samples from patients with carotid artery stenosis
Q28215623Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease
Q37867438Chlamydia pneumoniae DNA is more frequent in advanced than in mild atherosclerosis lesions
Q37880091Chlamydia pneumoniae DNA is not detectable within sarcoidosis tissue
Q37855685Chlamydia pneumoniae DNA is present in peripheral blood mononuclear cells during acute coronary syndrome and correlates with chlamydial lipopolysaccharide levels in serum
Q37857945Chlamydia pneumoniae GroEL1 protein is cell surface associated and required for infection of HEp-2 cells
Q89224116Chlamydia pneumoniae Hijacks a Host Autoregulatory IL-1β Loop to Drive Foam Cell Formation and Accelerate Atherosclerosis
Q37856431Chlamydia pneumoniae IgA and elevated level of IL-6 may synergize to accelerate coronary artery disease
Q37866621Chlamydia pneumoniae IgA seropositivity and sudden sensorineural hearing loss.
Q37869611Chlamydia pneumoniae IgA seropositivity is associated with increased risk for atherosclerotic vascular disease, myocardial infarction and stroke in dialysis patients
Q43422316Chlamydia pneumoniae IgA titres and coronary heart disease: prospective study and meta-analysis
Q37872578Chlamydia pneumoniae IgA titres and coronary heart disease; prospective study and meta-analysis
Q37872308Chlamydia pneumoniae IgA- and IgG antibodies in young survivors of myocardial infarction. A comparison of antibody detection by a microimmunofluorescence test and an enzyme immunoassay
Q37853478Chlamydia pneumoniae IgG and IgA antibody titers and prognosis in patients with coronary heart disease: results from the CLARICOR trial
Q37865674Chlamydia pneumoniae IgG and the severity of coronary atherosclerosis
Q37889391Chlamydia pneumoniae IgG antibody prevalence in south-western and eastern Finland in 1982 and 1987.
Q37865887Chlamydia pneumoniae IgG serological status and venous thromboembolism: a cross-sectional hospital based study
Q37868358Chlamydia pneumoniae IgG seropositivity and clinical history of ischemic heart disease in Singapore
Q43426762Chlamydia pneumoniae IgG seropositivity and risk of deep-vein thrombosis.
Q43426220Chlamydia pneumoniae IgG seropositivity in deep-vein thrombosis
Q37346172Chlamydia pneumoniae IgG titres and coronary heart disease: prospective study and meta-analysis
Q37834265Chlamydia pneumoniae Induces Interferon Gamma Responses in Peripheral Blood Mononuclear Cells in Children with Allergic Asthma.
Q55038629Chlamydia pneumoniae Infection Exacerbates Atherosclerosis in ApoB100only/LDLR-/- Mouse Strain.
Q91243909Chlamydia pneumoniae Infection and Inflammatory Diseases
Q55503472Chlamydia pneumoniae Infection in Human Monocytes.
Q126784098Chlamydia pneumoniae Infections in an Immunocompetent Patient Compared With a Neutropenic Cancer Patient
Q89697993Chlamydia pneumoniae Influence on Cytokine Production in Steroid-Resistant and Steroid-Sensitive Asthmatics
Q92910713Chlamydia pneumoniae Polioencephalomyelitis and Ganglionitis in Captive Houston Toads (Anaxyrus houstonensis)
Q37868385Chlamydia pneumoniae accelerates coronary artery disease progression in transgenic hyperlipidemia-genetic hypertension rat model
Q37858896Chlamydia pneumoniae accompanied by inflammation is associated with the progression of atherosclerosis in CAPD patients: a prospective study for 3 years
Q37871324Chlamydia pneumoniae activates IKK/I kappa B-mediated signaling, which is inhibited by 4-HNE and following primary exposure
Q37868580Chlamydia pneumoniae activates epithelial cell proliferation via NF-kappaB and the glucocorticoid receptor
Q37876664Chlamydia pneumoniae activates nuclear factor kappaB and activator protein 1 in human vascular smooth muscle and induces cellular proliferation
Q37840234Chlamydia pneumoniae acute liver infection affects hepatic cholesterol and triglyceride metabolism in mice.
Q50284454Chlamydia pneumoniae adversely modulates vascular cell properties by direct interaction with signalling cascades.
Q37869704Chlamydia pneumoniae affect surfactant trafficking and secretion due to changes of type II cell cytoskeleton
Q33308923Chlamydia pneumoniae aggravates vein graft intimal hyperplasia in a rat model
Q37863456Chlamydia pneumoniae alters mildly oxidized low-density lipoprotein-induced cell death in human endothelial cells, leading to necrosis rather than apoptosis.
Q42718306Chlamydia pneumoniae and COPD exacerbation.
Q51726841Chlamydia pneumoniae and Cardiovascular Disease.
Q37841290Chlamydia pneumoniae and Chlamydia Trachomatis Infection Differentially Modulates Human Dendritic Cell Line (MUTZ) Differentiation and Activation.
Q37887835Chlamydia pneumoniae and Chronic Pharyngitis
Q37868723Chlamydia pneumoniae and Epstein-Barr antibodies are not associated with carotid thickness: the effect of hypertension
Q37840324Chlamydia pneumoniae and Helicobacter pylori IgG seropositivities are not predictors of osteoporosis-associated bone loss: a prospective cohort study
Q37882487Chlamydia pneumoniae and Helicobacter pylori infections in Sámi and Finnish reindeer herders.
Q37874751Chlamydia pneumoniae and Helicobacter pylori infections in acute myocardial infarction
Q36358387Chlamydia pneumoniae and Mycoplasma pneumoniae
Q37864424Chlamydia pneumoniae and Mycoplasma pneumoniae in calcified nodes of stenosed aortic valves
Q103034936Chlamydia pneumoniae and Mycoplasma pneumoniae in children with Cystic Fibrosis: impact on bacterial respiratory microbiota diversity
Q37876913Chlamydia pneumoniae and Mycoplasma pneumoniae in children with acute respiratory infection in general practices in The Netherlands
Q37864930Chlamydia pneumoniae and Mycoplasma pneumoniae in young children from China with community-acquired pneumonia
Q37878540Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia in children
Q37863465Chlamydia pneumoniae and Mycoplasma pneumoniae pneumonia: comparison of clinical, epidemiological characteristics and laboratory profiles
Q43421736Chlamydia pneumoniae and NAION
Q37856717Chlamydia pneumoniae and acute aortic syndrome: a call for a multi-institutional study.
Q43432114Chlamydia pneumoniae and acute arterial thrombotic disease
Q37870319Chlamydia pneumoniae and acute chest syndrome in patients with sickle cell disease
Q43419334Chlamydia pneumoniae and acute coronary syndrome
Q60178617Chlamydia pneumoniae and acute coronary syndrome
Q37882349Chlamydia pneumoniae and acute myocardial infarction in Jerusalem
Q37871351Chlamydia pneumoniae and acute respiratory tract infections in breast-feeding infants: simultaneous mother-child serological study in Niamey (Niger)
Q36735756Chlamydia pneumoniae and age-related macular degeneration: a role in pathogenesis or merely a chance association?
Q43418238Chlamydia pneumoniae and airway remodeling
Q33732232Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery disease
Q37869933Chlamydia pneumoniae and aortic aneurysms
Q37876934Chlamydia pneumoniae and arteriosclerosis
Q43428028Chlamydia pneumoniae and arteriosclerosis: an innocent onlooker?
Q35532326Chlamydia pneumoniae and asthma
Q37877265Chlamydia pneumoniae and asthma
Q42998006Chlamydia pneumoniae and asthma
Q43420431Chlamydia pneumoniae and asthma in children: diagnostic issues
Q43061266Chlamydia pneumoniae and asthma.
Q43421264Chlamydia pneumoniae and asthma: more than just exacerbations
Q37883619Chlamydia pneumoniae and asthmatic disease in adults: relations to be clarified
Q28237111Chlamydia pneumoniae and atherosclerosis
Q37877184Chlamydia pneumoniae and atherosclerosis
Q43430276Chlamydia pneumoniae and atherosclerosis
Q56829181Chlamydia pneumoniae and atherosclerosis
Q71406522Chlamydia pneumoniae and atherosclerosis
Q73161965Chlamydia pneumoniae and atherosclerosis
Q73178879Chlamydia pneumoniae and atherosclerosis
Q73256770Chlamydia pneumoniae and atherosclerosis
Q73311061Chlamydia pneumoniae and atherosclerosis
Q74181270Chlamydia pneumoniae and atherosclerosis
Q77552594Chlamydia pneumoniae and atherosclerosis
Q78627684Chlamydia pneumoniae and atherosclerosis
Q81576764Chlamydia pneumoniae and atherosclerosis
Q93931450Chlamydia pneumoniae and atherosclerosis
Q34572654Chlamydia pneumoniae and atherosclerosis -- what we know and what we don't
Q37868049Chlamydia pneumoniae and atherosclerosis following carotid endarterectomy.
Q37883725Chlamydia pneumoniae and atherosclerosis--an update.
Q37877643Chlamydia pneumoniae and atherosclerosis--the hen, the egg or five feathers?
Q33534714Chlamydia pneumoniae and atherosclerosis.
Q37876031Chlamydia pneumoniae and atherosclerosis. Identification of bacterial DNA in the arterial wall
Q37858402Chlamydia pneumoniae and atherosclerosis: The end?
Q33905858Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies
Q43414627Chlamydia pneumoniae and atherosclerosis: current state and future prospectives
Q34208034Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role?
Q36180789Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials
Q37877547Chlamydia pneumoniae and atherosclerosis: links to the disease process
Q35758705Chlamydia pneumoniae and atherosclerosis: no way-out or long way? What about renal failure patients?
Q43414252Chlamydia pneumoniae and atherosclerosis: the role of mast cells.
Q33822287Chlamydia pneumoniae and atherosclerosis: what we know and what we don't know
Q62279926Chlamydia pneumoniae and atherosclerotic cardiovascular disease
Q43431575Chlamydia pneumoniae and atherosclerotic plaque
Q33935019Chlamydia pneumoniae and atherosclerotic risk in populations: the role of seroepidemiology
Q74420646Chlamydia pneumoniae and cardiovascular disease
Q77729398Chlamydia pneumoniae and cardiovascular disease
Q34995266Chlamydia pneumoniae and cardiovascular disease.
Q33934999Chlamydia pneumoniae and cardiovascular disease: an evolutionary perspective on infectious causation and antibiotic treatment
Q35584450Chlamydia pneumoniae and cardiovascular disease: current status.
Q37866157Chlamydia pneumoniae and cardiovascular diseases
Q37885330Chlamydia pneumoniae and cardiovascular diseases
Q37874379Chlamydia pneumoniae and cerebrovascular disease
Q37873723Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation
Q35535328Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment
Q43414895Chlamydia pneumoniae and chronic diseases with a great impact on public health
Q37883738Chlamydia pneumoniae and chronic lung diseases
Q37876229Chlamydia pneumoniae and chronic obstructive pulmonary disease: bronchial biopsies (PCR and culture) and specific serum antibodies in patients and controls
Q34582500Chlamydia pneumoniae and chronic skin wounds: a focused review
Q43417953Chlamydia pneumoniae and coronary artery disease: controversial results of serological studies
Q35696285Chlamydia pneumoniae and coronary artery disease: legitimized linkages?
Q35083268Chlamydia pneumoniae and coronary artery disease: the antibiotic trials
Q33659387Chlamydia pneumoniae and coronary heart disease
Q57953474Chlamydia pneumoniae and coronary heart disease
Q37871787Chlamydia pneumoniae and cytomegalovirus in degenerative aortic valve stenoses
Q37873342Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
Q37880928Chlamydia pneumoniae and exacerbations of asthma in adults
Q37867881Chlamydia pneumoniae and future risk in patients with coronary heart disease
Q43426806Chlamydia pneumoniae and heart
Q37849596Chlamydia pneumoniae and helicobacter pylori serology - importance in patients with coronary heart disease
Q34130686Chlamydia pneumoniae and hyperlipidemia are co-risk factors for atherosclerosis: infection prior to induction of hyperlipidemia does not accelerate development of atherosclerotic lesions in C57BL/6J mice
Q43425347Chlamydia pneumoniae and its proposed link to multiple sclerosis: to be or not to be?
Q43425888Chlamydia pneumoniae and its relation with human atherosclerosis
Q37881193Chlamydia pneumoniae and its role in chronic obstructive pulmonary disease
Q43427310Chlamydia pneumoniae and lipoprotein(a): the right combination for atherosclerosis?
Q37873867Chlamydia pneumoniae and luminal narrowing after coronary angioplasty
Q34410654Chlamydia pneumoniae and lung cancer: epidemiologic evidence
Q43413271Chlamydia pneumoniae and metabolic syndrome
Q37870129Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis
Q43425292Chlamydia pneumoniae and multiple sclerosis: innocent bystander or culprit?
Q37874491Chlamydia pneumoniae and multiple sclerosis: no significant association
Q37870043Chlamydia pneumoniae and multiple sclerosis: the latest etiologic candidate
Q37872646Chlamydia pneumoniae and myocardial infarct? (Serologic study)
Q37874627Chlamydia pneumoniae and myocardial infarction (CLINF). Preliminary randomized controlled study with clarithromycin. CLAINF protocol
Q37883727Chlamydia pneumoniae and myocarditis.
Q37867013Chlamydia pneumoniae and newly diagnosed asthma: a case-control study in 1 to 6-year-old children
Q37880994Chlamydia pneumoniae and occlusive vascular disease: identification and characterization
Q37847655Chlamydia pneumoniae and osteoporosis-associated bone loss: a new risk factor?
Q37879665Chlamydia pneumoniae and other Chlamydia species in community-acquired pneumonia
Q33935014Chlamydia pneumoniae and other risk factors for atherosclerosis
Q27009367Chlamydia pneumoniae and oxidative stress in cardiovascular disease: state of the art and prevention strategies
Q37879684Chlamydia pneumoniae and possible relationship to asthma. Serum immunoglobulins and histamine release in patients and controls.
Q37847433Chlamydia pneumoniae and progression of subclinical atherosclerosis
Q32061763Chlamydia pneumoniae and respiratory pathology. Epidemiological data
Q37874740Chlamydia pneumoniae and screening for tubal factor subfertility
Q34116681Chlamydia pneumoniae and severity of asthma
Q37854372Chlamydia pneumoniae and stroke: is there a direct relationship?
Q37859300Chlamydia pneumoniae and symptomatic carotid atherosclerotic plaque: a prospective study
Q43422992Chlamydia pneumoniae and the "Dutch Hypothesis".
Q35042320Chlamydia pneumoniae and the heart: impact of diagnostic methods.
Q34128399Chlamydia pneumoniae and the lung
Q37868000Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients
Q37876105Chlamydia pneumoniae and the risk of first ischemic stroke : The Northern Manhattan Stroke Study
Q37865774Chlamydia pneumoniae and the risk of ischaemic heart disease. Prevalence in a group of hospitalized elderly men
Q37844710Chlamydia pneumoniae and typical bacteria occurrence in adenoid in children qualified for adenoidectomy
Q37880177Chlamydia pneumoniae and vascular disease
Q34536607Chlamydia pneumoniae and vascular disease: an update
Q43425842Chlamydia pneumoniae and vascular pathology
Q55311657Chlamydia pneumoniae antibodies and C-reactive protein levels in patients with abdominal aortic aneurysms.
Q43426672Chlamydia pneumoniae antibodies and adult-onset asthma
Q37875315Chlamydia pneumoniae antibodies and angiographically demonstrated coronary artery disease in Thailand
Q37878044Chlamydia pneumoniae antibodies and angiographically demonstrated coronary artery disease in a sample population from Italy.
Q37869682Chlamydia pneumoniae antibodies and endothelial function as assessed by flow-mediated dilation in patients with chest pain with and without ischemic heart disease
Q37877684Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in Northern Sweden
Q37866124Chlamydia pneumoniae antibodies and inflammatory reaction in patients with ischemic heart disease.
Q37862706Chlamydia pneumoniae antibodies and markers of inflammation in patients with cardiovascular diseases
Q37869958Chlamydia pneumoniae antibodies and other atherosclerosis risk factors in haemodialysed patients. Preliminary report
Q36244426Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study
Q35370873Chlamydia pneumoniae antibodies are associated with an atherogenic lipid profile
Q37878800Chlamydia pneumoniae antibodies associated with altered serum lipid profile
Q37884929Chlamydia pneumoniae antibodies in chronic obstructive pulmonary disease
Q43430166Chlamydia pneumoniae antibodies in myalgia of unknown cause (including fibromyalgia)
Q37881616Chlamydia pneumoniae antibodies in severe essential hypertension
Q37857236Chlamydia pneumoniae antibodies in various subtypes of ischemic stroke in Indian patients
Q77330455Chlamydia pneumoniae antibodies may predict fatal heart disease
Q37862130Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods
Q37881662Chlamydia pneumoniae antibody response in patients with acute myocardial infarction and their follow-up
Q37859213Chlamydia pneumoniae antibody titers and cardiac calcifications: a cross-sectional serological-echocardiographic correlative study.
Q34457169Chlamydia pneumoniae antibody titers are significantly associated with acute stroke and transient cerebral ischemia: the West Birmingham Stroke Project
Q37874292Chlamydia pneumoniae antibody titers in patients with acute ischemic stroke
Q37870864Chlamydia pneumoniae antigens facilitate experimental aortic dilatation: prevention with azithromycin
Q35395485Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions
Q37864940Chlamydia pneumoniae arthritis in a patient with common variable immunodeficiency.
Q31153517Chlamydia pneumoniae as a biological factor contributing to pathological changes of arterial walls in patients with atherosclerosis
Q37878569Chlamydia pneumoniae as a causative agent in atherosclerosis
Q37884890Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin
Q43433738Chlamydia pneumoniae as a cause of reactive arthritis
Q37882995Chlamydia pneumoniae as a new source of infectious outbreaks in nursing homes
Q43420946Chlamydia pneumoniae as a pathogenetic risk factor in the development of arteriosclerosis and its complications
Q34542090Chlamydia pneumoniae as a respiratory pathogen
Q43428017Chlamydia pneumoniae as a trigger of reactive arthritis
Q37878245Chlamydia pneumoniae as a triggering infection in reactive arthritis
Q35013298Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease
Q37883696Chlamydia pneumoniae as an etiologic agent in severe pneumonias
Q37881602Chlamydia pneumoniae as an etiologic factor in disease of the respiratory tract
Q43419946Chlamydia pneumoniae as risk factor of cardiovascular disease in dialysis patients.
Q37885952Chlamydia pneumoniae associated with central nervous system infections
Q33883485Chlamydia pneumoniae augments the oxidized low-density lipoprotein-induced death of mouse macrophages by a caspase-independent pathway
Q37869092Chlamydia pneumoniae binds to platelets and triggers P-selectin expression and aggregation: a causal role in cardiovascular disease?
Q37850239Chlamydia pneumoniae binds to the lectin-like oxidized LDL receptor for infection of endothelial cells
Q37863789Chlamydia pneumoniae burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum
Q37879204Chlamydia pneumoniae but not cytomegalovirus antibodies are associated with future risk of stroke and cardiovascular disease: a prospective study in middle-aged to elderly men with treated hypertension
Q37867858Chlamydia pneumoniae carriage and infection in hospitalized children with respiratory tract diseases
Q37879761Chlamydia pneumoniae chronic infection in the development of arteriosclerosis
Q37885417Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients
Q37866728Chlamydia pneumoniae decreases smooth muscle cell proliferation through induction of prostaglandin E2 synthesis
Q37876375Chlamydia pneumoniae detection in atherosclerotic plaques in Italy
Q37859832Chlamydia pneumoniae directly interferes with HIF-1alpha stabilization in human host cells.
Q37844231Chlamydia pneumoniae disrupts lipid metabolism in human umbilical vein endothelial cells
Q37852303Chlamydia pneumoniae disturbs cholesterol homeostasis in human THP-1 macrophages via JNK-PPARγ dependent signal transduction pathways
Q37874405Chlamydia pneumoniae does not increase atherosclerosis in the aortic root of apolipoprotein E-deficient mice
Q37877209Chlamydia pneumoniae does not influence atherosclerotic plaque behavior in patients with established carotid artery stenosis
Q30389751Chlamydia pneumoniae effector chlamydial outer protein N sequesters fructose bisphosphate aldolase A, providing a benefit to bacterial growth
Q37240380Chlamydia pneumoniae elementary body antigenic reactivity with fluorescent antibody is destroyed by methanol
Q34066394Chlamydia pneumoniae encodes a functional aromatic amino acid hydroxylase
Q91474035Chlamydia pneumoniae enhances Interleukin 8 (IL-8) production with reduced azithromycin sensitivity under hypoxia
Q33556766Chlamydia pneumoniae enhances cytokine-stimulated human monocyte matrix metalloproteinases through a prostaglandin E2-dependent mechanism
Q37837295Chlamydia pneumoniae enhances the Th2 profile of stimulated peripheral blood mononuclear cells from asthmatic patients
Q37849602Chlamydia pneumoniae entry into epithelial cells by clathrin-independent endocytosis
Q37877463Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study
Q28362988Chlamydia pneumoniae exacerbates aortic inflammatory foci caused by murine cytomegalovirus infection in normocholesterolemic mice
Q44059235Chlamydia pneumoniae exploits adipocyte lipid chaperone FABP4 to facilitate fat mobilization and intracellular growth in murine adipocytes.
Q37873779Chlamydia pneumoniae exposure and inflammatory markers in acute coronary syndrome (CIMACS).
Q34008875Chlamydia pneumoniae expresses genes required for DNA replication but not cytokinesis during persistent infection of HEp-2 cells
Q37874547Chlamydia pneumoniae facilitates monocyte adhesion to endothelial and smooth muscle cells
Q37864525Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8+ T cell epitopes recognized by infection-primed T cells.
Q36703071Chlamydia pneumoniae growth inhibition in cells by the steroid receptor antagonist RU486 (mifepristone).
Q37863610Chlamydia pneumoniae growth inhibition in human monocytic THP-1 cells and human epithelial HEp-2 cells by a novel phenoxazine derivative
Q37843635Chlamydia pneumoniae harness host NLRP3 inflammasome-mediated caspase-1 activation for optimal intracellular growth in murine macrophages
Q37851643Chlamydia pneumoniae heat shock protein 60 enhances expression of ERK, TLR-4 and IL-8 in atheromatous plaques of coronary artery disease patients
Q37850283Chlamydia pneumoniae heat shock protein 60 is associated with apoptotic signaling pathway in human atheromatous plaques of coronary artery disease patients
Q33472674Chlamydia pneumoniae hides inside apoptotic neutrophils to silently infect and propagate in macrophages
Q37870908Chlamydia pneumoniae immunoglobulin A reactivation and airway inflammation in acute asthma
Q90095318Chlamydia pneumoniae immunoglobulin E antibody levels in patients with asthma compared with non-asthma
Q37863793Chlamydia pneumoniae immunoreactivity in coronary artery plaques of patients with acute coronary syndromes and its relation with serology
Q36585704Chlamydia pneumoniae impairs the innate immune response in infected epithelial cells by targeting TRAF3
Q37866528Chlamydia pneumoniae in HIV-infected patients and controls assessed by a novel whole blood interferon-gamma assay, serology and PCR.
Q37865541Chlamydia pneumoniae in PBMC: reproducibility of the OMPA nested touchdown PCR.
Q37891935Chlamydia pneumoniae in Swedish patients
Q37878264Chlamydia pneumoniae in a free-ranging giant barred frog (Mixophyes iteratus) from Australia.
Q37877432Chlamydia pneumoniae in abdominal aortic aneurysms: abundance of membrane components in the absence of heat shock protein 60 and DNA.
Q37882035Chlamydia pneumoniae in acute otitis media
Q37863827Chlamydia pneumoniae in an ex vivo human artery culture model
Q37881991Chlamydia pneumoniae in arteries: a tale of the unexpected
Q33588103Chlamydia pneumoniae in arteries: the facts, their interpretation, and future studies
Q37862638Chlamydia pneumoniae in asymptomatic carotid atherosclerosis.
Q37228857Chlamydia pneumoniae in atheroma: consideration of criteria for causality
Q33890410Chlamydia pneumoniae in atherosclerosis
Q37876378Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic tissue
Q37874015Chlamydia pneumoniae in atherosclerotic carotid artery plaques: high prevalence among heavy smokers.
Q37871650Chlamydia pneumoniae in atherosclerotic lesions of patients undergoing vascular surgery
Q37873484Chlamydia pneumoniae in atherosclerotic middle cerebral artery
Q33935024Chlamydia pneumoniae in atherosclerotic tissue
Q37870664Chlamydia pneumoniae in carotid artery atherosclerosis: a comparison of its presence in atherosclerotic plaque, healthy vessels, and circulating leukocytes from the same individuals.
Q37870574Chlamydia pneumoniae in central retinal artery occlusion
Q37880658Chlamydia pneumoniae in children attending day-care centers in Gävle, Sweden
Q37874692Chlamydia pneumoniae in children undergoing adenoidectomy.
Q37869076Chlamydia pneumoniae in children with MS: frequency and quantity of intrathecal antibodies
Q37881390Chlamydia pneumoniae in children with acute respiratory tract infections
Q37881894Chlamydia pneumoniae in children with otitis media.
Q37874519Chlamydia pneumoniae in community-acquired pneumonia.
Q37871021Chlamydia pneumoniae in community-acquired pneumonia: seven years of experience.
Q37879945Chlamydia pneumoniae in coronary and iliac arteries of Japanese patients with atherosclerotic cardiovascular diseases
Q43427298Chlamydia pneumoniae in coronary artery disease
Q44028702Chlamydia pneumoniae in coronary artery disease
Q43412635Chlamydia pneumoniae in coronary atherosclerotic plaques and coronary instability
Q37866240Chlamydia pneumoniae in coronary bypass grafts of redo patients. The concept of the 'adventitial baseline infection'.
Q37878503Chlamydia pneumoniae in coronary plaques: Increased detection with acute coronary syndrome
Q37872492Chlamydia pneumoniae in different coronary artery segments in the young
Q37870539Chlamydia pneumoniae in elderly patients with stroke (C-PEPS): a case-control study on the seroprevalence of Chlamydia pneumoniae in elderly patients with acute cerebrovascular disease
Q37863621Chlamydia pneumoniae in foci of "early" calcification of the tunica media in arteriosclerotic arteries: an incidental presence?
Q37881211Chlamydia pneumoniae in human abdominal aortic aneurysms
Q35586029Chlamydia pneumoniae in infrequently examined blood vessels
Q37874332Chlamydia pneumoniae in multiple sclerosis: humoral immune responses in serum and cerebrospinal fluid and correlation with disease activity marker
Q37861614Chlamydia pneumoniae in otorhinolaryngological infection
Q37869930Chlamydia pneumoniae in patients undergoing surgery for thoracic aortic disease
Q37878330Chlamydia pneumoniae in patients with acquired pneumonia in the Santiago of Chile community
Q37868011Chlamydia pneumoniae in patients with atherosclerotic ischemia of the lower limbs
Q42863714Chlamydia pneumoniae in peripheral blood mononuclear cells isolated from individuals younger than 20 years or older than 60 years
Q43428010Chlamydia pneumoniae in redo and first-time coronary artery bypass graft surgery
Q37845113Chlamydia pneumoniae in the atherosclerotic plaques of coronary artery disease patients
Q37868662Chlamydia pneumoniae in the atherosclerotic plaques of patients with unstable angina undergoing coronary artery bypass grafting: does it have prognostic implications?
Q37872756Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis and neurological controls
Q37854537Chlamydia pneumoniae in the etiology of the keratoconjunctivitis sicca in adult patients (a pilot study)
Q43429089Chlamydia pneumoniae in the female genital tract
Q37879489Chlamydia pneumoniae in vascular tissue
Q43429587Chlamydia pneumoniae in vascular tissues from heart-transplant donors
Q35395532Chlamydia pneumoniae in vitro and in vivo: a critical evaluation of in situ detection methods
Q41993419Chlamydia pneumoniae inclusion membrane protein Cpn0147 interacts with host protein CREB3
Q28251473Chlamydia pneumoniae inclusion membrane protein Cpn0585 interacts with multiple Rab GTPases
Q37867591Chlamydia pneumoniae induces Alzheimer-like amyloid plaques in brains of BALB/c mice
Q37854176Chlamydia pneumoniae induces T cell apoptosis through glutathione redox imbalance and secretion of TNF-alpha
Q37854249Chlamydia pneumoniae induces THP-1-derived foam cell formation by up-regulating the expression of acyl-coenzyme A: cholesterol acyltransferase 1
Q37849579Chlamydia pneumoniae induces a pro-inflammatory phenotype in murine vascular smooth muscle cells independently of elevating reactive oxygen species
Q24798576Chlamydia pneumoniae induces aponecrosis in human aortic smooth muscle cells
Q37850586Chlamydia pneumoniae induces chemokine expression by platelets in patients with atherosclerosis
Q37412127Chlamydia pneumoniae induces expression of pro-atherogenic factors through activation of the lectin-like oxidized LDL receptor-1
Q34007947Chlamydia pneumoniae induces inflammatory changes in the heart and aorta of normocholesterolemic C57BL/6J mice
Q37875553Chlamydia pneumoniae induces interleukin-10 production that down-regulates major histocompatibility complex class I expression.
Q37835221Chlamydia pneumoniae induces interleukin-12 responses in peripheral blood mononuclear cells in asthma and the role of toll like receptor 2 versus 4: a pilot study
Q37856118Chlamydia pneumoniae induces interleukin-6 and interleukin-10 in human gingival fibroblasts.
Q37856080Chlamydia pneumoniae induces macrophage-derived foam cell formation by up-regulating acyl-coenzyme A: cholesterol acyltransferase 1.
Q24311609Chlamydia pneumoniae induces macrophage-derived foam cell formation via PPAR alpha and PPAR gamma-dependent pathways
Q37869992Chlamydia pneumoniae induces neointima formation in coronary arteries of normal pigs
Q53660409Chlamydia pneumoniae induces nitric oxide synthase and lipoxygenase-dependent production of reactive oxygen species in platelets. Effects on oxidation of low density lipoproteins.
Q37867963Chlamydia pneumoniae induces the expression of inhibitor of apoptosis 2 (c-IAP2) in a human monocytic cell line by an NF-kappaB-dependent pathway
Q37870068Chlamydia pneumoniae induces tissue factor expression in mouse macrophages via activation of Egr-1 and the MEK-ERK1/2 pathway
Q37865222Chlamydia pneumoniae infected macrophages exhibit enhanced plasma membrane fluidity and show increased adherence to endothelial cells
Q37873686Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice
Q37878302Chlamydia pneumoniae infection accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice
Q36780378Chlamydia pneumoniae infection acts as an endothelial stressor with the potential to initiate the earliest heat shock protein 60-dependent inflammatory stage of atherosclerosis
Q127247439Chlamydia pneumoniae infection affects the effect of lipid-lowering drug on carotid atherosclerosis
Q37865528Chlamydia pneumoniae infection after lung transplantation.
Q37870583Chlamydia pneumoniae infection alters the junctional complex proteins of human brain microvascular endothelial cells
Q37871739Chlamydia pneumoniae infection among healthy children and children hospitalised with pneumonia in Greece
Q37743247Chlamydia pneumoniae infection and Alzheimer's disease: a connection to remember?
Q43417606Chlamydia pneumoniae infection and MPO-ANCA-associated glomerulonephritis
Q37877131Chlamydia pneumoniae infection and Mycoplasma pneumoniae infection in pediatric patients
Q43426387Chlamydia pneumoniae infection and PFO-associated ischemic stroke
Q37872931Chlamydia pneumoniae infection and accelerated development of coronary artery disease in patients with chronic renal failure
Q37873250Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD).
Q37872256Chlamydia pneumoniae infection and arteriosclerosis
Q43435152Chlamydia pneumoniae infection and asthma
Q37877788Chlamydia pneumoniae infection and atherosclerosis
Q43424105Chlamydia pneumoniae infection and atherosclerosis: methodological considerations.
Q37878342Chlamydia pneumoniae infection and atherosclerotic coronary disease
Q37879253Chlamydia pneumoniae infection and cardiac ischemic syndromes
Q35945225Chlamydia pneumoniae infection and cardiac risk factors in patients with myocardial infection.
Q37844796Chlamydia pneumoniae infection and cerebral infarction risk: a meta-analysis
Q26859186Chlamydia pneumoniae infection and cerebrovascular disease: a systematic review and meta-analysis
Q43427803Chlamydia pneumoniae infection and coronary artery disease
Q42786795Chlamydia pneumoniae infection and coronary heart disease. Other infections might have role in South Asians.
Q42786775Chlamydia pneumoniae infection and coronary heart disease. Role of C pneumoniae in pathogenesis of atherosclerosis must be determined
Q42786761Chlamydia pneumoniae infection and coronary heart disease. Trials should assess whether antibiotics eliminate organism from atherosclerotic lesions
Q37877895Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis
Q37878142Chlamydia pneumoniae infection and ethnic origin
Q37857508Chlamydia pneumoniae infection and hyperlipidaemia-induced expression of P50 and c-Fos in the heart of C57BL6J mice
Q37878104Chlamydia pneumoniae infection and incident coronary heart disease: the Atherosclerosis Risk in Communities Study
Q37867540Chlamydia pneumoniae infection and inflammation in adults with asthma
Q37862833Chlamydia pneumoniae infection and ischemic heart disease in hemodialysis patients
Q37873843Chlamydia pneumoniae infection and its association with coronary heart disease and cardiovascular risk factors in a sample South Asian population
Q34951727Chlamydia pneumoniae infection and its role in asthma and chronic obstructive pulmonary disease
Q34157076Chlamydia pneumoniae infection and lung cancer risk: a meta-analysis
Q37876040Chlamydia pneumoniae infection and mortality from ischaemic heart disease: large prospective study
Q37871402Chlamydia pneumoniae infection and multiple sclerosis
Q37871996Chlamydia pneumoniae infection and nonspecific aortoarteritis: search for a link with a nonatherosclerotic inflammatory arterial disease
Q37869302Chlamydia pneumoniae infection and restenosis in patients with coronary heart disease
Q37852996Chlamydia pneumoniae infection and risk for lung cancer
Q37866340Chlamydia pneumoniae infection and risk of lung cancer.
Q37859944Chlamydia pneumoniae infection and stroke
Q43421745Chlamydia pneumoniae infection and the risk of female early-onset lung cancer
Q34556018Chlamydia pneumoniae infection and the risk of multiple sclerosis: a meta-analysis
Q37852381Chlamydia pneumoniae infection as a risk factor for accelerated atherosclerosis in hemodialysis patients.
Q37865525Chlamydia pneumoniae infection as a risk factor for subarachnoid hemorrhage
Q37889936Chlamydia pneumoniae infection as a risk factor in acute myocardial infarction.
Q37864797Chlamydia pneumoniae infection as a trigger for a Cogan's syndrome
Q43412034Chlamydia pneumoniae infection associated to acute fibrinous and organizing pneumonia
Q37885115Chlamydia pneumoniae infection associated with autoimmune hemolytic anemia due to warm antibodies
Q37871138Chlamydia pneumoniae infection associated with enhanced MRI spinal lesions in multiple sclerosis
Q37878919Chlamydia pneumoniae infection associated with multi-organ failure and fatal outcome in a previously healthy patient
Q37848689Chlamydia pneumoniae infection associated with uncontrolled asthma: a hospital based cross sectional study
Q37874064Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice
Q43426027Chlamydia pneumoniae infection during an influenza virus A epidemic: preliminary report
Q34481798Chlamydia pneumoniae infection enhances cellular proliferation and reduces steroid responsiveness of human peripheral blood mononuclear cells via a tumor necrosis factor-alpha-dependent pathway
Q37862016Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells
Q37856171Chlamydia pneumoniae infection enhances microglial activation in atherosclerotic mice
Q37865648Chlamydia pneumoniae infection in HIV-positive patients: prevalence and relationship with lipid profile.
Q37857551Chlamydia pneumoniae infection in IL-10 knock out mice: accelerated clearance but severe pulmonary inflammatory response
Q37887111Chlamydia pneumoniae infection in Italian patients
Q81265970Chlamydia pneumoniae infection in Slovenian patients with diffuse coronary artery disease
Q37886937Chlamydia pneumoniae infection in Thai children: serological diagnosis.
Q37093889Chlamydia pneumoniae infection in a breeding colony of African clawed frogs (Xenopus tropicalis).
Q37881846Chlamydia pneumoniae infection in a family
Q37865326Chlamydia pneumoniae infection in abdominal aortic aneurysm (AAA) patients and its clinical impact.
Q37891841Chlamydia pneumoniae infection in acute exacerbations of COPD.
Q37872934Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: analysis of 250 hospitalizations
Q37848337Chlamydia pneumoniae infection in adolescents with type 1 diabetes mellitus.
Q37869961Chlamydia pneumoniae infection in adult patients with persistent cough
Q37875905Chlamydia pneumoniae infection in adults with chronic cough compared with healthy blood donors
Q37865458Chlamydia pneumoniae infection in asthmatic patients
Q37846181Chlamydia pneumoniae infection in atherosclerotic lesion development through oxidative stress: a brief overview
Q37879993Chlamydia pneumoniae infection in children with asthma exacerbation
Q37887865Chlamydia pneumoniae infection in children with lower respiratory tract infections
Q43102311Chlamydia pneumoniae infection in children with persistent cough
Q31829380Chlamydia pneumoniae infection in circulating human monocytes is refractory to antibiotic treatment
Q37876577Chlamydia pneumoniae infection in community-acquired pneumonia in Taiwan
Q34000720Chlamydia pneumoniae infection in human monocytes
Q35035253Chlamydia pneumoniae infection in mice induces chronic lung inflammation, iBALT formation, and fibrosis
Q37855399Chlamydia pneumoniae infection in patients after kidney transplantation treated with spiramycin.
Q101388462Chlamydia pneumoniae infection in patients hospitalised for community-acquired pneumonia in Southern Jordan
Q37876266Chlamydia pneumoniae infection in patients with acute bronchitis and bronchial asthma
Q37867053Chlamydia pneumoniae infection in patients with acute coronary syndrome: a clinical and serological 1-year follow-up.
Q37865567Chlamydia pneumoniae infection in patients with advanced carotid atherosclerosis
Q37872766Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease
Q24644991Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease
Q37885100Chlamydia pneumoniae infection in patients with cystic fibrosis
Q37879921Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD.
Q37880257Chlamydia pneumoniae infection in patients with myocardial infarct and angina pectoris
Q37886945Chlamydia pneumoniae infection in patients with pneumonia, bronchitis and acute upper respiratory tract infection in Beijing
Q33877198Chlamydia pneumoniae infection in polarized epithelial cell lines
Q37852414Chlamydia pneumoniae infection in preeclampsia
Q37867152Chlamydia pneumoniae infection in young stroke patients: a case--control study
Q24641977Chlamydia pneumoniae infection increases adherence of mouse macrophages to mouse endothelial cells in vitro and to aortas ex vivo
Q37865398Chlamydia pneumoniae infection increases the risk of coronary artery disease in the patients with dyslipidemia
Q33939577Chlamydia pneumoniae infection induced allergic airway sensitization is controlled by regulatory T-cells and plasmacytoid dendritic cells
Q37869175Chlamydia pneumoniae infection induces an unstable atherosclerotic plaque phenotype in LDL-receptor, ApoE double knockout mice
Q37872148Chlamydia pneumoniae infection induces differentiation of monocytes into macrophages
Q35559048Chlamydia pneumoniae infection induces inflammatory changes in the aortas of rabbits.
Q37845512Chlamydia pneumoniae infection induces vascular smooth muscle cell migration via Rac1 activation
Q43419797Chlamydia pneumoniae infection is an unlikely cause of primary biliary cirrhosis
Q60699536Chlamydia pneumoniae infection is associated with HLA-B⁎35 in patients with coronary artery disease
Q37867103Chlamydia pneumoniae infection is associated with coronary artery disease but not implicated in inducing plaque instability
Q37853903Chlamydia pneumoniae infection is associated with elevated body mass index in young men.
Q37879407Chlamydia pneumoniae infection is frequent but not associated with coronary arteriosclerosis in cardiac transplant recipients
Q33928612Chlamydia pneumoniae infection is not an independent risk factor for arterial disease
Q37860476Chlamydia pneumoniae infection is not associated with chronic transplant dysfunction in a rat aortic allograft model
Q37871830Chlamydia pneumoniae infection is not involved in carotid artery stenosis
Q37869783Chlamydia pneumoniae infection of alveolar macrophages: a model
Q37859141Chlamydia pneumoniae infection of aortic smooth muscle cells reduces platelet-derived growth factor receptor-beta expression
Q37862494Chlamydia pneumoniae infection of brain cells: an in vitro study
Q37871910Chlamydia pneumoniae infection of endothelial cells induces transcriptional activation of platelet-derived growth factor-B: a potential link to intimal thickening in a rabbit model of atherosclerosis
Q37878378Chlamydia pneumoniae infection of human endothelial cells induces proliferation of smooth muscle cells via an endothelial cell-derived soluble factor(s).
Q37844344Chlamydia pneumoniae infection of lungs and macrophages indirectly stimulates the phenotypic conversion of smooth muscle cells and mesenchymal stem cells: potential roles in vascular calcification and fibrosis
Q37862086Chlamydia pneumoniae infection of microglial cells in vitro: a model of microbial infection for neurological disease
Q37842499Chlamydia pneumoniae infection of monocytes in vitro stimulates innate and adaptive immune responses relevant to those in Alzheimer's disease
Q34260373Chlamydia pneumoniae infection of the central nervous system
Q33867663Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis
Q36376620Chlamydia pneumoniae infection of the central nervous system worsens experimental allergic encephalitis
Q37877720Chlamydia pneumoniae infection of vascular smooth muscle and endothelial cells activates NF-kappaB and induces tissue factor and PAI-1 expression: a potential link to accelerated arteriosclerosis
Q37863853Chlamydia pneumoniae infection predicts a reduced risk for subsequent atopic disease
Q84618381Chlamydia pneumoniae infection presenting with angioedema in an adolescent
Q33927267Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo
Q49808551Chlamydia pneumoniae infection promotes monocyte transendothelial migration by increasing vascular endothelial cell permeability via the tyrosine phosphorylation of VE-cadherin
Q37870146Chlamydia pneumoniae infection promotes the transmigration of monocytes through human brain endothelial cells
Q37834498Chlamydia pneumoniae infection promotes vascular endothelial cell angiogenesis through an IQGAP1-related signaling pathway
Q37336070Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration through a Toll-like receptor 2-related signaling pathway
Q93169095Chlamydia pneumoniae infection promotes vascular smooth muscle cell migration via c-Fos/interleukin-17C signaling
Q37867366Chlamydia pneumoniae infection related atherosclerotic clinical variables on carotid stenosis
Q37857039Chlamydia pneumoniae infection results in generalized bone loss in mice.
Q37874834Chlamydia pneumoniae infection significantly exacerbates aortic atherosclerosis in an LDLR-/- mouse model within six months.
Q37853142Chlamydia pneumoniae infection suppresses Staphylococcus enterotoxin B-induced proliferation associated with down-expression of CD25 in lymphocytes
Q37853504Chlamydia pneumoniae infection was associated with risk of mortality from coronary heart disease in Japanese women but not men: the JACC Study.
Q37353309Chlamydia pneumoniae infection, complement factor H variants and age-related macular degeneration
Q37846128Chlamydia pneumoniae infection-associated erythema multiforme
Q93011416Chlamydia pneumoniae infection-induced endoplasmic reticulum stress causes fatty acid-binding protein 4 secretion in murine adipocytes
Q37851268Chlamydia pneumoniae infection-related hemophagocytic lymphohistiocytosis and acute encephalitis and poliomyelitis-like flaccid paralysis
Q37862830Chlamydia pneumoniae infection: an additional factor for chronic allograft rejection
Q43431103Chlamydia pneumoniae infection: an uncommon cause of rhabdomyolysis
Q43423121Chlamydia pneumoniae infection: which role in atherosclerosis?
Q37861218Chlamydia pneumoniae infections
Q37862759Chlamydia pneumoniae infections augment atherosclerotic lesion formation: a role for serum amyloid P.
Q37882214Chlamydia pneumoniae infections in Norway
Q37895606Chlamydia pneumoniae infections in Norway 1981-87 earlier diagnosed as ornithosis
Q35627745Chlamydia pneumoniae infections in asthma: clinical implications.
Q36003606Chlamydia pneumoniae infections in mouse models: relevance for atherosclerosis research
Q37871890Chlamydia pneumoniae infections in patients with community-acquired pneumonia in Slovenia.
Q37870988Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line
Q60634822Chlamydia pneumoniae infections prevent the programmed cell death on THP-1 cell line
Q37871406Chlamydia pneumoniae infections--diagnostic methods
Q43434453Chlamydia pneumoniae infections.
Q34009858Chlamydia pneumoniae infects and multiplies in lymphocytes in vitro
Q36108530Chlamydia pneumoniae inhibits activated human T lymphocyte proliferation by the induction of apoptotic and pyroptotic pathways
Q37872097Chlamydia pneumoniae inhibits apoptosis in human epithelial and monocyte cell lines
Q37876614Chlamydia pneumoniae inhibits apoptosis in human peripheral blood mononuclear cells through induction of IL-10.
Q43423075Chlamydia pneumoniae inside the atherosclerotic plaque--does it affect plaque inflammation and plaque progression?
Q37858986Chlamydia pneumoniae is a likely risk factor for ischemic stroke in young patients
Q37881308Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not.
Q37877800Chlamydia pneumoniae is an important cause of community-acquired pneumonia in school-aged children: serological results of a prospective, population-based study
Q37874645Chlamydia pneumoniae is associated with graft dysfunction after lung transplantation
Q43412476Chlamydia pneumoniae is frequently detected in the blood after acute lung infection
Q27314770Chlamydia pneumoniae is genetically diverse in animals and appears to have crossed the host barrier to humans on (at least) two occasions
Q37862257Chlamydia pneumoniae is not detectable in subretinal neovascular membranes in the exudative stage of age-related macular degeneration.
Q34007275Chlamydia pneumoniae major outer membrane protein is a surface-exposed antigen that elicits antibodies primarily directed against conformation-dependent determinants
Q37877665Chlamydia pneumoniae may be associated with lung cancer. Preliminary report on a seroepidemiological study.
Q43429477Chlamydia pneumoniae may cause respiratory distress syndrome.
Q37847636Chlamydia pneumoniae modulates human monocyte-derived dendritic cells functions driving the induction of a Type 1/Type 17 inflammatory response.
Q99730797Chlamydia pneumoniae mucositis syndrome
Q37889130Chlamydia pneumoniae multiplies in human endothelial cells in vitro
Q37867863Chlamydia pneumoniae multiply in neutrophil granulocytes and delay their spontaneous apoptosis
Q43432236Chlamydia pneumoniae myocarditis
Q37844121Chlamydia pneumoniae negatively regulates ABCA1 expression via TLR2-Nuclear factor-kappa B and miR-33 pathways in THP-1 macrophage-derived foam cells
Q37876682Chlamydia pneumoniae not detected in temporal artery biopsies from patients with temporal arteritis
Q37860239Chlamydia pneumoniae occurrence in children with adenoid vegetations
Q43423309Chlamydia pneumoniae pathogenesis
Q37844025Chlamydia pneumoniae persistent infection is associated with primary IgA nephropathy
Q37864218Chlamydia pneumoniae pneumonia
Q37875342Chlamydia pneumoniae pneumonia
Q43428182Chlamydia pneumoniae pneumonia
Q37863960Chlamydia pneumoniae pneumonia and Mycoplasma pneumoniae pneumonia: comparison of clinical findings and CT findings
Q37884686Chlamydia pneumoniae pneumonia in hospitalized patients. Clinical characteristics and diagnostic value of polymerase chain reaction detection in BAL.
Q37882840Chlamydia pneumoniae pneumonia in hospitalized patients. Clinical characteristics and diagnostic value of polymerase chain reaction detection in bronchoalveolar lavage
Q43430823Chlamydia pneumoniae pneumonia with acute hemorrhagic pericarditis in patient with acute leukemia.
Q43432507Chlamydia pneumoniae pneumonia with endocarditis
Q37894340Chlamydia pneumoniae pneumonia with pleural effusion: diagnosis by culture
Q37878283Chlamydia pneumoniae pneumonia. Radiographic features in a patient with lung transplantation
Q35892972Chlamydia pneumoniae pneumonia: An evolving clinical spectrum
Q37886212Chlamydia pneumoniae pneumonia: role of new macrolides
Q37876174Chlamydia pneumoniae present in the human synovium are viable and metabolically active.
Q35945524Chlamydia pneumoniae promotes dysfunction of pancreatic beta cells
Q37875071Chlamydia pneumoniae proteins induce secretion of the 92-kDa gelatinase by human monocyte- derived macrophages
Q37878307Chlamydia pneumoniae reactive T lymphocytes in the walls of abdominal aortic aneurysms
Q37861022Chlamydia pneumoniae replicates in Kupffer cells in mouse model of liver infection
Q35014062Chlamydia pneumoniae resists antibiotics in lymphocytes
Q37872245Chlamydia pneumoniae respiratory infection after allogeneic stem cell transplantation
Q37892153Chlamydia pneumoniae respiratory infection in a child--a case report
Q37872121Chlamydia pneumoniae respiratory infections
Q37881880Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.
Q37859568Chlamydia pneumoniae respiratory infections in Taiwan
Q37895602Chlamydia pneumoniae respiratory tract infection: the interpretation of high titres in the complement fixation test
Q37879569Chlamydia pneumoniae revisited
Q34116447Chlamydia pneumoniae secretion of a protease-like activity factor for degrading host cell transcription factors required for [correction of factors is required for] major histocompatibility complex antigen expression
Q90433303Chlamydia pneumoniae sero-prevalence in Moroccan patients with cardiovascular diseases
Q37876545Chlamydia pneumoniae serological status is not associated with asthma in children or young adults
Q37865536Chlamydia pneumoniae serology in donors and recipients and the risk of bronchiolitis obliterans syndrome after lung transplantation.
Q37872023Chlamydia pneumoniae serology is associated with thrombosis-related but not with plaque-related microembolization during carotid endarterectomy
Q33889878Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease.
Q37869577Chlamydia pneumoniae serology: comparing a commercial enzyme immunoassay and microimmunofluorescence test in patients with cardiovascular disease
Q33972282Chlamydia pneumoniae serology: importance of methodology in patients with coronary heart disease and healthy individuals
Q37876389Chlamydia pneumoniae serology: interlaboratory variation in microimmunofluorescence assay results
Q127739974Chlamydia pneumoniae seropositivity and Carotid Atherosclerosis — A Japanese population-based study
Q37866396Chlamydia pneumoniae seropositivity and cardiovascular risk factors: The InCHIANTI Study.
Q37871330Chlamydia pneumoniae seropositivity and early carotid atherosclerosis in a suburban Japanese population
Q37873964Chlamydia pneumoniae seropositivity and hyperhomocysteinemia are linked in patients with atherosclerosis
Q37863266Chlamydia pneumoniae seropositivity and risk of developing coronary heart disease in Western Saudi Arabia
Q37865328Chlamydia pneumoniae seropositivity and risk of ischemic stroke: a nested case-control study
Q37872233Chlamydia pneumoniae seropositivity and systemic and renovascular atherosclerotic disease
Q43422150Chlamydia pneumoniae seropositivity and the risk of NAION.
Q37872225Chlamydia pneumoniae seropositivity and the risk of nonarteritic ischemic optic neuropathy
Q37850880Chlamydia pneumoniae seropositivity in Iranian patients with multiple sclerosis: a pilot study
Q35121619Chlamydia pneumoniae seropositivity in adults with acute ischemic stroke: A case-control study
Q37858958Chlamydia pneumoniae seropositivity in aetiological subtypes of brain infarction and carotid atherosclerosis: a case control study.
Q37867621Chlamydia pneumoniae seropositivity in patients with cerebral ischemic attack with or without silent brain infarcts
Q37863523Chlamydia pneumoniae seropositivity in women with pre-eclampsia
Q37876102Chlamydia pneumoniae seropositivity is associated with carotid artery intima-media thickness
Q37871806Chlamydia pneumoniae seropositivity is associated with increased plasma levels of soluble cellular adhesion molecules in community-dwelling subjects: the Shimanami Health Promoting Program (J-SHIPP) study
Q37871240Chlamydia pneumoniae seropositivity predicts the risk of restenosis after percutaneous transluminal coronary angioplasty.
Q37884226Chlamydia pneumoniae seroprevalence among HIV-1-infected and uninfected people with known HIV risk factor
Q36292173Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan
Q45311740Chlamydia pneumoniae sp. nov. for Chlamydia sp. Strain TWAR
Q37866797Chlamydia pneumoniae stimulates IFN-gamma synthesis through MyD88-dependent, TLR2- and TLR4-independent induction of IL-18 release
Q37868585Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60.
Q37860473Chlamydia pneumoniae stimulates the proliferation of HUVEC through the induction of VEGF by THP-1.
Q37894988Chlamydia pneumoniae strain TWAR antibody and angiographically demonstrated coronary artery disease
Q37889561Chlamydia pneumoniae strain TWAR pharyngitis in US Air Force basic trainees.
Q37896248Chlamydia pneumoniae strain TWAR, Mycoplasma pneumoniae, and viral infections in acute respiratory disease in a university student health clinic population
Q37869878Chlamydia pneumoniae survival in macrophages is regulated by free Ca2+ dependent reactive nitrogen and oxygen species
Q37867634Chlamydia pneumoniae together with collagenase-2 (MMP-8) in periodontal lesions.
Q37864340Chlamydia pneumoniae uses the mannose 6-phosphate/insulin-like growth factor 2 receptor for infection of endothelial cells
Q43426375Chlamydia pneumoniae viability in atherosclerotic tissue: true or false?
Q37871833Chlamydia pneumoniae, Helicobacter pylori and cytomegalovirus infections and the risk of peripheral arterial disease in young women
Q37865854Chlamydia pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila in elderly patients with stroke (C-PEPS, M-PEPS, L-PEPS): a case-control study on the infectious burden of atypical respiratory pathogens in elderly patients with acute cerebrov
Q37894217Chlamydia pneumoniae, Strain TWAR, Infection in Patients with Chronic Obstructive Pulmonary Disease
Q37836597Chlamydia pneumoniae, and mycoplasma pneumoniae: Are they related to severe asthma in childhood?
Q43422157Chlamydia pneumoniae, antibiotic treatment, and early atherosclerosis
Q37879825Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: a critical overview
Q33763030Chlamydia pneumoniae, asthma, and COPD: what is the evidence?
Q37869074Chlamydia pneumoniae, atherosclerosis, and coronary disease
Q37869752Chlamydia pneumoniae, but not Bartonella quintana, is associated with coronary heart disease: results of a French case-control study
Q43424710Chlamydia pneumoniae, clarithromycin, and severe asthma
Q37882074Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery
Q43418992Chlamydia pneumoniae, harmful only for peripheral arteries?
Q28196475Chlamydia pneumoniae, heat shock proteins 60 and risk of secondary cardiovascular events in patients with coronary heart disease under special consideration of diabetes: a prospective study
Q37863872Chlamydia pneumoniae, herpes simplex virus and cytomegalovirus in symptomatic and asymptomatic high-grade internal carotid artery stenosis. Does infection influence plaque stability?
Q37875347Chlamydia pneumoniae, herpes simplex virus type 1, and cytomegalovirus and incident myocardial infarction and coronary heart disease death in older adults : the Cardiovascular Health Study
Q33762172Chlamydia pneumoniae, monocyte activation, and azithromycin in coronary heart disease
Q37869080Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD).
Q37889932Chlamydia pneumoniae, strain TWAR and atherosclerosis.
Q36086894Chlamydia pneumoniae, strain TWAR pneumonia
Q36473368Chlamydia pneumoniae, strain TWAR, as the cause of an outbreak in a boys' school previously called psittacosis
Q37898682Chlamydia pneumoniae, strain TWAR.
Q43418669Chlamydia pneumoniae, stroke, and serological associations: anything learned from the atherosclerosis-cardiovascular literature or do we have to start over again?
Q37872221Chlamydia pneumoniae, systemic inflammation and the risk of venous thrombosis
Q37875263Chlamydia pneumoniae, the Heart, and Coronary Artery Disease: Is There a Cause and Effect Relationship?
Q33566092Chlamydia pneumoniae--a new causative agent of reactive arthritis and undifferentiated oligoarthritis
Q37895617Chlamydia pneumoniae--a new important respiratory pathogen
Q37864581Chlamydia pneumoniae--a new risk factor for calcific aortic stenosis?
Q43427691Chlamydia pneumoniae--a pathogen with cardiovascular significance
Q37877819Chlamydia pneumoniae--a suspected pathogenetic factor in coronary arteriosclerosis
Q43424399Chlamydia pneumoniae--aetiologic agent of what?
Q35701591Chlamydia pneumoniae--an infectious risk factor for atherosclerosis?
Q37872685Chlamydia pneumoniae--chronic infection and atherosclerosis
Q37868708Chlamydia pneumoniae--etiology of ophthalmia neonatorum
Q37860795Chlamydia pneumoniae--induced macrophage foam cell formation is mediated by Toll-like receptor 2.
Q37891366Chlamydia pneumoniae--pathogenesis and perspectives
Q43431232Chlamydia pneumoniae--reactive arthritis and persistent infection
Q43418252Chlamydia pneumoniae--seroprevalance among adults presenting with acute community-acquired pneumonia (CAP).
Q37868493Chlamydia pneumoniae--the etiologic agent of follicular conjunctivitis followed by keratoconjunctivitis sicca in adult patients
Q26783046Chlamydia pneumoniae-Mediated Inflammation in Atherosclerosis: A Meta-Analysis
Q37875762Chlamydia pneumoniae-associated ADEM.
Q43423018Chlamydia pneumoniae-atherosclerosis link: a sound concept in search for clinical relevance
Q37063300Chlamydia pneumoniae-based atherosclerosis: a smoking gun.
Q33935073Chlamydia pneumoniae-induced atherosclerosis in a rabbit model
Q37887085Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells
Q37856309Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation
Q33825748Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns
Q37413421Chlamydia pneumoniae-induced pathological signaling in the vasculature
Q37877086Chlamydia pneumoniae-induced transactivation of the major immediate early promoter of cytomegalovirus: potential synergy of infectious agents in the pathogenesis of atherosclerosis
Q54963193Chlamydia pneumoniae-induced tumour necrosis factor alpha responses are lower in children with asthma compared with non-asthma.
Q37873339Chlamydia pneumoniae-infected monocytes exhibit increased adherence to human aortic endothelial cells
Q37878309Chlamydia pneumoniae-reactive T lymphocytes in abdominal aortic aneurysms: the smoking gun?
Q37839480Chlamydia pneumoniae-related hemophagocytic lymphohistiocytosis in an adult patient with clonal karyotype abnormality
Q21090921Chlamydia pneumoniae-specific IgE is prevalent in asthma and is associated with disease severity
Q37880847Chlamydia pneumoniae-specific cell-mediated and humoral immunity in healthy people
Q37891247Chlamydia pneumoniae-specific circulating immune complexes in patients with chronic coronary heart disease
Q43425868Chlamydia pneumoniae-specific humoral immune responses and clinical disease parameters in multiple sclerosis
Q37853820Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms.
Q37858226Chlamydia pneumoniae-specific serum immune complexes in patients with multiple sclerosis.
Q55519882Chlamydia pneumoniae.
Q43431376Chlamydia pneumoniae. New diagnostic tools for detection of a common pathogen
Q73680456Chlamydia pneumoniae. Proceedings of a meeting. Gavle, Sweden, 9-10 November 1995
Q37883021Chlamydia pneumoniae: a new opportunistic infectious agent in AIDS?
Q37879668Chlamydia pneumoniae: an agent involved in the pathogenesis of asthma
Q37872915Chlamydia pneumoniae: an cause of reactive arthritis?
Q37876610Chlamydia pneumoniae: an etiologic of coronary heart disease?
Q43422370Chlamydia pneumoniae: another agent added to the growing list of transfusion-transmitted pathogens?
Q43429160Chlamydia pneumoniae: association with asthma and cardiovascular disease. Therapeutic interventions
Q43429866Chlamydia pneumoniae: can it cause atherosclerosis?
Q37891331Chlamydia pneumoniae: clinical, epidemiological and laboratory aspects
Q36320102Chlamydia pneumoniae: comparison with findings of Mycoplasma pneumoniae and Streptococcus pneumoniae at thin-section CT.
Q43421089Chlamydia pneumoniae: crossing the barriers?
Q33821294Chlamydia pneumoniae: defining the clinical spectrum of infection requires precise laboratory diagnosis
Q37879482Chlamydia pneumoniae: inflammation and instability of the atherosclerotic plaque
Q37847505Chlamydia pneumoniae: modern insights into an ancient pathogen.
Q43409261Chlamydia pneumoniae: possible association with asthma in children
Q37892016Chlamydia pneumoniae: possibly, the third cause of epidemic bacterial pneumopathies?
Q37882848Chlamydia psittaci and Chlamydia pneumoniae infection in Caceres
Q64888348Chlamydia trachomatis and Chlamydia pneumoniae Interaction with the Host: Latest Advances and Future Prospective.
Q37895235Chlamydia trachomatis and Chlamydia pneumoniae bind specifically to phosphatidylethanolamine in HeLa cells and to GalNAc beta 1-4Gal beta 1-4GLC sequences-found in asialo-GM1 and asial-GM2.
Q35644776Chlamydia trachomatis and Chlamydia pneumoniae infections in children and adolescents
Q37861545Chlamydial heat-shock protein 60 : A marker for chronic infection with Chlamydia Pneumoniae in atherosclerosis: Investigation of atherosclerotic coronary arteries by immunocytochemistry
Q37870954Chlamydial heat-shock protein-60 antibody and correlation with Chlamydia pneumoniae in atherosclerotic plaques
Q37870991Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice
Q37835017Cholesterol uptake in the mouse aorta increases during Chlamydia pneumoniae infection
Q33555801Choroidal neovascularization enhanced by Chlamydia pneumoniae via Toll-like receptor 2 in the retinal pigment epithelium
Q37867792Chronic Chlamydia pneumonia--complications
Q37893723Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study
Q37881200Chronic Chlamydia pneumoniae infection and asthma exacerbations in children
Q37856331Chronic Chlamydia pneumoniae infection and bronchial asthma: is there a link?
Q37862941Chronic Chlamydia pneumoniae infection and stroke in Cameroon: a case-control study
Q37875613Chronic Chlamydia pneumoniae infection in patients with asthma
Q37870867Chronic Chlamydia pneumoniae infection in patients with coronary disease. Relation with increased fibrinogen values
Q37863343Chronic Chlamydia pneumoniae infection in patients with symptomatic atherothrombosis
Q37868896Chronic Chlamydia pneumoniae infection increases the risk of occlusion of lumbar segmental arteries of patients with sciatica: a 3-year follow-up study
Q37865636Chronic Chlamydia pneumoniae infection is a risk factor for the development of COPD.
Q37881850Chronic Chlamydia pneumoniae infection is associated with a serum lipid profile known to be a risk factor for atherosclerosis
Q37861245Chronic Chlamydia pneumoniae infection may promote coronary artery disease in humans through enhancing secretion of interleukin-4.
Q33873239Chronic Chlamydia pneumoniae infection: a treatable cause of chronic fatigue syndrome
Q43406867Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma?
Q43406869Chronic Chlamydia pneumoniae lung infection: a neglected explanation for macrolide effects in wheezing and asthma? - Authors' reply
Q37880791Chronic follicular conjunctivitis associated with Chlamydia psittaci or Chlamydia pneumoniae
Q33596962Chronic infection in the aetiology of atherosclerosis--focus on Chlamydia pneumoniae
Q37882065Chronic infection in the etiology of atherosclerosis--the case for Chlamydia pneumoniae
Q35371043Chronic infection with Helicobacter pylori, Chlamydia pneumoniae, or cytomegalovirus: population based study of coronary heart disease
Q37862624Chronic peripheral arteriopathy is associated with seropositivity to Chlamydia pneumoniae
Q101326897Chronic wasting associated with Chlamydia pneumoniae in three ex situ breeding facilities for tropical frogs
Q37861299Circulating Chlamydia pneumoniae DNA and advanced coronary artery disease
Q37877457Circulating Chlamydia pneumoniae DNA as a predictor of coronary artery disease
Q33971224Circulating nucleic acids of Chlamydia pneumoniae and cytomegalovirus in patients undergoing coronary angiography
Q37864193Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice
Q37887448Clinical aspects of Chlamydia pneumoniae infection
Q37877825Clinical characteristics of Chlamydia pneumoniae infection as the sole cause of community-acquired pneumonia
Q37873945Clinical comparison of Chlamydia pneumoniae pneumonia, ornithosis, and Mycoplasma pneumoniae pneumonia
Q37885334Clinical features of Chlamydia pneumoniae acute respiratory infection
Q37885757Clinical manifestations of Chlamydia pneumoniae infections
Q43431997Clinical manifestations of Chlamydia pneumoniae infections
Q37871612Clinical manifestations of atherosclerosis in an elderly population are related to plasma neopterin, NGAL and endothelin-1, but not to Chlamydia pneumoniae serology.
Q36512610Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia
Q37871776Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults
Q37875119Clinical relevance of Chlamydia pneumoniae infection--from the respiratory tract to the vascular system
Q64055332Clinical study of chlamydia pneumoniae infection in patients with coronary heart disease
Q37874312Clinical study on acute respiratory infection caused by chlamydia pneumoniae
Q37874526Cloning and characterization of adenylate kinase from Chlamydia pneumoniae
Q37867510Cloning, expression, and characterization of uracil-DNA glycosylase of Chlamydia pneumoniae in Escherichia coli
Q37864622Close association of Chlamydia pneumoniae IgA seropositivity by ELISA with the presence of coronary artery stenosis in haemodialysis patients
Q37869204Co-infection with Chlamydia pneumoniae and Helicobacter pylori results in vascular endothelial dysfunction and enhanced VCAM-1 expression in apoE-knockout mice
Q37870157Coinfection of laboratory rats with Mycoplasma pulmonis and Chlamydia pneumoniae
Q37868829Coinfection with Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured plaques associated with acute myocardial infarction
Q37876359Collaborative multidisciplinary workshop report: detection, culture, serology, and antimicrobial susceptibility testing of Chlamydia pneumoniae
Q37876325Collaborative multidisciplinary workshop report: progress toward a Chlamydia pneumoniae vaccine
Q37876386Collaborative multidisciplinary workshop report: the role of epidemiology studies in determining a possible relationship between Chlamydia pneumoniae infection and atherothrombotic diseases
Q37876339Collaborative multidisciplinary workshop report: what questions regarding the role of Chlamydia pneumoniae in atherosclerosis and cardiovascular disease need to be addressed utilizing animal models?
Q99607562Combined and interaction effect of chlamydia pneumoniae infection and smoking on lung cancer: a case-control study in Southeast China
Q37870081Combined role of the Lewis antigenic system, Chlamydia pneumoniae, and C-reactive protein in unstable angina
Q37878386Commentary: Chlamydia pneumoniae infection and ischaemic heart disease
Q43421679Comments on the Failure to Detect Chlamydia pneumoniae in Atherosclerosis
Q37895663Community acquired pneumonia caused by Chlamydia pneumoniae strain TWAR in chronic cardiopulmonary disease in the elderly
Q42423990Community-acquired Chlamydia pneumoniae pneumonia
Q37870563Community-acquired Chlamydia pneumoniae pneumonia in Japan: a prospective multicenter community-acquired pneumonia study.
Q43427473Community-acquired chlamydia pneumoniae pneumonia
Q43423078Community-acquired pneumonia, acute respiratory distress syndrome, and severe sepsis due to Chlamydia pneumoniae
Q37869639Comparative Studies of Glycosaminoglycan Involvement inChlamydia pneumoniaeandC. trachomatisInvasion of Host Cells
Q36202987Comparative analysis of the growth and biological activity of a respiratory and atheroma isolate of Chlamydia pneumoniae reveals strain-dependent differences in inflammatory activity and innate immune evasion.
Q22122313Comparative genomes of Chlamydia pneumoniae and C. trachomatis
Q37838935Comparative genomic analysis of human Chlamydia pneumoniae isolates from respiratory, brain and cardiac tissues
Q37866691Comparative study of community-acquired pneumonia caused by Streptococcus pneumoniae, Legionella pneumophila or Chlamydia pneumoniae
Q87821794Comparative study of the effects of acepromazine and structurally related compounds on the TNF-a release by monocytes stimulated by Chlamydia pneumoniae
Q34174788Comparative study of the presence of Chlamydia pneumoniae in cerebrospinal fluid of Patients with clinically definite and monosymptomatic multiple sclerosis
Q43414282Comparative study of the seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae infection in the course of chronic asthma in children
Q37095262Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene.
Q22066146Comparison of Outer Membrane Protein Genes omp and pmp in the Whole Genome Sequences of Chlamydia pneumoniae Isolates from Japan and the United States
Q37879026Comparison of PCR protocols including positive controls for detection of Chlamydia pneumoniae in respiratory specimens
Q128494403Comparison of Th1 and Th2 Immune Responses in Chlamydia pneumoniae-infected Peripheral Blood Mononuclear Cells (PBMC) of Adult and Pediatric Asthmatics
Q37874634Comparison of a new commercial EIA kit and the microimmunofluorescence technique for the determination of IgG and IgA antibodies to Chlamydia pneumoniae
Q34752011Comparison of a new quantitative ompA-based real-Time PCR TaqMan assay for detection of Chlamydia pneumoniae DNA in respiratory specimens with four conventional PCR assays
Q37871676Comparison of an industry-derived LCx Chlamydia pneumoniae PCR research kit to in-house assays performed in five laboratories
Q37875671Comparison of anesthetics for inoculation of mice with Chlamydia pneumoniae
Q37867281Comparison of clinical presentation of mixed pneumonia with Chlamydia pneumoniae and Streptococcus pneumoniae and S. pneumoniae pneumonia
Q37850352Comparison of echocardiographic findings in AVS patients with and without high IgG, IgM, IgA titers against Chlamydia pneumoniae during 12 months' observation of AVS natural course
Q34203352Comparison of eleven commercial tests for Chlamydia pneumoniae-specific immunoglobulin G in asymptomatic healthy individuals
Q33998580Comparison of five serologic tests for diagnosis of acute infections by Chlamydia pneumoniae
Q37870838Comparison of individuals with and without specific IgA antibodies to Chlamydia pneumoniae: respiratory morbidity and the metabolic syndrome
Q33636893Comparison of koala LPCoLN and human strains of Chlamydia pneumoniae highlights extended genetic diversity in the species
Q37883766Comparison of nasopharyngeal and throat swabs for the detection of Chlamydia pneumoniae and Mycoplasma pneumoniae by polymerase chain reaction
Q37857956Comparison of polymerase chain reaction methods, in situ hybridization, and enzyme immunoassay for detection of Chlamydia pneumoniae in atherosclerotic carotid plaques.
Q37888291Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR.
Q37892730Comparison of sensitivity of Hep-2 cells with that of HL cells against Chlamydia pneumoniae
Q37890053Comparison of serological tests for the detection of antibodies against Chlamydia trachomatis and Chlamydia pneumoniae in rheumatological patients.
Q30327855Comparison of the morphology and the reactivity of Chlamydia pneumoniae isolated in north-Kanto Area, Ibaraki Prefecture, Japan
Q37880640Comparison of throat swabs with sputum specimens for the detection of Chlamydia pneumoniae antigen by direct immunofluorescence
Q33999140Comparison of two commercial microimmunofluorescence kits and an enzyme immunoassay kit for detection of serum immunoglobulin G antibodies to Chlamydia pneumoniae
Q37871437Comparison of two microimmunofluorescence tests for detecting antibodies to Chlamydia pneumoniae
Q37879644Comparison of two serological methods and a polymerase chain reaction-enzyme immunoassay for the diagnosis of acute respiratory infections with Chlamydia pneumoniae in adults
Q37876203Comparison of whole genome sequences of Chlamydia pneumoniae J138 from Japan and CWL029 from USA.
Q36860941Complement factor H gene polymorphisms and Chlamydia pneumoniae infection in age-related macular degeneration
Q37877343Computational analysis of the polymorphic membrane protein superfamily of Chlamydia trachomatis and Chlamydia pneumoniae
Q37880332Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis
Q37848664Conformation study of 2-arylbenzimidazoles as inhibitors of Chlamydia pneumoniae growth.
Q21266688Construction of a highly flexible and comprehensive gene collection representing the ORFeome of the human pathogen Chlamydia pneumoniae
Q37880308Construction of an internal control for the detection of Chlamydia pneumoniae by PCR.
Q37885820Continuous isolation and characterization of Chlamydia pneumoniae from a patient with diffuse panbronchiolitis
Q37849862Corn mint (Mentha arvensis) extract diminishes acute Chlamydia pneumoniae infection in vitro and in vivo
Q33974569Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies
Q74181267Coronary heart disease - any likelihood of benefit from the control of Chlamydia pneumoniae?
Q43426679Coronary heart disease and Chlamydia pneumoniae DNA in blood mononuclear cells
Q37877554Coronary heart disease, Helicobacter pylori, dental disease, Chlamydia pneumoniae, and cytomegalovirus: meta-analyses of prospective studies
Q94301961Correction: Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors
Q60553100Correction: Immunization of Chlamydia pneumoniae (Cpn)-Infected Apobtm2SgyLdlrtm1Her/J Mice with a Combined Peptide of Cpn Significantly Reduces Atherosclerotic Lesion Development
Q43418432Correlation between Chlamydia pneumoniae detection from coronary angioplasty balloons and atherosclerosis severity
Q37847334Correlation between Chlamydia pneumoniae infection and chronic obstructive pulmonary disease
Q37851331Correlation between chlamydia pneumoniae IgG positive in lung cancer patients and cytokines related to radiation-induced pulmonary lesion
Q37874278Correlation between detection methods of Chlamydia pneumoniae in atherosclerotic and non-atherosclerotic tissues
Q37857827Correlation between rises in Chlamydia pneumoniae-specific antibodies, platelet activation and lipid peroxidation after percutaneous coronary intervention.
Q35851191Correlation of Chlamydia pneumoniae infection with primary biliary cirrhosis
Q37872297Correlation of chlamydia pneumoniae infection and severity of accelerated graft arteriosclerosis after cardiac transplantation
Q37858820Correlation of hyperhomocysteinaemia and Chlamydia pneumoniae IgG seropositivity with coronary artery disease in a general population.
Q57160270Corrigendum to “Chlamydia pneumoniae genome sequence analysis and identification of HLA-A2-restricted CD8(+) T cell epitopes recognized by infection-primed T cells” [Vaccine 23 (2005) 5028–5037]
Q33157589Cough syncope caused by a possible Chlamydia pneumoniae pneumonia
Q37846901Could past Chlamydial vascular infection promote the dissemination of Chlamydia pneumoniae to the brain?
Q37898201Countrywide epidemics of Chlamydia pneumoniae, strain TWAR, in Scandinavia, 1981-1983.
Q37866801Cox-2 inhibition abrogates Chlamydia pneumoniae-induced PGE2 and MMP-1 expression
Q37855450Cultivation and laboratory maintenance of Chlamydia pneumoniae
Q37869305Culture and immunohistochemical evidence of Chlamydia pneumoniae infection in ulcerative pyoderma gangrenosum
Q37894592Culture-confirmed pneumonia due to Chlamydia pneumoniae
Q34945146Culture-negative endocarditis due to Chlamydia pneumoniae.
Q37897113Culture-negative endocarditis probably due to Chlamydia pneumoniae
Q32085737Current infection with Helicobacter pylori, but not seropositivity to Chlamydia pneumoniae or cytomegalovirus, is associated with an atherogenic, modified lipid profile
Q43429360Current knowledge of Chlamydia pneumoniae and atherosclerosis
Q37898698Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases
Q37889873Current topics of chlamydial respiratory tract infections--special reference to the epidemiology and clinical findings of Chlamydia pneumoniae infections in Japan.
Q37870502Cutaneous vasculitis and reactive arthritis following respiratory infection due to Chlamydia pneumoniae: report of a case.
Q37864893Cytokine response of lymphocytes persistently infected with Chlamydia pneumoniae
Q128661841Cytokine responses in Chlamydia pneumoniae-stimulated PBMC in asthmatic and non-asthmatic subjects.
Q37866364Cytomegalovirus and Chlamydia pneumoniae as predictors for adverse events and angina pectoris after percutaneous coronary intervention.
Q35378284Cytomegalovirus, Chlamydia pneumoniae, and Helicobacter pylori IgG antibodies and restenosis after stent implantation: an angiographic and intravascular ultrasound study
Q37866631DNA immunization followed by a viral vector booster in a Chlamydia pneumoniae mouse model.
Q37877605De Novo induction of atherosclerosis by Chlamydia pneumoniae in a rabbit model.
Q37875816Decontamination of a Mycoplasma-infected Chlamydia pneumoniae strain by pulmonary passage in SCID mice
Q33916075Decreased expression of liver X receptor-α in macrophages infected with Chlamydia pneumoniae in human atherosclerotic arteries in situ.
Q33946655Degradation of Chlamydia pneumoniae by peripheral blood monocytic cells
Q37864162Delivery of Chlamydia pneumoniae to the vessel wall aggravates atherosclerosis in LDLr-/- mice
Q37873684Demonstration of Chlamydia pneumoniae in atherosclerotic arteries from various vascular regions
Q37891287Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries
Q37879184Demonstration of Chlamydia pneumoniae in cardiovascular tissues from children with Kawasaki disease
Q37883633Demonstration of Chlamydia pneumoniae in patients with chronic pharyngitis
Q37874705Demonstration of Chlamydia pneumoniae in the adenoid from children with and without secretory otitis media using immunohistochemistry and PCR.
Q37883353Demonstration of Chlamydia pneumoniae in the walls of abdominal aortic aneurysms
Q37877662Demonstration of Chlamydia pneumoniae in tissue by immunohistochemistry.
Q43435469Demonstration of Chlamydia pneumoniae in water used for gargling
Q74006063Demonstration of an association between Chlamydia pneumoniae infection and venous thromboembolic disease
Q37865917Demonstration of intracellular microorganisms (Rickettsia spp., Chlamydia pneumoniae, Bartonella spp.) in pathological human aortic valves by PCR.
Q37878157Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction.
Q37846612Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae
Q37864721Density of Chlamydia pneumoniae is increased in fibrotic and calcified areas of degenerative aortic stenosis
Q37877956Depletion of CD8+ cells abolishes memory in acquired immunity against Chlamydia pneumoniae in BALB/c mice
Q34042489Depletion of resident Chlamydia pneumoniae through leukoreduction by filtration of blood for transfusion
Q37862124Description of immunogens of Chlamydia pneumoniae recognized by serum of individuals with peripheral artery disease
Q37852214Design and synthesis of 2-arylbenzimidazoles and evaluation of their inhibitory effect against Chlamydia pneumoniae
Q33762202Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis
Q37866780Detailed protocol for purification of Chlamydia pneumoniae elementary bodies
Q37896004Detection and differentiation of Chlamydia trachomatis, Chlamydia psittaci, and Chlamydia pneumoniae by DNA amplification
Q37214056Detection and widespread distribution of Chlamydia pneumoniae in the vascular system and its possible implications
Q43435779Detection of Chlamydia pneumoniae
Q68295810Detection of Chlamydia pneumoniae
Q37869499Detection of Chlamydia pneumoniae -Specific Antibodies Binding to the VD2 and VD3 Regions of the Major Outer Membrane Protein
Q34004325Detection of Chlamydia pneumoniae DNA and antigen in the circulating mononuclear cell fractions of humans and koalas
Q37875345Detection of Chlamydia pneumoniae DNA in CD3+ lymphocytes from healthy blood donors and patients with coronary artery disease
Q37878712Detection of Chlamydia pneumoniae DNA in atheromatous tissues by polymerase chain reaction
Q37874394Detection of Chlamydia pneumoniae DNA in buffy-coat samples of patients with abdominal aortic aneurysm
Q43420141Detection of Chlamydia pneumoniae DNA in the coronary arteries and bypass in three patients with diffuse coronary artery disease.
Q37886690Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues.
Q37891239Detection of Chlamydia pneumoniae and Chlamydia psittaci in sputum samples by PCR.
Q33970537Detection of Chlamydia pneumoniae and Helicobacter pylori DNA in human atherosclerotic plaques by PCR
Q37863878Detection of Chlamydia pneumoniae and Helicobacter pylori in atherosclerotic plaques of carotid artery by polymerase chain reaction
Q37873461Detection of Chlamydia pneumoniae antigenin PBMNCs of healthy blood donors
Q36541516Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms
Q37879001Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts
Q33186908Detection of Chlamydia pneumoniae but not of Helicobacter pylori in symptomatic atherosclerotic carotids associated with enhanced serum antibodies, inflammation and apoptosis rate.
Q37878481Detection of Chlamydia pneumoniae by colorimetric in situ hybridization
Q37891328Detection of Chlamydia pneumoniae by polymerase chain reaction
Q37893831Detection of Chlamydia pneumoniae by polymerase chain reaction
Q37890224Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in an immunocompromised population
Q37871476Detection of Chlamydia pneumoniae by polymerase chain reaction-enzyme immunoassay in intestinal mucosal biopsies from patients with inflammatory bowel disease and controls
Q37871627Detection of Chlamydia pneumoniae deoxyribonucleic acid in blood samples taken from coronary sinus after coronary angioplasty
Q35915792Detection of Chlamydia pneumoniae in a bilateral orbital mucosa-associated lymphoid tissue lymphoma
Q37840356Detection of Chlamydia pneumoniae in a collection of captive snakes and response to treatment with marbofloxacin.
Q37890285Detection of Chlamydia pneumoniae in aortic lesions of atherosclerosis by immunocytochemical stain
Q37876382Detection of Chlamydia pneumoniae in arterial tissues
Q43431324Detection of Chlamydia pneumoniae in atheroma specimens
Q37866352Detection of Chlamydia pneumoniae in atherosclerotic coronary arteries
Q37882562Detection of Chlamydia pneumoniae in atherosclerotic plaques in the walls of arteries of lower extremities from patients undergoing bypass operation for arterial obstruction
Q37854947Detection of Chlamydia pneumoniae in atherosclerotic plaques of patients in Tehran, Iran
Q37863148Detection of Chlamydia pneumoniae in atherosclerotic tissue: a comparative study of PCR and immunocytochemistry
Q37869219Detection of Chlamydia pneumoniae in cholesteatoma tissue: any pathogenetic role?
Q37888492Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers
Q37892518Detection of Chlamydia pneumoniae in coronary arterial fatty streaks and atheromatous plaques
Q37876046Detection of Chlamydia pneumoniae in giant cell vasculitis and correlation with the topographic arrangement of tissue-infiltrating dendritic cells
Q37863062Detection of Chlamydia pneumoniae in human aortic tissue: kdtA gene amplification and in vitro hybridization
Q37883146Detection of Chlamydia pneumoniae in human nonrheumatic stenotic aortic valves
Q37889751Detection of Chlamydia pneumoniae in intrathoracic abscesses--a case report
Q37866807Detection of Chlamydia pneumoniae in liver transplant patients with chronic allograft rejection.
Q43418116Detection of Chlamydia pneumoniae in patients with peripheral arterial occlusive disease: relationship between infection and disease
Q37853209Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors in Tehran Regional Educational Blood Transfusion Centre.
Q37869679Detection of Chlamydia pneumoniae in peripheral blood mononuclear cells: correlation with inflammation and atherosclerosis in haemodialysis patients
Q37868453Detection of Chlamydia pneumoniae in the cerebrospinal fluid of patients with multiple sclerosis by combination of cell culture and PCR: no evidence for possible association
Q37872587Detection of Chlamydia pneumoniae in unexplained pulmonary hypertension
Q37236613Detection of Chlamydia pneumoniae on cytospin preparations from bronchoalveolar lavage in COPD patients and in lung tissue from advanced emphysema
Q37876368Detection of Chlamydia pneumoniae within peripheral blood monocytes of patients with unstable angina or myocardial infarction
Q37876734Detection of Chlamydia pneumoniae-reactive T lymphocytes in human atherosclerotic plaques of carotid artery
Q37855608Detection of Chlamydophila pneumoniae (Chlamydia pneumoniae) in endarteroctomy specimens of coronary heart diseases patients.
Q37864308Detection of Helicobacter pylori and Chlamydia pneumoniae DNA in human coronary arteries and evaluation of the results with serologic evidence of inflammation
Q35662608Detection of Helicobacter pylori and Chlamydia pneumoniae genes in primary orbital lymphoma
Q37892279Detection of IgM antibodies to Chlamydia trachomatis, Chlamydia pneumoniae, and Chlamydia psittaci from Japanese infants and children with pneumonia
Q37875757Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques.
Q37851205Detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella spp. in clinical specimens using a single-tube multiplex real-time PCR assay
Q36087554Detection of amyloid beta aggregates in the brain of BALB/c mice after Chlamydia pneumoniae infection
Q37886835Detection of anti-Chlamydia pneumoniae IgE in children with reactive airway disease
Q34638664Detection of bacterial antigens and Alzheimer's disease-like pathology in the central nervous system of BALB/c mice following intranasal infection with a laboratory isolate of Chlamydia pneumoniae
Q37865796Detection of cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae DNA in carotid atherosclerotic plaques by the polymerase chain reaction.
Q37865729Detection of enterovirus, cytomegalovirus, and Chlamydia pneumoniae in atheromas.
Q37867323Detection of serum Chlamydia pneumoniae (Cpn) immune complex and Cpn antibody in patients with coronary heart disease.
Q30826314Detection of serum Chlamydia pneumoniae antibodies and analysis of epidemiologic data in 5 years
Q37884878Detection of serum antibodies against Chlamydia pneumoniae by ELISA.
Q37884866Detection of serum antibodies against Chlamydia pneumoniae by in vitro neutralization and microimmunofluorescence assays.
Q37881977Detection of serum antibodies to Chlamydia pneumoniae in patients with endogenous uveitis and acute conjunctivitis
Q40048610Detection of specific Chlamydia pneumoniae and cytomegalovirus antigens in human carotid atherosclerotic plaque in a Chinese population
Q37876171Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms
Q37877979Detection of viral, Chlamydia pneumoniae and Mycoplasma pneumoniae infections in exacerbations of asthma in children
Q24798213Determination of PCR efficiency in chelex-100 purified clinical samples and comparison of real-time quantitative PCR and conventional PCR for detection of Chlamydia pneumoniae
Q34946766Development and evaluation of real-time PCR-based fluorescence assays for detection of Chlamydia pneumoniae
Q50124300Development of a multiplex TaqMan real-time PCR assay for the detection of Chlamydia psittaci and Chlamydia pneumoniae in human clinical specimens
Q36269709Development of a multiplex real-time PCR assay for detection of Mycoplasma pneumoniae, Chlamydia pneumoniae and mutations associated with macrolide resistance in Mycoplasma pneumoniae from respiratory clinical specimens
Q37870019Development of a multiplex real-time quantitative PCR assay to detect Chlamydia pneumoniae, Legionella pneumophila and Mycoplasma pneumoniae in respiratory tract secretions
Q37885185Development of a simplified polymerase chain reaction-enzyme immunoassay for the detection of Chlamydia pneumoniae
Q37893420Development of an enzyme immunoassay to detect antibody to Chlamydia pneumoniae strain twar and its application in a limited seroepidemiological survey
Q37862482Development of diabetes in non-obese diabetic mice promotes Chlamydia pneumoniae dissemination from lung to peripheral blood
Q37873371Development of enzyme immunoassays to detect salivary sIgA to Chlamydia pneumoniae and Mycoplasma pneumoniae
Q43425311Diabetic foot ulcers and Chlamydia pneumoniae: innocent bystander or opportunistic pathogen?
Q37881628Diagnosis and therapy of Chlamydia pneumoniae and trachomatis
Q37875971Diagnosis of Chlamydia pneumoniae in community-acquired pneumonia in children in Chile
Q37881958Diagnosis of Chlamydia pneumoniae infection in patients with chronic obstructive pulmonary disease by micro-immunofluorescence and ELISA.
Q37888724Diagnosis of Chlamydia pneumoniae infection in patients with community-acquired pneumonia by polymerase chain reaction enzyme immunoassay
Q37872480Diagnosis of Chlamydia pneumoniae.
Q37885769Diagnosis of Legionella pneumophila, Mycoplasma pneumoniae, or Chlamydia pneumoniae lower respiratory infection using the polymerase chain reaction on a single throat swab specimen
Q37899046Diagnosis of infection caused by Chlamydia pneumoniae (strain TWAR) in patients with "ornithosis" in southern Sweden 1981-1987.
Q37879274Diagnosis of infections with difficulty in isolation and identification of causative organisms. 2) Chlamydia pneumoniae infection
Q37875910Diagnostic procedures in Chlamydia pneumoniae infections
Q37074513Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients
Q37862421Diagnostic value of an ELISA using a recombinant 54-kDa species-specific protein from Chlamydia pneumoniae
Q37840798Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis
Q37885504Differences in the envelope proteins of Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci shown by two-dimensional gel electrophoresis
Q35261754Different presence of Chlamydia pneumoniae, herpes simplex virus type 1, human herpes virus 6, and Toxoplasma gondii in schizophrenia: meta-analysis and analytical study.
Q37860452Differential effects of Chlamydia pneumoniae infection on cytokine levels in human T lymphocyte- and monocyte-derived cell cultures
Q37873314Differential expression of Pmp10 in cell culture infected with Chlamydia pneumoniae CWL029.
Q37869973Differential expression of genes encoding membrane proteins between acute and continuous Chlamydia pneumoniae infections
Q37874069Differential expression of ompA, ompB, pyk, nlpD and Cpn0585 genes between normal and interferon-gamma treated cultures of Chlamydia pneumoniae
Q37862553Differential involvement of TLR2 and TLR4 in host survival during pulmonary infection with Chlamydia pneumoniae
Q37855048Differential transcriptional responses between the interferon-gamma-induction and iron-limitation models of persistence for Chlamydia pneumoniae.
Q35381304Dilated cardiomyopathy and Chlamydia pneumoniae infection
Q37864937Discordant detection of Chlamydia pneumoniae in patients with carotid artery disease using polymerase chain reaction, immunofluorescence microscopy and serological methods
Q37860486Discovery of a vaccine antigen that protects mice from Chlamydia pneumoniae infection.
Q37860435Disparate innate immune responses to persistent and acute Chlamydia pneumoniae infection in chronic obstructive pulmonary disease
Q35169118Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis
Q37835990Distribution characteristics of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in hospitalized children with acute respiratory tract infection: an analysis of 13 198 cases
Q37869629Distribution of Chlamydia pneumoniae DNA in atherosclerotic carotid arteries: significance for sampling procedures
Q37874544Distribution of Chlamydia pneumoniae in the human arterial system and its relation to the local amount of atherosclerosis within the individual
Q37881215Distribution of Chlamydia pneumoniae infection in the athersclerotic carotid artery
Q37852650Divergent modulation of Chlamydia pneumoniae infection cycle in human monocytic and endothelial cells by iron, tryptophan availability and interferon gamma
Q33733197Does Chlamydia pneumoniae cause atherosclerosis?
Q43430155Does Chlamydia pneumoniae cause coronary atherosclerosis and should we all take macrolides?
Q37861249Does Chlamydia pneumoniae cause coronary heart disease?
Q34684124Does Chlamydia pneumoniae have a role in atherosclerosis?
Q37854041Does Chlamydia pneumoniae infection trigger to development of asthma in wheezy infants?
Q43427591Does Chlamydia pneumoniae play a role in the pathogenesis of multiple sclerosis?
Q37870567Does chronic Chlamydia pneumoniae infection increase the risk of myocardial injury? Insights from patients with non-ST-elevation acute coronary syndromes
Q37871004Does infection with Chlamydia pneumoniae and/or Helicobacter pylori increase the expression of endothelial cell adhesion molecules in humans?
Q43428230Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure?
Q43411846Does respiratory infection due to Chlamydia pneumoniae still exist?
Q37884141Double infection of Chlamydia pneumoniae and Mycoplasma pneumoniae in children
Q52609199Doxycycline suppresses Chlamydia pneumoniae induced interferon-gamma responses in peripheral blood mononuclear cells in children with allergic asthma.
Q37846414Doxycycline suppresses Chlamydia pneumoniae-mediated increases in ongoing immunoglobulin E and interleukin-4 responses by peripheral blood mononuclear cells of patients with allergic asthma
Q37844989Draft Genome and Plasmid Sequences of Chlamydia pneumoniae Strain B21 from an Australian Endangered Marsupial, the Western Barred Bandicoot
Q37848290Dual-color bioluminescent assay using infected HepG2 cells sheds new light on Chlamydia pneumoniae and human cytomegalovirus effects on human cholesterol 7α-hydroxylase (CYP7A1) transcription
Q82861062EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture
Q37869614Early atherosclerosis and Chlamydia pneumoniae infection in the coronary arteries
Q37848734Early atherosclerotic plaques show evidence of infection by Chlamydia pneumoniae.
Q43420636Early carotid atherosclerosis and Chlamydia pneumoniae seropositivity: are there arguments to treat with antibiotics?
Q37863965Early detection and successful therapy of fulminant chlamydia pneumoniae myocarditis
Q37871079Early impairment of coronary flow reserve is not associated with Chlamydia pneumoniae antibodies
Q33935504Ectasia and severe atherosclerosis: relationships with chlamydia pneumoniae, helicobacterpylori, and inflammatory markers
Q37852394Ectopic lymphoid tissue formation in the lungs of mice infected with Chlamydia pneumoniae is associated with epithelial macrophage inflammatory protein-2/CXCL2 expression.
Q37865245Effect of Chlamydia pneumoniae infection and hyperlipidaemia on the expression of PPARgamma, P50 and c-Fos in aortic endothelial cells in C57bL/6J mice
Q37871803Effect of Chlamydia pneumoniae infection on carotid atherosclerosis development
Q37872753Effect of Chlamydia pneumoniae infection on coronary flow reserve and intimal hyperplasia after stent implantation in patients with angina pectoris.
Q33883493Effect of Chlamydia pneumoniae on cellular ATP content in mouse macrophages: role of Toll-like receptor 2
Q33965613Effect of a Mycoplasma hominis-like Mycoplasma on the infection of HEp-2 cells by the TW-183 strain of Chlamydia pneumoniae
Q37870659Effect of acute Chlamydia pneumoniae infection on lipoprotein metabolism in NIH/S mice
Q36136797Effect of age and vaccination on extent and spread of Chlamydia pneumoniae infection in C57BL/6 mice
Q128451092Effect of azithromycin on Chlamydia pneumoniae –mediated Interleukin-4 responses
Q43423134Effect of azithromycin on endothelial function of patients with coronary artery disease and evidence of Chlamydia pneumoniae infection
Q31713580Effect of azithromycin on murine arteriosclerosis exacerbated by Chlamydia pneumoniae
Q33979917Effect of azithromycin plus rifampin versus amoxicillin alone on eradication and inflammation in the chronic course of Chlamydia pneumoniae pneumonitis in mice
Q33976999Effect of azithromycin plus rifampin versus that of azithromycin alone on the eradication of Chlamydia pneumoniae from lung tissue in experimental pneumonitis
Q37872325Effect of azithromycin treatment on endothelial function in patients with coronary artery disease and evidence of Chlamydia pneumoniae infection
Q33752851Effect of clarithromycin treatment on Chlamydia pneumoniae in vascular tissue of patients with coronary artery disease: a randomized, double-blind, placebo-controlled trial
Q37873349Effect of extended pre-incubation with chlamydia pneumoniae and extended incubation with antimicrobial on the minimum inhibitory concentrations (MICs) of five antimicrobials
Q43424209Effect of fenofibrate on Chlamydia pneumoniae antibody levels in patients with coronary artery disease
Q37871972Effect of gemifloxacin on viability of Chlamydia pneumoniae (Chlamydophila pneumoniae) in an in vitro continuous infection model
Q36539263Effect of hydrocortisone succinate on growth of Chlamydia pneumoniae in vitro.
Q37866076Effect of levofloxacin on the viability of intracellular Chlamydia pneumoniae and modulation of proinflammatory cytokine production by human monocytes
Q37871907Effect of macrolide antibiotics on human endothelial cells activated by Chlamydia pneumoniae infection and tumor necrosis factor-alpha
Q43417045Effect of pravastatin treatment on Chlamydia pneumoniae infection, inflammation and serum lipids in NIH/S mice
Q37875878Effect of prior exposure to Chlamydia pneumoniae, Helicobacter pylori, or cytomegalovirus on the degree of inflammation and one-year prognosis of patients with unstable angina pectoris or non-Q-wave acute myocardial infarction
Q37872800Effect of prolonged treatment with azithromycin, clarithromycin, or levofloxacin on Chlamydia pneumoniae in a continuous-infection Model
Q43422848Effect of roxithromycin treatment on the endothelial function of Chlamydia pneumoniae seropositive men suffering from peripheral arterial occlusive disease
Q37869882Effect of short-term antibiotic treatment on Chlamydia pneumoniae and peripheral endothelial function.
Q33935447Effect of simvastatin, an established lipid-lowering drug, on pulmonary Chlamydia pneumoniae infection in mice
Q37863336Effect of therapy with antibiotics on lipid metabolism and antioxidant reserve of patients with ischemic heart disease during Chlamydia pneumoniae infection
Q37871321Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).
Q37859967Effect on carotid atherosclerosis of probucol plus levofloxacin for Chlamydia pneumoniae infection
Q37869486Effective macrophage redox defense against Chlamydia pneumoniae depends on L-type Ca2+ channel activation
Q37854835Effects of CD14, TLR2, TLR4, LPB, and IL-6 gene polymorphisms on Chlamydia pneumoniae growth in human macrophages in vitro.
Q37866034Effects of COX-2 inhibitors on ROS produced by Chlamydia pneumoniae-primed human promonocytic cells (THP-1).
Q37003254Effects of Murine Norovirus on Chlamydia pneumoniae-Accelerated Atherosclerosis in ApoE(-/-) Mice
Q37859155Effects of bradykinin on aortic endothelial function in apoe-knockout mice with chronic Chlamydia pneumoniae infection
Q37850156Effects of coadministration of natural polyphenols with doxycycline or calcium modulators on acute Chlamydia pneumoniae infection in vitro
Q37864916Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells
Q40968088Effects of fluoroquinolones on the migration of human phagocytes through Chlamydia pneumoniae-infected and tumor necrosis factor alpha-stimulated endothelial cells
Q37873559Effects of interleukin-1 gene polymorphisms on the development of coronary artery disease associated with Chlamydia pneumoniae infection
Q34033240Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice
Q35110637Effects of two antibiotic regimens on course and persistence of experimental Chlamydia pneumoniae TWAR pneumonitis
Q37857886Efficacy of benzoxazinorifamycins in a mouse model of Chlamydia pneumoniae lung infection
Q37122830Efficient culture of Chlamydia pneumoniae with cell lines derived from the human respiratory tract
Q43428517Electron microscopy, Chlamydia pneumoniae and atherosclerosis
Q37882420Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction
Q37867424Elevated antibody levels against Chlamydia pneumoniae, human HSP60 and mycobacterial HSP65 are independent risk factors in myocardial infarction and ischaemic heart disease
Q37872599Elevated interleukin-6 predicts progressive carotid artery atherosclerosis in dialysis patients: association with Chlamydia pneumoniae seropositivity
Q37859197Elevated levels of anti-Chlamydia pneumoniae IgA and IgG antibodies in young adults with ischemic stroke.
Q37853592Elevated serum immunoglobulin G titers against Chlamydia pneumoniae in primary open-angle glaucoma patients without systemic disease
Q37866956Elicitation of reactive oxygen species in Chlamydia pneumoniae-stimulated macrophages: a Ca2+-dependent process involving simultaneous activation of NADPH oxidase and cytochrome oxidase genes
Q34548131Emerging role of Mycoplasma pneumoniae and Chlamydia pneumoniae in paediatric respiratory-tract infections
Q37873974Encephalitis associated with Chlamydia pneumoniae
Q37895599Endemic prevalence of Chlamydia pneumoniae in subjectively healthy persons
Q37867025Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL.
Q37878782Endothelial cytotoxicity mediated by serum antibodies to heat shock proteins of Escherichia coli and Chlamydia pneumoniae: immune reactions to heat shock proteins as a possible link between infection and atherosclerosis
Q37875799Endothelial dysfunction after repeated Chlamydia pneumoniae infection in apolipoprotein E-knockout mice
Q37861805Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae
Q37879484Endovascular presence of Chlamydia pneumoniae DNA is a generalized phenomenon in atherosclerotic vascular disease
Q37882356Endovascular presence of Chlamydia pneumoniae in patients with hemodynamically effective carotid artery stenosis
Q37881317Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease
Q37874654Enhanced progression of early carotid atherosclerosis is related to Chlamydia pneumoniae (Taiwan acute respiratory) seropositivity
Q43421757Enigmatic relationship between Chlamydia pneumoniae and atherosclerosis
Q30940528Enzyme immunoassay to determine exposure to Chlamydia pneumoniae (strain TWAR)
Q37883750Epidemic patterns and carriage of Chlamydia pneumoniae in Norway
Q33935008Epidemiologic association of Chlamydia pneumoniae and atherosclerosis: the initial serologic observation and more
Q37879440Epidemiologic study of Chlamydia pneumoniae with ELISA
Q34283855Epidemiological and clinical aspects on infections due to Chlamydia pneumoniae (strain TWAR).
Q33762140Epidemiology of Chlamydia pneumoniae in atherosclerosis
Q37878762Epidemiology of Chlamydia pneumoniae infection in a randomly selected population in a developed country
Q37872484Epidemiology of Chlamydia pneumoniae.
Q37882014Epidemiology of acute lower respiratory tract infections in adults. Role of Chlamydia pneumoniae and Mycoplasma pneumoniae
Q37858302Epidemiology of severe pneumonia caused by Legionella longbeachae, Mycoplasma pneumoniae, and Chlamydia pneumoniae: 1-year, population-based surveillance for severe pneumonia in Thailand
Q37836131Epigallocatechin gallate suppresses Chlamydia pneumoniae mediated IgE responses in peripheral blood mononuclear cells: a pilot study
Q37873105Epithelial cells infected with Chlamydophila pneumoniae (Chlamydia pneumoniae) are resistant to apoptosis.
Q43423428Eradication of Chlamydia pneumoniae from coronary artery endothelium
Q57446268Erratum - The Progression of Lower Limb Atherosclerosis is Associated with IgA-antibodies Against Chlamydia pneumoniae
Q94083531Erratum: The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987
Q37860685Erythema multiforme majus and Chlamydia pneumoniae infection
Q37895103Erythema nodosum in Chlamydia pneumoniae infection
Q37899042Erythema nodosum--a manifestation of Chlamydia pneumoniae (strain TWAR) infection
Q43423125Essential hypertension is associated with Chlamydia pneumoniae but not Epstein-Barr antibodies
Q37872883Establishment and experimental study on mouse model of Chlamydia pneumoniae pneumonitis
Q98186306Etiological analysis of virus, mycoplasma pneumoniae and chlamydia pneumoniae in hospitalized children with acute respiratory infections in Huzhou
Q37860365Evaluation of CSF-Chlamydia pneumoniae, CSF-tau, and CSF-Abeta42 in Alzheimer's disease and vascular dementia
Q37883374Evaluation of Chlamydia immunoglobulin M (IgM), IgG, and IgA rELISAs Medac for diagnosis of Chlamydia pneumoniae infection
Q33999796Evaluation of Chlamydia pneumoniae 43- and 53-kilodalton recombinant proteins for serodiagnosis by Western Blot
Q34943465Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults.
Q33676311Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections
Q37876797Evaluation of a commercial test for antibodies to the chlamydial lipopolysaccharide (Medac) for serodiagnosis of acute infections by Chlamydia pneumoniae (TWAR) and Chlamydia psittaci
Q37885489Evaluation of a direct fluorescent antibody assay for detection of Chlamydia pneumoniae
Q37882001Evaluation of a new commercial microimmunofluorescence test for detection of antibodies to Chlamydia pneumoniae, Chlamydia trachomatis, and Chlamydia psittaci
Q37862533Evaluation of association between an acute attack of childhood bronchial asthma and Chlamydia pneumoniae infection
Q37887477Evaluation of culture conditions used for isolation of Chlamydia pneumoniae
Q37856450Evaluation of direct immunofluorescence test for diagnosis of upper respiratory tract infection by Chlamydia pneumoniae.
Q24802120Evaluation of five DNA extraction methods for purification of DNA from atherosclerotic tissue and estimation of prevalence of Chlamydia pneumoniae in tissue from a Danish population undergoing vascular repair
Q37873927Evaluation of real-time quantitative PCR for identification and quantification of Chlamydia pneumoniae by comparison with immunohistochemistry
Q37890204Evaluation of serological methods in the diagnosis of Chlamydia pneumoniae pneumonia during an epidemic in Finland
Q37853995Evaluation of the combination of the NucliSENS easyMAG and the EasyQ applications for the detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory tract specimens
Q37881546Evidence for Chlamydia pneumoniae infection in steroid-dependent asthma
Q37890100Evidence for Chlamydia pneumoniae of non-human origin
Q37876593Evidence for infection with Chlamydia pneumoniae in a subgroup of patients with multiple sclerosis
Q37858639Evidence for persistent Chlamydia pneumoniae infection of human coronary atheromas
Q37878198Evidence of 2 waves of Chlamydia pneumoniae infection in Gävle, Sweden, 1990-96.
Q43430224Evidence of Chlamydia pneumoniae infection obtained by the polymerase chain reaction (PCR) in patients with acute myocardial infarction and coronary heart disease
Q37869154Evidence of an association between Chlamydia pneumoniae and cerebrovascular accidents
Q37866634Evidence of chronic Chlamydia pneumoniae infection in patients with Behçet's disease
Q37881023Evidence of systemic dissemination of Chlamydia pneumoniae via macrophages in the mouse
Q37873002Evidence that Chlamydia pneumoniae affects platelet activity in patients with acute myocardial infarction and ST-segment elevations.
Q37890130Evidence that Chlamydia pneumoniae causes pneumonia and bronchitis
Q37897937Evidence that Chlamydia pneumoniae, strain TWAR, is not sexually transmitted
Q37451419Evidence that human Chlamydia pneumoniae was zoonotically acquired
Q33570163Evolution to a chronic disease niche correlates with increased sensitivity to tryptophan availability for the obligate intracellular bacterium Chlamydia pneumoniae
Q33756457Expansion of a novel pulmonary CD3(-) CD4(+) CD8(+) cell population in mice during Chlamydia pneumoniae infection
Q37871964Experimental Chlamydia pneumoniae infection in NIH/S mice: effect of reinoculation with chlamydial or cell preparation on culture, PCR and histological findings of lung tissue
Q37887313Experimental Chlamydia pneumoniae infection in mice: effect of reinfection and passive immunization
Q37867617Experimental infection by Chlamydia pneumoniae in the hamster
Q37890203Experimental infection of Chlamydia pneumoniae in mice
Q37898047Experimental infection of baboons (Papio cynocephalus anubis) with Chlamydia pneumoniae strain 'TWAR'.
Q36977911Experimental infection with Chlamydia pneumoniae in nonhuman primates
Q35774105Experimental rabbit models of Chlamydia pneumoniae infection
Q37889605Experimental study on the mechanisms of Chlamydia pneumoniae respiratory infection in mice with former chlamydial exposure
Q37655094Exploring the role of Chlamydia pneumoniae in cardiovascular disease: a narrative review.
Q37859149Exposure to Chlamydia pneumoniae infection and age-related macular degeneration: the Blue Mountains Eye Study
Q37864806Exposure to Chlamydia pneumoniae infection and progression of age-related macular degeneration
Q37842070Exposure to cigarette smoke and Chlamydia pneumoniae infection in mice: Effect on infectious burden, systemic dissemination and cytokine responses: A pilot study
Q37883033Exposures to Legionella pneumophila and Chlamydia pneumoniae in South African Mine Workers
Q37868333Expression and localization of type III secretion-related proteins of Chlamydia pneumoniae
Q34006871Expression of Chlamydia pneumoniae polymorphic membrane protein family genes
Q37884222Expression of adhesion molecules on endothelial cells stimulated by Chlamydia pneumoniae
Q37865448Expression of both Chlamydia pneumoniae RNase HIIs in Escherichia coli
Q37870132Extraction of Chlamydia pneumoniae DNA from vascular tissue for use in PCR: an evaluation of four procedures
Q37868688Extrarespiratory Chlamydia pneumoniae infection associated with immune disorder, hepatitis and renal disease
Q37852951FDG/PET uptake in asymptomatic multilobar Chlamydia pneumoniae pneumonia
Q37893037Factors influencing the infectivity of Chlamydia pneumoniae elementary bodies on HL cells
Q63363778Faculty of 1000 evaluation for Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents
Q37874971Failure to demonstrate Chlamydia pneumoniae in cardiovascular tissue from children with Kawasaki disease
Q37881207Failure to demonstrate Chlamydia pneumoniae in symptomatic abdominal aortic aneurysms by a nested polymerase chain reaction (PCR).
Q35130220Failure to detect Chlamydia pneumoniae DNA in cerebral aneursymal sac tissue with two different polymerase chain reaction methods
Q37869472Failure to detect Chlamydia pneumoniae by cell culture and polymerase chain reaction in major arteries of 93 patients with atherosclerosis
Q37871083Failure to detect Chlamydia pneumoniae in aortic valves and peripheral blood mononuclear cells from patients undergoing aortic valve replacement in Norway
Q37880753Failure to detect Chlamydia pneumoniae in atherosclerotic plaques of Australian patients.
Q24551398Failure to detect Chlamydia pneumoniae in brain sections of Alzheimer's disease patients
Q37877411Failure to detect Chlamydia pneumoniae in brain tissues of Alzheimer's disease
Q37880226Failure to detect Chlamydia pneumoniae in calcific and degenerative arteriosclerotic aortic valves excised during open heart surgery.
Q37885296Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy
Q37886254Failure to detect Chlamydia pneumoniae in ear fluids from children with otitis media.
Q37871128Failure to detect Chlamydia pneumoniae in senile calcific aortic stenosis or calcified congenital bicuspid aortic valve by immunofluorescence, polymerase chain reaction and electron microscopy
Q37877202Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.
Q43424813Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.
Q44029828Failure to detect Chlamydia pneumoniae in the central nervous system of patients with MS.
Q33968146Failure to detect Chlamydia pneumoniae in the late-onset Alzheimer's brain
Q37881776Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens
Q37885509Familial occurrence of Chlamydia pneumoniae infection
Q37867096Fatal hemorrhagic pneumonia concomitant with Chlamydia pneumoniae and parainfluenza virus 4 infection
Q37873074Field epidemiological investigation on an outbreak of Chlamydia pneumoniae infection--first recognized incidence in a nursing home for elderly in Japan
Q37867494First-choice antibiotics at subinhibitory concentrations induce persistence of Chlamydia pneumoniae
Q35805536Flotillin-1 (Reggie-2) contributes to Chlamydia pneumoniae growth and is associated with bacterial inclusion
Q37872007Foam cell formation inhibits growth of Chlamydia pneumoniae but does not attenuate Chlamydia pneumoniae-induced secretion of proinflammatory cytokines
Q37859729Frequency of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in children
Q37876254Frequency of coexistence of cytomegalovirus and Chlamydia pneumoniae in atherosclerotic plaques
Q37873672Frequency of occurrence of cytomegalovirus and Chlamydia pneumoniae in lymphocytes of atherosclerotic patients
Q37875485Frequent contamination of Chlamydia trachomatis and Chlamydia pneumoniae strains with mycoplasma. Biological relevance and selective eradication of mycoplasma from chlamydial cultures with mupirocin
Q37887875Further characterization of Chlamydia pneumoniae specific monoclonal antibodies
Q37885326Future trends in Chlamydia pneumoniae research and the place of macrolides in treatment
Q37854904Gene expression signatures characterizing the development of lymphocyte response during experimental Chlamydia pneumoniae infection.
Q37866577Genetic and culture-based approaches for detecting macrolide resistance in Chlamydia pneumoniae
Q37858513Genetic control of susceptibility to pulmonary infection with Chlamydia pneumoniae in the mouse
Q37836256Genome Wide Analysis of Chlamydia pneumoniae for Candidate Vaccine Development
Q22065998Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39.
Q92462206Genome-wide DNA methylation and RNA expression profiles identified RIPK3 as a differentially methylated gene in Chlamydia pneumoniae infection lung carcinoma patients in China
Q31032708Genomic approach for analysis of surface proteins in Chlamydia pneumoniae
Q35607714Genomic factors related to tissue tropism in Chlamydia pneumoniae infection
Q37866651Genomic, serologic, and clinical case-control study of Chlamydia pneumoniae and peripheral artery occlusive disease
Q37868431Genotypic Differences in theChlamydia pneumoniae tyrP Locus Related to Vascular Tropism and Pathogenicity
Q35078469GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, impairs neovascularization by decreasing endothelial progenitor cell function
Q37851235GroEL1, a heat shock protein 60 of Chlamydia pneumoniae, induces lectin-like oxidized low-density lipoprotein receptor 1 expression in endothelial cells and enhances atherogenesis in hypercholesterolemic rabbits
Q34382599GroEL1, from Chlamydia pneumoniae, induces vascular adhesion molecule 1 expression by p37(AUF1) in endothelial cells and hypercholesterolemic rabbit
Q37866670Growth factor production in human endothelial cells after Chlamydia pneumoniae infection
Q37890113Growth in serum-free medium improves isolation of Chlamydia pneumoniae
Q33935046Growth in vascular cells and cytokine production by Chlamydia pneumoniae
Q47104865Growth of Chlamydia pneumoniae Is Enhanced in Cells with Impaired Mitochondrial Function
Q37884521Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response
Q37884265Growth of Chlamydia pneumoniae induces cytokine production and expression of CD14 in a human monocytic cell line
Q43435375Guillain-Barré syndrome after Chlamydia pneumoniae infection
Q37866115Heat shock protein 60 autoimmunity and early lipid lesions in cholesterol-fed C57BL/6JBom mice during Chlamydia pneumoniae infection
Q37866477Heat shock protein 60 from Chlamydia pneumoniae elicits an unusual set of inflammatory responses via Toll-like receptor 2 and 4 in vivo
Q37869150Helicobacter pylori, Chlamydia pneumoniae and myocardial infarction
Q33821315Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus: chronic infections and coronary heart disease
Q37877079Helicobacter pylori, Chlamydia pneumoniae, reactive C protein, and cerebrovascular diseases
Q37873984Heparan sulfate-like glycosaminoglycan is a cellular receptor for Chlamydia pneumoniae
Q37881382Herd immunity and the role of Chlamydia pneumoniae in the etiology of respiratory diseases in the Czech Republic
Q115769780Heterogeneous expression of Chlamydia pneumoniae antigen candidates and high-level soluble expression of its inclusion membrane proteins in Escherichia coli
Q127718877High Incidence of Chlamydia Pneumoniae in Atherosclerosis of Coronary Arteries With Both Genus and Species Specific Antisera
Q36262589High Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in Children with Acute Respiratory Infections from Lima, Peru.
Q92765759High Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae among Scrub Typhus Patients in South Korea
Q93043812High frequency of Chlamydia pneumoniae and risk factors in children with acute respiratory infection
Q37856127High immunoglobulin A seropositivity for combined Chlamydia pneumoniae, Helicobacter pylori infection, and high-sensitivity C-reactive protein in coronary artery disease patients in India can serve as atherosclerotic marker
Q37883688High incidence of Chlamydia pneumoniae in sclerotic heart valves of patients undergoing aortic valve replacement
Q37880679High prevalence of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in patients with cardiovascular disease and in middle-aged blood donors.
Q37865107High prevalence of Chlamydia pneumoniae antibodies and increased high-sensitive C-reactive protein in patients with vascular dementia
Q37869178High prevalence of Chlamydia pneumoniae antibodies in white-coat hypertensives
Q37846411High prevalence of Chlamydia pneumoniae infection in an asymptomatic Jordanian population
Q37892244High prevalence of Chlamydia pneumoniae infection in children and young adults in Spain
Q37867181High prevalence of Chlamydia pneumoniae infection in cyclosporin A-induced post-transplant gingival overgrowth tissue and evidence for the possibility of persistent infection despite short-term treatment with azithromycin
Q37866592High prevalence of Chlamydia pneumoniae seropositivity in Mexican patients with ischemic heart disease.
Q36503604High prevalence of antibodies to Chlamydia pneumoniae; determinants of IgG and IgA seropositivity among Jerusalem residents
Q37864512High rate of seropositivity of Chlamydia pneumoniae IgA in male patients with nonalcoholic steatohepatitis
Q37857914High sensitivity C-reactive protein and immunoglobulin G against Chlamydia pneumoniae and chlamydial heat shock protein-60 in ischemic heart disease.
Q33286200Higher incidence of persistent chronic infection of Chlamydia pneumoniae among coronary artery disease patients in India is a cause of concern
Q37869441Higher prevalence of Chlamydia pneumoniae seropositivity in Finnish twins compared with co-twins living in Sweden: relationships with markers of subclinical atherosclerosis
Q37843935Higher titers of anti-Chlamydia pneumoniae IgG in diabetic retinopathy: a cross-sectional study
Q37893957Hilar lymphadenopathy associated with Chlamydia pneumoniae infection
Q74181274Histological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis
Q37866443Histopathologic signs for the inflammatory role of Chlamydia pneumoniae in the high-grade atherosclerotic coronary artery wall.
Q37848046Host cell Golgi anti-apoptotic protein (GAAP) and growth of Chlamydia pneumoniae
Q37856089Host cell cytokines induced by Chlamydia pneumoniae decrease the expression of interstitial collagens and fibronectin in fibroblasts
Q37860251Host cell responses to Chlamydia pneumoniae in gamma interferon-induced persistence overlap those of productive infection and are linked to genes involved in apoptosis, cell cycle, and metabolism
Q37873710Host immune response to Chlamydia pneumoniae heat shock protein 60 is associated with asthma
Q37846580Host metabolism promotes growth of Chlamydia pneumoniae in a low oxygen environment.
Q37841986Human Chlamydia pneumoniae isolates demonstrate ability to recover infectivity following penicillin treatment whereas animal isolates do not.
Q35005258Human herpesvirus 6 and Chlamydia pneumoniae as etiologic agents in multiple sclerosis - a critical review
Q37874441Human monocyte-derived insulin-like growth factor-2 enhances the infection of human arterial endothelial cells by Chlamydia pneumoniae
Q37880204Humoral immune response to Chlamydia pneumoniae in twin discordant for smoking.
Q37869027Hydroxymethylglutaryl coenzyme A reductase inhibition reduces Chlamydia pneumoniae-induced cell interaction and activation
Q37876716Hydroxymethylglutaryl coenzyme A reductase inhibitors modify the inflammatory response of human macrophages and endothelial cells infected with Chlamydia pneumoniae
Q47557566Hyperbolic relation between beta-cell function and insulin sensitivity for type 2 diabetes mellitus, malaria, influenza, Helicobacter pylori, Chlamydia pneumoniae, and hepatitis C virus infection-induced inflammation/oxidative stress and temporary i
Q37872162Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease
Q37875205Hyperinsulinemia, lipoprotein (a), and Chlamydia pneumoniae antibodies--are they risk factors or serologic predictors for progression of coronary artery disease?
Q43422125Hypothalamic-pituitary-adrenal (HPA) system activity in depression and infection with Borna disease virus and Chlamydia pneumoniae
Q35688972Hypothetical protein Cpn0308 is localized in the Chlamydia pneumoniae inclusion membrane
Q37833851Hypothetical protein Cpn0423 triggers NOD2 activation and contributes to Chlamydia pneumoniae-mediated inflammation
Q43433706Hypoxemic pneumopathy caused by Chlamydia pneumoniae
Q37868127IFN-gamma induced persistent Chlamydia pneumoniae infection in HL and Mono Mac 6 cells: characterization by real-time quantitative PCR and culture
Q37852203IL-17A Is Proatherogenic in High-Fat Diet-Induced and Chlamydia pneumoniae Infection-Accelerated Atherosclerosis in Mice
Q36539539Identification and characterization of Chlamydia pneumoniae-specific proteins that activate tumor necrosis factor alpha production in RAW 264.7 murine macrophages
Q28283487Identification and localization of Chlamydia pneumoniae in the Alzheimer's brain
Q37869309Identification and quantification of Chlamydia pneumoniae in human atherosclerotic plaques by LightCycler real-time-PCR.
Q37118408Identification of Chlamydia pneumoniae by DNA amplification of the 16S rRNA gene
Q88670694Identification of Chlamydia pneumoniae candidate genes that interact with human apoptotic factor caspase-9
Q37864868Identification of Chlamydia pneumoniae in intracranial and extracranial arteries in patients with stroke and in controls: combined immunohistochemical and polymerase chain reaction analyses
Q37861617Identification of Chlamydia pneumoniae proteins in the transition from reticulate to elementary body formation
Q37864777Identification of Chlamydia pneumoniae within human choroidal neovascular membranes secondary to age-related macular degeneration.
Q34125106Identification of Chlamydia pneumoniae-derived mouse CD8 epitopes
Q37889915Identification of Chlamydia pneumoniae-specific protein antigens in immunoblots
Q37871641Identification of MEK- and phosphoinositide 3-kinase-dependent signalling as essential events during Chlamydia pneumoniae invasion of HEp2 cells
Q37844467Identification of Sphingomyelinase on the Surface of Chlamydia pneumoniae: Possible Role in the Entry into Its Host Cells
Q37867654Identification of an in vivo CD4+ T cell-mediated response to polymorphic membrane proteins of Chlamydia pneumoniae during experimental infection
Q37855987Identification of high- and low-virulent strains of Chlamydia pneumoniae by their characterization in a mouse pneumonia model
Q37865826Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings.
Q37879463Identification of two novel genes encoding 97- to 99-kilodalton outer membrane proteins of Chlamydia pneumoniae
Q37879806IgG subclass-specific antibodies in Chlamydia pneumoniae infections
Q37868702Imbalanced secretion of IL-1beta and IL-1RA in Chlamydia pneumoniae-infected mononuclear cells from COPD patients
Q37886113Immune response to Chlamydia trachomatis heat-shock protein in infertile female patients and influence of Chlamydia pneumoniae antibodies
Q30837656Immune response to genital chlamydial infection and influence of Chlamydia pneumoniae (TWAR) antibodies
Q37879386Immune responses to Chlamydia pneumoniae in twins in relation to gender and smoking
Q37875113Immunity to Chlamydia pneumoniae induced by vaccination with DNA vectors expressing a cytoplasmic protein (Hsp60) or outer membrane proteins (MOMP and Omp2).
Q35069480Immunization of Chlamydia pneumoniae (Cpn)-infected Apob(tm2Sgy)Ldlr(tm1Her)/J mice with a combined peptide of Cpn significantly reduces atherosclerotic lesion development
Q37871565Immunoblotting analysis of abdominal aortic aneurysms using antibodies against Chlamydia pneumoniae recombinant MOMP.
Q37870086Immunofluorescence in situ and the serologic indices of Chlamydia pneumoniae infection in patients with an abdominal aortic aneurysm.
Q37862860Immunoglobulin A and CD8 T-cell mucosal immune defenses protect against intranasal infection with Chlamydia pneumoniae.
Q37878292Immunoglobulin A antibodies against Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysm.
Q37884075Immunohistochemical detection of Chlamydia pneumoniae in abdominal aortic aneurysms
Q37875668Immunohistochemical staining for Chlamydia pneumoniae is increased in lung tissue from subjects with chronic obstructive pulmonary disease
Q33701035Immunohistological detection of Chlamydia pneumoniae in the Alzheimer's disease brain
Q37866783Immunohistostaining assays for detection of Chlamydia pneumoniae in atherosclerotic arteries indicate cross-reactions with nonchlamydial plaque constituents
Q37885660Immunopathogenesis of Chlamydia pneumoniae Infections in children
Q37857721Immunoproteomic identification and serological responses to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections
Q37888611Immunoreactivity of the 60 kDa cysteine-rich proteins of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae expressed in Escherichia coli
Q37866555Immunoserodiagnosis of acute Streptococcus pneumoniae and Chlamydia pneumoniae infections in the period of epidemic rise of non-hospital pneumonia in children in St. Petersburg, 1998-2001
Q37870063Impact of Chlamydia pneumoniae infection on survival rate after heart transplantation
Q37875466Impact of Chlamydia pneumoniae infections on asthma
Q44059306Impact of capsaicin, an active component of chili pepper, on pathogenic chlamydial growth (Chlamydia trachomatis and Chlamydia pneumoniae) in immortal human epithelial HeLa cells
Q37859394Impact of chronic Chlamydia pneumoniae infection on left ventricular remodeling after myocardial infarction
Q37876456Impact of chronic infection with chlamydia pneumoniae on incidence of cardiac allograft vasculopathy
Q35523803Impact of serological methodology on assessment of the link between Chlamydia pneumoniae and vascular diseases
Q34690945Impact of seropositivity to Chlamydia pneumoniae and anti-hHSP60 on cardiovascular events in hemodialysis patients
Q37885361Importance of Chlamydia pneumoniae as a new respiratory pathogen
Q37874789Importance of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia
Q37874461Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing
Q37868658Importance of methodology in determination of Chlamydia pneumoniae seropositivity in healthy subjects and in patients with coronary atherosclerosis
Q37888014Importance of smoking for Chlamydia pneumoniae seropositivity
Q36545356Improvement of growth of Chlamydia pneumoniae on HEp-2 cells by pretreatment with polyethylene glycol in combination with additional centrifugation and extension of culture time.
Q92500148In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae
Q90226068In Vitro Activity of Omadacycline against Chlamydia pneumoniae
Q33565253In situ detection of Chlamydia pneumoniae, C. trachomatis, and cytokines among cardiovascular diseased patients from the Amazon region of Brazil
Q37872796In vitro activities of BMS-284756 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae
Q37888833In vitro activities of OPC-17116, a new quinolone; ofloxacin; and sparfloxacin against Chlamydia pneumoniae
Q35126064In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae
Q37877849In vitro activities of azithromycin and ofloxacin against Chlamydia pneumoniae in a continuous-infection model
Q35885610In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae
Q37884244In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae
Q35121993In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae
Q37893696In vitro activities of five quinolones against Chlamydia pneumoniae
Q34141733In vitro activities of garenoxacin and levofloxacin against Chlamydia pneumoniae are not affected by presence of Mycoplasma DNA.
Q37877492In vitro activities of gemifloxacin (SB 265805, LB20304) against recent clinical isolates of Chlamydia pneumoniae.
Q37870051In vitro activities of rifamycin derivatives ABI-1648 (Rifalazil, KRM-1648), ABI-1657, and ABI-1131 against Chlamydia trachomatis and recent clinical isolates of Chlamydia pneumoniae
Q37876885In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae
Q37843405In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae
Q37874904In vitro activity of GAR-936 against Chlamydia pneumoniae and Chlamydia trachomatis
Q37881176In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.
Q37869802In vitro activity of a new antibiotic, NVP-PDF386 (VRC4887), against Chlamydia pneumoniae
Q37880865In vitro activity of a new ketolide antibiotic, HMR 3647, against Chlamydia pneumoniae.
Q35818615In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae
Q37868805In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae
Q37869288In vitro activity of garenoxacin against recent clinical isolates of Chlamydia pneumoniae
Q37871838In vitro activity of levofloxacin against contemporary clinical isolates of Legionella pneumophila, Mycoplasma pneumoniae and Chlamydia pneumoniae from North America and Europe
Q43426019In vitro activity of midecamycin diacetate against Mycoplasma pneumoniae and Chlamydia pneumoniae
Q37845251In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae
Q37873518In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae
Q35138264In vitro activity of trovafloxacin against Chlamydia pneumoniae
Q43422417In vitro antibiotic activity against Chlamydia pneumoniae clinical isolates.
Q37856179In vitro characterisation of koala Chlamydia pneumoniae: morphology, inclusion development and doubling time
Q37872973In vitro degradation of aortic elastin by Chlamydia pneumoniae
Q35824208In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae
Q37878237In vitro hyperreactivity to lipopolysaccharide in patients with history of unstable angina is not associated with seropositivity for Cytomegalovirus, Helicobacter pylori and Chlamydia pneumoniae
Q37877535In vitro infection and pathogenesis of Chlamydia pneumoniae in endovascular cells
Q37883558In vitro infection of smooth muscle cells by Chlamydia pneumoniae.
Q37868351In vitro inhibitory effects of tea polyphenols on the proliferation of Chlamydia trachomatis and Chlamydia pneumoniae
Q37855338In vitro neutralization of tumor necrosis factor-alpha during Chlamydia pneumoniae infection impairs dendritic cells maturation/function and increases chlamydial progeny
Q37876245In vitro pharmacodynamics of the new ketolides HMR 3004 and HMR 3647 (Telithromycin) against Chlamydia pneumoniae
Q37897794In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
Q37878178In vitro susceptibilities of Chlamydia pneumoniae isolates from German patients and synergistic activity of antibiotic combinations
Q37880155In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries.
Q37873067In vitro susceptibility and eradication of Chlamydia pneumoniae cardiovascular strains from coronary artery endothelium and smooth muscle cells
Q36524413In vitro susceptibility of human vascular wall cells to infection with Chlamydia pneumoniae
Q37864023In vivo treatment of acute Chlamydia pneumoniae infection with the flavonoids quercetin and luteolin and an alkyl gallate, octyl gallate, in a mouse model
Q37882878In-vitro activity of dirithromycin against Chlamydia pneumoniae
Q37877336In-vitro activity of gatifloxacin against Chlamydia trachomatis and Chlamydia pneumoniae
Q37894473In-vitro susceptibility of Chlamydia pneumoniae (TWAR) to seven antibiotics
Q37873507Incidence of Chlamydia pneumoniae infection in patients with coronary artery disease subjected to angioplasty or bypass surgery.
Q37879453Incidence of Chlamydia pneumoniae infection in vertically HIV-1 infected children.
Q37892040Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study
Q37890395Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients
Q37872995Incidence of immunoglobulin G antibodies to Chlamydia pneumoniae in acute myocardial infarction patients.
Q33943276Inclusion fluorescent-antibody test as a screening assay for detection of antibodies to Chlamydia pneumoniae
Q37873486Increased CD8(+) T cells associated with Chlamydia pneumoniae in symptomatic carotid plaque
Q37863199Increased aortic intima-media thickness in 11-year-old healthy children with persistent Chlamydia pneumoniae seropositivity
Q37872208Increased circulating immune complexes in acute stroke: the triggering role of Chlamydia pneumoniae and cytomegalovirus
Q37880979Increased fibrinogen levels are associated with persistent Chlamydia pneumoniae infection in unstable coronary artery disease
Q37874359Increased frequency of Chlamydia pneumoniae antibodies in patients with asthma
Q35586809Increased incidence of cytomegalovirus but not Chlamydia pneumoniae in atherosclerotic lesions of arteries of lower extremities from patients with diabetes mellitus undergoing amputation
Q37867086Increased prevalence of and gene transcription by Chlamydia pneumoniae in cerebrospinal fluid of patients with relapsing-remitting multiple sclerosis
Q37868606Increased production of matrix metalloproteinases 1 and 3 by smooth muscle cells upon infection with Chlamydia pneumoniae
Q37861838Increased prostanoid dependency of arterial relaxation in Chlamydia pneumoniae-infected mice
Q37844042Increased sensitivity to tryptophan bioavailability is a positive adaptation by the human strains of Chlamydia pneumoniae.
Q43434465Increasing prevalence of specific antibodies to Chlamydia pneumoniae in Sweden
Q37874609Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis.
Q37873698Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms.
Q64987702Indoleamine 2,3-Dioxygenase Activity in Chlamydia muridarum and Chlamydia pneumoniae Infected Mouse Lung Tissues.
Q37852800Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin
Q37848659Induction of VEGF and MMP-9 expression by toll-like receptor 2/4 in human endothelial cells infected with Chlamydia pneumoniae
Q33553163Induction of interferon-stimulated genes by Chlamydia pneumoniae in fibroblasts is mediated by intracellular nucleotide-sensing receptors.
Q37855545Induction of interleukin-18 in atherosclerotic patients: a role for Chlamydia pneumoniae
Q37867692Induction of lipoprotein lipase gene expression in Chlamydia pneumoniae-infected macrophages is dependent on Ca2+ signaling events
Q37881436Induction of macrophage foam cell formation by Chlamydia pneumoniae
Q37869398Induction of oral tolerance as treatment or prevention of chronic diseases associated with Chlamydia pneumoniae infection--hypothesis.
Q37850249Induction of proinflammatory cytokines and cell apoptosis by Chlamydia pneumoniae Cpn0810
Q34581245Induction of proinflammatory cytokines in human lung epithelial cells during Chlamydia pneumoniae infection
Q37850475Induction of proinflammatory cytokines in human osteoblastic cells by Chlamydia pneumoniae.
Q37862282Induction of tissue factor expression and release as microparticles in ECV304 cell line by Chlamydia pneumoniae infection
Q37875332Infection and activation of airway epithelial cells by Chlamydia pneumoniae
Q37879391Infection and atherosclerosis--focus on cytomegalovirus and Chlamydia pneumoniae
Q37877767Infection hypothesis for the pathogenesis of atherosclerosis--caused by Chlamydia pneumoniae?
Q37883200Infection of Acanthamoeba castellanii by Chlamydia pneumoniae
Q37868327Infection of U937 Monocytic Cells withChlamydia pneumoniaeInduces Extensive Changes in Host Cell Gene Expression
Q37879018Infection of human endothelial cells with Chlamydia pneumoniae stimulates transendothelial migration of neutrophils and monocytes
Q35144785Infection of human monocytes by Chlamydia pneumoniae and Chlamydia trachomatis: an in vitro comparative study
Q37881464Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model
Q33729334Infection with Chlamydia pneumoniae and atherosclerosis: a review.
Q34180015Infection with Chlamydia pneumoniae and risk of multiple sclerosis
Q35821202Infection with Chlamydia pneumoniae as a cause of coronary heart disease: the hypothesis is still untested
Q37863230Infection with Chlamydia pneumoniae but not Helicobacter pylori is related to elevated apolipoprotein B levels
Q37895177Infection with Chlamydia pneumoniae in Brooklyn
Q37887510Infection with Chlamydia pneumoniae in infants and children with acute lower respiratory tract disease
Q33216385Infection with chlamydia pneumoniae increases oxidative stress and accelerates the development of atherosclerosis in C57BL/6J mice
Q33706917Infection-mediated asthma: etiology, mechanisms and treatment options, with focus on Chlamydia pneumoniae and macrolides
Q44058986Infections and Chlamydia pneumoniae antibodies influence the functional outcome in thrombolysed strokes
Q35535575Infections caused by Chlamydia pneumoniae strain TWAR
Q37191198Infections with Chlamydia pneumoniae strain TWAR
Q37876989Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis
Q37875835Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis
Q37851763Infectious Chlamydia pneumoniae is associated with elevated interleukin-8 and airway neutrophilia in children with refractory asthma
Q35079371Infectious agents and multiple sclerosis--are Chlamydia pneumoniae and human herpes virus 6 involved?
Q37866530Infectious risk factors for atherosclerotic vascular disease in hemodialysis patients--Chlamydia pneumoniae but not Helicobacter pylori or cytomegalovirus is associated with increased C-reactive protein
Q37876952Infective Chlamydia pneumoniae and coronary disease: where is the truth?
Q37840502Infective endocarditis caused by Chlamydia pneumoniae after liver transplantation. Case report
Q37863087Inflammation and Chlamydia pneumoniae infection correlate with the severity of peripheral arterial disease
Q37862004Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation?
Q35164422Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome
Q43419781Inflammatory abdominal aortic aneurysm and Chlamydia pneumoniae infection
Q37875398Inflammatory cells, apoptosis and Chlamydia pneumoniae infection in atherosclerosis.
Q37860389Inflammatory responses following Chlamydia pneumoniae infection of glial cells
Q37868136Influence of Chlamydia pneumoniae infection on aortic stiffness in healthy young men.
Q37886900Influence of centrifugation on the infectivity of Chlamydia pneumoniae IOL-207.
Q37871579Influence of clarithromycin on early atherosclerotic lesions after Chlamydia pneumoniae infection in a rabbit model
Q32091287Influence of iron restriction on Chlamydia pneumoniae and C. trachomatis
Q37890521Influence of temperature and relative humidity on the survival of Chlamydia pneumoniae in aerosols
Q33829172Influence of the Chlamydia pneumoniae AR39 bacteriophage ϕCPAR39 on chlamydial inclusion morphology.
Q35425745Inhibition of Chlamydia pneumoniae growth in HEp-2 cells pretreated with gamma interferon and tumor necrosis factor alpha.
Q37881021Inhibition of Chlamydia pneumoniae replication in HEp-2 cells by interferon-gamma: role of tryptophan catabolism.
Q37875477Inhibition of Chlamydia pneumoniae replication in human aortic smooth muscle cells by gamma interferon-induced indoleamine 2, 3-dioxygenase activity
Q37866393Inhibitory actions of several natural products on proliferation of rat vascular smooth muscle cells induced by Hsp60 from Chlamydia pneumoniae J138.
Q37869167Inhibitory activities of quinolones against DNA gyrase of Chlamydia pneumoniae
Q37863140Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures.
Q37862855Inhibitory effect of heparan sulfate-like glycosaminoglycans on the infectivity of Chlamydia pneumoniae in HL cells varies between strains
Q37852736Inhibitory effect of the natural product betulin and its derivatives against the intracellular bacterium Chlamydia pneumoniae.
Q37861426Initial empiric antimicrobial treatment of Chlamydia pneumoniae: a study of 54 cases in the Republic of Macedonia
Q27027451Innate immune responses to Chlamydia pneumoniae infection: role of TLRs, NLRs, and the inflammasome
Q37374326Innate immunity and vaccines in chlamydial infection with special emphasis on Chlamydia pneumoniae.
Q37859349Inoculation of Chlamydia pneumoniae or Chlamydia trachomatis with ligands that inhibit attachment to host cells reduces infectivity in the mouse model of lung infection: implication for anti-adhesive therapy
Q102068539Insights Into a Chlamydia pneumoniae-Specific Gene Cluster of Membrane Binding Proteins
Q37861388Interaction between Chlamydia pneumoniae seropositivity, inflammation and risk factors for atherosclerosis in patients with severe coronary stenosis.
Q37879844Interaction of Chlamydia pneumoniae and human alveolar macrophages: infection and inflammatory response
Q37877539Interaction of Chlamydia pneumoniae infection with other risk factors of atherosclerosis
Q37869550Interactions between Chlamydia pneumoniae and Trace Elements: A Possible Link to Aortic Valve Sclerosis
Q33526048Interactions between flagellar and type III secretion proteins in Chlamydia pneumoniae
Q33935050Interactions of Chlamydia pneumoniae with human endothelial cells
Q37073869Interference of immunoglobulin G (IgG) antibodies in IgA antibody determinations of Chlamydia pneumoniae by microimmunofluorescence test
Q37872949Interferon-beta induction by Chlamydia pneumoniae in human smooth muscle cells
Q33711781Interlaboratory reliability of microimmunofluorescence test for measurement of Chlamydia pneumoniae-specific immunoglobulin A and G antibody titers
Q37872553Interleukin-1 receptor antagonist is detectable in human carotid artery plaques and is related to triglyceride levels and Chlamydia pneumoniae IgA antibodies
Q37851321Interleukin-6-174 G/C promoter polymorphism is associated with persistence of Chlamydia pneumoniae antibodies in young men.
Q37865312Intermittent azithromycin treatment for respiratory symptoms in patients with chronic Chlamydia pneumoniae infection
Q37856905Interrelationship of interleukin 6, C-reactive protein and Chlamydia pneumoniae IgG antibodies in patients with acute coronary syndromes
Q37857618Intragastric primary infection sensitizes to lung reinfection in a Chlamydia pneumoniae mouse model
Q37861522Intranasal administration of chlamydial outer protein N (CopN) induces protection against pulmonary Chlamydia pneumoniae infection in a mouse model.
Q90562999Intranasal immunization with recombinant chlamydial protease-like activity factor attenuates atherosclerotic pathology following Chlamydia pneumoniae infection in mice
Q34760989Intranasal vaccination with Chlamydia pneumoniae induces cross-species immunity against genital Chlamydia muridarum challenge in mice
Q24795045Intrastrain and interstrain genetic variation within a paralogous gene family in Chlamydia pneumoniae
Q37874029Intrathecal antibody production against Chlamydia pneumoniae in multiple sclerosis is part of a polyspecific immune response
Q37867930Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms.
Q43424949Introducing Chlamydophila pneumoniae: the TWAR agent Chlamydia pneumoniae in a new perspective
Q37842537Invariant Natural Killer T Cells Promote T Cell Immunity by Modulating the Function of Lung Dendritic Cells during Chlamydia pneumoniae Infection.
Q37865216Inverse association between Chlamydia pneumoniae respiratory tract infection and initiation of asthma or allergic rhinitis in children
Q37874824Inverse association of Chlamydia pneumoniae infection with high blood pressure in Japanese adults
Q37862723Investigation of Chlamydia pneumoniae DNA, chlamydial lipopolisaccharide antigens, and Helicobacter pylori DNA in atherosclerotic plaques of patients with aortoiliac occlusive disease
Q40068224Investigation of Chlamydia pneumoniae infection in Moroccan patients suffering from cardiovascular diseases
Q36370964Investigation of a Chlamydia pneumoniae outbreak in a Federal correctional facility in Texas
Q36000970Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence
Q37869400Involvement of nicotinic acetylcholine receptors in controlling Chlamydia pneumoniae growth in epithelial HEp-2 cells
Q37833858Iron Homeostasis in Tissues Is Affected during Persistent Chlamydia pneumoniae Infection in Mice.
Q43197268Iron and the role of Chlamydia pneumoniae in heart disease
Q37872373Iron chelation and hydroxyl radical scavenging reduce the inflammatory response of endothelial cells after infection with Chlamydia pneumoniae or influenza A.
Q37861473Iron enhances endothelial cell activation in response to Cytomegalovirus or Chlamydia pneumoniae infection
Q37860532Is Chlamydia pneumoniae a risk factor for peripheral atherosclerosis?
Q43422245Is Chlamydia pneumoniae an important pathogen in patients with community-acquired pneumonia?
Q37871479Is Chlamydia pneumoniae found in spinal fluid samples from multiple sclerosis patients? Conflicting results
Q43424830Is Chlamydia pneumoniae important in asthma? The first controlled trial of therapy leaves the question unanswered
Q35590958Is Chlamydia pneumoniae infection a risk factor for age related macular degeneration?
Q37867446Is Chlamydia pneumoniae infection associated with stroke in children with sickle cell disease?
Q33970414Is Chlamydia pneumoniae present in brain lesions of patients with multiple sclerosis?
Q42940513Is Chlamydia pneumoniae present in cerebrospinal fluid of multiple sclerosis patients?
Q43426528Is Chlamydia pneumoniae present in the central nervous system of multiple sclerosis patients?
Q43429266Is Chlamydia pneumoniae responsible for disease in children?
Q37855880Is Chlamydia pneumoniae seropositivity associated with atherothrombotic cerebrovascular infarction?
Q43413598Is Chlamydia pneumoniae the causative agent of microscopic polyangiitis?
Q37888501Is coronary disease caused by an infection with Chlamydia pneumoniae?
Q37879915Is infection with Chlamydia pneumoniae a causative agent in atherosclerosis?
Q43418862Is seropositivity enough to show the association between coronary artery disease and Chlamydia pneumoniae and Helicobacter pylori infection?
Q37511385Is the perceived association between Chlamydia pneumoniae and vascular diseases biased by methodology?
Q37840151Is there a relationship between Parkinson's disease and Chlamydia pneumoniae?
Q37875235Is there a role for Chlamydia pneumoniae in hemodialysis vascular access thrombosis?
Q37867147Is there a role for Chlamydia pneumoniae infection in systemic lupus erythematosus and in the associated atherosclerotic cardiovascular disease?
Q37876415Is there an association between Kawasaki disease and Chlamydia pneumoniae?
Q37859691Is there any relationship between asthma and asthma attack in children and atypical bacterial infections; Chlamydia pneumoniae, Mycoplasma pneumoniae and Helicobacter pylori
Q43425132Isolated 6th nerve palsy in a child associated with asymptomatic Chlamydia pneumoniae infection and elevated anti-GQ1b antibody
Q43425149Isolated pleural effusion as unusual manifestation of Chlamydia pneumoniae infection
Q35774875Isolation and characterization of a gene encoding a Chlamydia pneumoniae 76-kilodalton protein containing a species-specific epitope
Q37876438Isolation and continuous growth of Chlamydia pneumoniae from arterectomy specimens
Q36990657Isolation and sequence analysis of the Chlamydia pneumoniae GroE operon
Q37893426Isolation of Chlamydia pneumoniae and Antibodies to the Agent in Patients with Acute Bronchitis
Q34132478Isolation of Chlamydia pneumoniae clonal variants by a focus-forming assay
Q37882581Isolation of Chlamydia pneumoniae from a carotid endarterectomy specimen
Q37893376Isolation of Chlamydia pneumoniae from a patient with acute bronchitis
Q43436564Isolation of Chlamydia pneumoniae from middle ear aspirates of otitis media with effusion: a case report
Q33949413Isolation of Chlamydia pneumoniae from serum samples of the patients with acute coronary syndrome.
Q37883953Isolation of Chlamydia pneumoniae from the coronary artery of a patient with coronary atherosclerosis. The Chlamydia pneumoniae/Atherosclerosis Study Group
Q37895371Isolation of Chlamydia pneumoniae from the lungs of patients infected with the human immunodeficiency virus
Q43434854Isolation of Chlamydia pneumoniae from the maxillary sinus of a patient with purulent sinusitis
Q37888193Isolation of Chlamydia pneumoniae in atypical pneumonia
Q37868911Joint effects of Chlamydia pneumoniae infection and classic coronary risk factors on risk of acute myocardial infarction
Q37870985KN-62 enhances Chlamydia pneumoniae-induced p44/p42 mitogen-activated protein kinase activation in murine fibroblasts and attenuates in vitro infection
Q88432949Kawasaki Disease and Chlamydia Pneumoniae Infection
Q37850591Keratoconjunctivitis sicca during folicular conjunctivitis in adult patients with Chlamydia pneumoniae etiology (summarizing twelve years study)
Q37873102Koala biovar of Chlamydia pneumoniae infects human and koala monocytes and induces increased uptake of lipids in vitro
Q35892967Laboratory diagnosis of Chlamydia pneumoniae infections
Q42727780Labsystems enzyme immunoassay for Chlamydia pneumoniae also detects Chlamydia psittaci infections
Q43419136Lack of PBC-specific antimitochondrial antibodies in patients with Chlamydia pneumoniae infection
Q24802081Lack of association between Chlamydia Pneumoniae serology and endothelial dysfunction of coronary arteries
Q37869460Lack of association between Chlamydia pneumoniae seropositivity and aortic atherosclerotic plaques: a population-based transesophageal echocardiographic study
Q37867443Lack of association between Chlamydia pneumoniae seropositivity and common carotid intima-media thickness in type 2 diabetic patients
Q37877152Lack of association between Kawasaki syndrome and Chlamydia pneumoniae infection: an investigation of a Kawasaki syndrome cluster in San Diego County.
Q37876520Lack of association between Kawasaki syndrome and infection with parvovirus B19, human herpesvirus 8, TT virus, GB virus C/hepatitis G virus or Chlamydia pneumoniae
Q37878909Lack of association between prior infection with Chlamydia pneumoniae and acute or chronic coronary artery disease
Q37877681Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis.
Q43415336Lack of association between serum antibodies of Chlamydia pneumoniae infection and the risk of lung cancer
Q37870809Lack of association between serum immunoreactivity and Chlamydia pneumoniae detection in the human aortic wall
Q24805877Lack of association between vascular dementia and Chlamydia pneumoniae infection: a case-control study
Q37835396Lack of association of Chlamydia pneumoniae with cardiovascular diseases in virologically suppressed HIV patients
Q37877791Lack of association of restenosis following coronary angioplasty with elevated C-reactive protein levels or seropositivity to Chlamydia pneumoniae
Q37877084Lack of correlation between Chlamydia pneumoniae antibody titers and adult-onset asthma
Q43426520Lack of detectable Chlamydia pneumoniae in brain lesions of patients with multiple sclerosis
Q37880013Lack of evidence for a pathogenic role of Chlamydia pneumoniae and cytomegalovirus infection in coronary atheroma formation
Q37890147Lack of evidence of Chlamydia pneumoniae infection in infants with acute lower respiratory tract disease
Q37836191Lack of strong association of Chlamydia pneumoniae and atherosclerosis in a Jordanian population
Q28069433Lead Discovery Strategies for Identification of Chlamydia pneumoniae Inhibitors
Q37877936Legionella, Chlamydia pneumoniae and Mycoplasma infection in patients admitted to Christchurch Hospital with pneumonia
Q37869588Levofloxacin kills Chlamydia pneumoniae and modulates interleukin 6 production by HEp-2 cells
Q37869986Limited association of Chlamydia pneumoniae detection with coronary atherosclerosis
Q37870203Lipoprotein(a), Chlamydia pneumoniae, leptin and tissue plasminogen activator as risk markers for valvular aortic stenosis
Q33767275Local immune responses to Chlamydia pneumoniae in the lungs of BALB/c mice during primary infection and reinfection
Q35746659Localization of the hypothetical protein Cpn0585 in the inclusion membrane of Chlamydia pneumoniae-infected cells
Q35217607Localization of the hypothetical protein Cpn0797 in the cytoplasm of Chlamydia pneumoniae-infected host cells
Q37873990Low iron availability modulates the course of Chlamydia pneumoniae infection
Q37853983Low mannose-binding lectin levels and MBL2 gene polymorphisms associate with Chlamydia pneumoniae antibodies.
Q37873727Low prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae among patients with symptoms of respiratory tract infections in Dutch general practices
Q37861708Low prevalence of Chlamydia pneumoniae in adults with community-acquired pneumonia
Q37877922Low prevalence of Chlamydia pneumoniae in atherectomy specimens from patients with coronary heart disease
Q98497975Low prevalence of Chlamydia pneumoniae infections during the Mycoplasma pneumoniae epidemic season: Results of nationwide surveillance in Japan
Q90675908Low-Dose Aspirin May Prevent Trophoblast Dysfunction in Women With Chlamydia Pneumoniae Infection
Q37877677Lower prevalence of Chlamydia pneumoniae DNA compared with Chlamydia trachomatis DNA in synovial tissue of arthritis patients
Q37888385Lower respiratory tract infection with Chlamydia pneumoniae
Q37887196Lp(a) lipoprotein, IgG, IgA and IgM antibodies to Chlamydia pneumoniae and HLA class II genotype in early coronary artery disease
Q37893041Lumbosacral meningoradiculitis associated with Chlamydia pneumoniae infection.
Q37888840Lung infections in children. IV. Pneumonia due to Chlamydia pneumoniae
Q37878373Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells.
Q37878697Löfgren's syndrome as the first manifestation of acute infection due to Chlamydia pneumoniae: a prospective study
Q35852332M2 Polarization of Human Macrophages Favors Survival of the Intracellular Pathogen Chlamydia pneumoniae
Q37844674MAPK-PPARα/γ signal transduction pathways are involved in Chlamydia pneumoniae-induced macrophage-derived foam cell formation
Q35709736Macrolide therapy for Chlamydia pneumoniae in the secondary prevention of coronary artery disease: a meta-analysis of randomized controlled trials.
Q43423265Macrolide treatment does not influence serum homocysteine in Chlamydia pneumoniae-seropositive patients suffering from atherosclerosis.
Q37868698Macrophage L-type Ca2+ channel antagonists alter Chlamydia pneumoniae MOMP and HSP-60 mRNA gene expression, and improve antibiotic susceptibility
Q37862226Macrophage antioxidant enzymes regulate Chlamydia pneumoniae chronicity: evidence of the effect of redox balance on host-pathogen relationship
Q37867764Macrophages, CD4+ or CD8+ cells are each sufficient for protection against Chlamydia pneumoniae infection through their ability to secrete IFN-gamma
Q37858375Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism
Q35563186Markers of inflammation in induced sputum in acute bronchitis caused by Chlamydia pneumoniae
Q35329165Mast cells play an important role in chlamydia pneumoniae lung infection by facilitating immune cell recruitment into the airway
Q37857465Maternal serum Chlamydia pneumoniae antibodies and CRP levels in women with preeclampsia and gestational hypertension
Q35583908Matrix metalloproteinase-9 expression is associated with the presence of Chlamydia pneumoniae in human coronary atherosclerotic plaques
Q37883625Means of diagnosis of Chlamydia pneumoniae infection
Q37859577Measurement of Chlamydia pneumoniae bacterial load in peripheral blood mononuclear cells may be helpful to assess the state of chlamydial infection in patients with carotid atherosclerotic disease
Q34579483Measurement of Chlamydia pneumoniae-specific immunoglobulin A (IgA) antibodies by the microimmunofluorescence (MIF) method: comparison of seven fluorescein-labeled anti-human IgA conjugates in an in-house MIF test using one commercial MIF and one en
Q35224726Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with Chlamydia pneumoniae
Q43424648Mechanism of Arterial Infection by Chlamydia pneumoniae.
Q37840495Mechanisms of apoptosis inhibition in Chlamydia pneumoniae-infected neutrophils.
Q37883684Mediastinal lymphadenitis associated with Chlamydia pneumoniae infection
Q37852001Members of the Pmp protein family of Chlamydia pneumoniae mediate adhesion to human cells via short repetitive peptide motifs
Q43426269Meningoencephalitis and Chlamydia pneumoniae infection
Q37869786Meta-analysis of sero-epidemiologic studies of the relation between Chlamydia pneumoniae and atherosclerosis: does study design influence results?
Q37865621Methodological aspects affecting the infectivity of Chlamydia pneumoniae in cell cultures in vitro
Q37833989Methods for Real-Time PCR-Based Diagnosis of Chlamydia pneumoniae, Chlamydia psittaci, and Chlamydia abortus Infections in an Opened Molecular Diagnostic Platform
Q37858349Microarray analysis of a Chlamydia pneumoniae-infected human epithelial cell line by use of gene ontology hierarchy.
Q37881682Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia.
Q37876262Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae
Q37869798Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae
Q42729698Microbiological efficacy of levofloxacin for treatment of community-acquired pneumonia due to Chlamydia pneumoniae
Q37868609Micromanipulation of the Chlamydia pneumoniae inclusion: implications for cloning and host-pathogen interactions
Q93366878Mint Flavorings from Candies Inhibit the Infectivity of Chlamydia pneumoniae
Q37857113Modulation of cytokine and beta-defensin 2 expressions in human gingival fibroblasts infected with Chlamydia pneumoniae
Q37858937Molecular beacons for isothermal fluorescence enhancement by the cleavage of RNase HII from Chlamydia pneumoniae
Q37877544Molecular biology of Chlamydia pneumoniae surface proteins and their role in immunopathogenicity
Q37883770Molecular biology of the Chlamydia pneumoniae surface
Q37847213Molecular cartography in acute Chlamydia pneumoniae infections--a non-targeted metabolomics approach
Q37834476Molecular characterization of Chlamydia pneumoniae associated to atherosclerosis
Q37836095Molecular characterization of Chlamydia pneumoniae in animals and humans from Argentina: Genetic characterization of Chlamydia pneumoniae.
Q34391663Molecular cloning, sequence analysis, and functional characterization of the lipopolysaccharide biosynthetic gene kdtA encoding 3-deoxy-alpha-D-manno-octulosonic acid transferase of Chlamydia pneumoniae strain TW-183.
Q37870924Molecular detection and seroepidemiology of the Chlamydia pneumoniae bacteriophage (PhiCpn1).
Q37867485Molecular diagnosis of Chlamydia pneumoniae diseases
Q33775972Molecular diagnosis of Chlamydia pneumoniae infection.
Q37394186Molecular pathogenesis of chronic Chlamydia pneumoniae infection: a brief overview
Q37876903Monocyte-endothelial cell coculture enhances infection of endothelial cells with Chlamydia pneumoniae
Q37893379Morphology and immunotyping of AC-43 strain of Chlamydia pneumoniae isolated from a Japanese child
Q80403543Morphometrical quantification of Chlamydia pneumoniae and Mycoplasma pneumoniae in human atherosclerotic abdominal aortic aneurysms
Q33232428Mouse model of respiratory Chlamydia pneumoniae infection for a genomic screen of subunit vaccine candidates
Q33762150Mouse models of Chlamydia pneumoniae infection and atherosclerosis
Q43405674Mucositis Secondary to Chlamydia pneumoniae Infection: Expanding the Mycoplasma pneumoniae-Induced Rash and Mucositis Concept
Q90858746Multi-peptide ELISAs overcome cross-reactivity and inadequate sensitivity of conventional Chlamydia pneumoniae serology
Q33971158Multicenter comparison trial of DNA extraction methods and PCR assays for detection of Chlamydia pneumoniae in endarterectomy specimens
Q37878856Multicenter screening of Chlamydia pneumoniae pneumonia by ELISA method
Q37871365Multiple Chlamydia pneumoniae antigens prime CD8+ Tc1 responses that inhibit intracellular growth of this vacuolar pathogen
Q37864464Multiple genotypes of Chlamydia pneumoniae identified in human carotid plaque
Q43427368Multiple sclerosis and Chlamydia pneumoniae
Q37881519Multiple sclerosis associated with Chlamydia pneumoniae infection of the CNS.
Q37877372Multiplex PCR for rapid and differential diagnosis of Mycoplasma pneumoniae and Chlamydia pneumoniae in respiratory infections
Q37866982Multiplex PCR for the simultaneous detection of Chlamydia pneumoniae, Mycoplasma pneumoniae and Legionella pneumophila in community-acquired pneumonia
Q37236246Multiplex polymerase chain reaction for the simultaneous detection of Mycoplasma pneumoniae, Chlamydia pneumoniae, and Chlamydia psittaci in respiratory samples
Q37870429Multisystemic severe infection with Chlamydia pneumoniae
Q37883205Murine models of Chlamydia pneumoniae infection and atherosclerosis
Q37864592MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia
Q37860176MyD88-dependent changes in the pulmonary transcriptome after infection with Chlamydia pneumoniae
Q37861476Mycobacterium tuberculosis-susceptible I/St mice develop severe disease following infection with taxonomically distant bacteria, Salmonella enterica and Chlamydia pneumoniae
Q37880276Mycoplasma contamination of Chlamydia pneumoniae isolates
Q37865844Mycoplasma pneumoniae and Chlamydia pneumoniae are associated to inflammation and rupture of the atherosclerotic coronary plaques
Q34641835Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients
Q43419404Mycoplasma pneumoniae and Chlamydia pneumoniae chronic cough in children: efficacy of clarithromycin.
Q37871773Mycoplasma pneumoniae and Chlamydia pneumoniae in asthma: effect of clarithromycin
Q37871282Mycoplasma pneumoniae and Chlamydia pneumoniae in calcified nodules of aortic stenotic valves
Q37886996Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate.
Q37874286Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgli Study Group
Q35119852Mycoplasma pneumoniae and Chlamydia pneumoniae seropositivity in patients with age-related macular degeneration
Q37889055Mycoplasma pneumoniae and Chlamydia pneumoniae strain TWAR infections in U.S. Marine Corps recruits
Q74181279Myocardial infarction associated with Chlamydia pneumoniae
Q37878997Myocardial infarction, culture-negative endocarditis, and Chlamydia pneumoniae infection: a dilemma?
Q43434914Myocarditis caused by Chlamydia pneumoniae (TWAR) and sudden unexpected death in a Swedish elite orienteer.
Q54259136N-acetyl-cysteine increases the replication of Chlamydia pneumoniae and prolongs the clearance of the pathogen from mice.
Q90617050Naked-Eye Enumeration of Single Chlamydia pneumoniae Based on Light Scattering of Gold Nanoparticle Probe
Q37851796Native properdin binds to Chlamydia pneumoniae and promotes complement activation
Q54449325Neonatal apnea with Chlamydia pneumoniae infection.
Q37869059Neopterin levels in patients with coronary artery disease are independent of Chlamydia pneumoniae seropositivity
Q36852751Neutrophil gelatinase-associated lipocalin and interleukin-10 regulate intramacrophage Chlamydia pneumoniae replication by modulating intracellular iron homeostasis
Q37884478New pneumonia pathogens, especially Chlamydia pneumoniae and Hantaviruses
Q37865502Nicotine modulates cytokine production by Chlamydia pneumoniae infected human peripheral blood cells
Q37868466Nitric oxide synthase plays a role in Chlamydia pneumoniae-induced atherosclerosis
Q43435454No Association of Chronic Chlamydia pneumoniae Infection with Chronic Fatigue Syndrome
Q37872190No causal association between inflammation and Chlamydia pneumoniae in patients with chronic ischemic arterial disease
Q37214119No correlation between giant cell arteritis and Chlamydia pneumoniae infection: investigation of 189 patients by standard and improved PCR methods
Q37860702No detectable Chlamydia pneumoniae and cytomegalovirus DNA in leukocytes in subjects with echolucent and echogenic carotid artery plaques
Q37869790No detection of Chlamydia pneumoniae in normal and atherosclerotic femoral arteries by polymerase chain reaction (PCR)--an autopsy study
Q43424853No evidence of CNS infection with Chlamydia pneumoniae in patients with multiple sclerosis
Q58610914No evidence of Chlamydia pneumoniae in the synovia of patients with osteoarthritis
Q37872004No evidence of acute Chlamydia pneumoniae infection in patients with Bell's palsy
Q37857319No evidence of involvement of Chlamydia pneumoniae in lung cancer by means of quantitative real-time polymerase chain reaction
Q37866756No evidence of involvement of Chlamydia pneumoniae in severe cerebrovascular atherosclerosis by means of quantitative real-time polymerase chain reaction
Q37872128No evidence of parvovirus B19, Chlamydia pneumoniae or human herpes virus infection in temporal artery biopsies in patients with giant cell arteritis.
Q37868783No evidence of skin infection with Chlamydia pneumoniae in patients with cutaneous T cell lymphoma
Q37859379No prognostic significance of chronic infection with Chlamydia pneumoniae in acute coronary syndromes: insights from the Global Utilization of Strategies to Open Occluded Arteries IV Acute Coronary Syndromes trial
Q37872216Non-LPS components of Chlamydia pneumoniae stimulate cytokine production through Toll-like receptor 2-dependent pathways
Q24804167Non-detection of Chlamydia species in carotid atheroma using generic primers by nested PCR in a population with a high prevalence of Chlamydia pneumoniae antibody
Q37872512Non-specific interstitial pneumonia and Chlamydia pneumoniae infection
Q33653680Novel Chlamydia pneumoniae vaccine candidates confirmed by Th1-enhanced genetic immunization
Q37871970Novel PCR-EIA method for the detection of Chlamydia pneumoniae in respiratory specimens
Q37843459Novel inflammatory biomarkers and their correlation to Chlamydia pneumoniae titres in acute ischemic stroke
Q37868428Nuclear Factor–κB Activation in Endothelium byChlamydia pneumoniaewithout Active Infection
Q37875738Nucleic acid sequence based amplification (NASBA) of Chlamydia pneumoniae major outer membrane protein (ompA) mRNA with bioluminescent detection
Q33545301Nucleotide sequence and taxonomic value of the major outer membrane protein gene of Chlamydia pneumoniae IOL-207.
Q37856218Occurrence of Chlamydia trachomatis and Chlamydia pneumoniae in paediatric respiratory infections
Q37895800Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections
Q37847633One-year observation of inflammatory markers in patients with aortic valve stenosis who expressed high or low Chlamydia pneumoniae antibody titers
Q91873242Opsonophagocytosis of Chlamydia pneumoniae by human monocytes and neutrophils
Q37859880Optimization of a polymerase chain reaction (PCR) for increasing its sensitivity to detect Chlamydia pneumoniae specific genome.
Q33963149Optimizing culture of Chlamydia pneumoniae by using multiple centrifugations
Q37848432Oral azithromycin in extended dosage schedule for chronic, subclinical Chlamydia pneumoniae infection causing coronary artery disease: a probable cure in sight? Results of a controlled preliminary trial
Q43436779Osler's endocarditis possibly caused by Chlamydia pneumoniae (TWAR stain)
Q37867663Outbreak and persistence of Chlamydia pneumoniae infection in an Italian family
Q64131400Outbreak of Chlamydia pneumoniae Infections and X-ray-Confirmed Pneumonia in Army Trainees at Fort Leonard Wood, Missouri, 2014
Q37860970Outbreak of Chlamydia pneumoniae infection in a Japanese nursing home, 1999-2000.
Q37889272Outbreak of Chlamydia pneumoniae infection in former injection-drug users
Q37892941Outbreak of Chlamydia pneumoniae infection in four farm families
Q33920289Outbreak of pneumonia in the setting of fatal pneumococcal meningitis among US Army trainees: potential role of Chlamydia pneumoniae infection
Q37861087Outbreak of respiratory tract infections on an islet in Korea: possible Chlamydia pneumoniae infection
Q37849945Outcome of Chlamydia pneumoniae associated acute ischemic stroke in elderly patients: a case-control study
Q37890342Outer membrane complex proteins of Chlamydia pneumoniae
Q37865098Overexpression of MMP9 and tissue factor in unstable carotid plaques associated with Chlamydia pneumoniae, inflammation, and apoptosis.
Q43427076Oxidation of low-density lipoproteins by acellular components of Chlamydia pneumoniae
Q37873419Oxidative processes in human promonocytic cells (THP-1) after differentiation into macrophages by incubation with Chlamydia pneumoniae extracts.
Q37849865Oxidized LDL promotes the mitogenic actions of Chlamydia pneumoniae in vascular smooth muscle cells.
Q37892450PCR detection and differentiation of Chlamydia pneumoniae, Chlamydia psittaci and Chlamydia trachomatis
Q37874307PCR-based method for isolation and detection of Chlamydia pneumoniae DNA in cerebrospinal fluids
Q47098892PD52 - Role of atypical pathogens mycoplasma pneumoniae and chlamydia pneumoniae in childhood asthma exacerbations
Q37865286Part of Chlamydia pneumoniae in atherosclerosis and exacerbation of chronic obstructive pulmonary disease and asthma
Q37875783Participation of Chlamydia pneumoniae in an epidemic of respiratory infections in Slovakia.
Q37890128Past infection by Chlamydia pneumoniae strain TWAR and asymptomatic carotid atherosclerosis. Atherosclerosis Risk in Communities (ARIC) Study Investigators
Q37889940Pathogenetic mechanisms and epidemiology of Chlamydia pneumoniae.
Q35199820Pathogenetic role of Chlamydia pneumoniae in calcific aortic stenosis: immunohistochemistry study and review of the literature.
Q37875463Percentage of asthmatic patients with acute bronchitis and Chlamydia pneumoniae seropositivity
Q37888974Performance of three commercially available monoclonal reagents for confirmation of Chlamydia pneumoniae in cell culture.
Q37871661Performance of three microimmunofluorescence assays for detection of Chlamydia pneumoniae immunoglobulin M, G, and A antibodies
Q37856602Permanent atrial fibrillation in patients without structural heart disease is not associated with signs of infection by Chlamydia pneumoniae and Helicobacter pylori.
Q43425629Persistence of Chlamydia pneumoniae in coronary plaque tissue
Q37877292Persistence of Chlamydia pneumoniae in coronary plaque tissue. A contribution to infection and immune hypothesis in unstable angina pectoris
Q37870173Persistence of Chlamydia pneumoniae in degenerative aortic valve stenosis indicated by heat shock protein 60 homologues.
Q37880723Persistence of Chlamydia pneumoniae in human arteriosclerotic plaque substance. Evidence and consequences
Q33672332Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men. Effect of persistent Chlamydia pneumoniae infection on lung function
Q37885849Persistent Chlamydia pneumoniae infection in a Swedish family
Q35570353Persistent Chlamydia pneumoniae infection of cardiomyocytes is correlated with fatal myocardial infarction
Q37874666Persistent airflow limitation in adult-onset nonatopic asthma is associated with serologic evidence of Chlamydia pneumoniae infection
Q37893923Persistent infection with Chlamydia pneumoniae following acute respiratory illness
Q37867354Phagocytes transmit Chlamydia pneumoniae from the lungs to the vasculature.
Q35875539Phylogenetic analysis of human Chlamydia pneumoniae strains reveals a distinct Australian indigenous clade that predates European exploration of the continent.
Q37856808Phylogenetic comparison of the known Chlamydia trachomatis sigma(66) promoters across to Chlamydia pneumoniae and Chlamydia caviae identifies seven poorly conserved promoters
Q37890714Phylogenetic relationship of Chlamydia pneumoniae to Chlamydia psittaci and Chlamydia trachomatis as determined by analysis of 16S ribosomal DNA sequences
Q90307122Pivotal Pathogenic and Biomarker Role of Chlamydia Pneumoniae in Neurovascular Diseases
Q37868469Placental infection with Chlamydia pneumoniae and intrauterine growth restriction
Q35080398Plasmacytoid dendritic cells mediate the regulation of inflammatory type T cell response for optimal immunity against respiratory Chlamydia pneumoniae infection
Q27340476Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice
Q28222522Platelet activation triggered by Chlamydia pneumoniae is antagonized by 12-lipoxygenase inhibitors but not cyclooxygenase inhibitors
Q37869355Pleiotropic effect of the micronized fenofibrate: the reduction of plasma chlamydia pneumoniae antibody levels in patients with coronary artery disease
Q35547839Pneumonia due to Chlamydia pneumoniae in children: Epidemiology, diagnosis, and treatment
Q43433820Pneumonia due to Chlamydia pneumoniae strain TWAR.
Q37886087Pneumonia due to Chlamydia pneumoniae: prevalence, clinical features, diagnosis, and treatment
Q37891807Pneumonia, myocarditis and reactive arthritis due to Chlamydia pneumoniae
Q37877613Polymerase chain reaction assay for detecting Chlamydia pneumoniae in middle ear fluid of children with otitis media with effusion
Q33935030Polymerase chain reaction detection of Chlamydia pneumoniae in circulating white blood cells
Q37887506Polymerase chain reaction for detection of Chlamydia pneumoniae in gargled-water specimens of children
Q37869136Polymorphic membrane protein (PMP) 20 and PMP 21 of Chlamydia pneumoniae induce proinflammatory mediators in human endothelial cells in vitro by activation of the nuclear factor-kappaB pathway.
Q37865116Polymorphonuclear neutrophils improve replication of Chlamydia pneumoniae in vivo upon MyD88-dependent attraction
Q37890935Polypeptide profiles of Chlamydia pneumoniae strains isolated from Japan and western blot analysis using patients' sera
Q37879706Poor correlation between microimmunofluorescence serology and polymerase chain reaction for detection of vascular Chlamydia pneumoniae infection in coronary artery disease patients.
Q37871590Positive Chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease
Q37875191Possible role of chronic infection with Chlamydia pneumoniae in Japanese patients with acute myocardial infarction
Q33935035Potential for antimicrobial resistance in Chlamydia pneumoniae
Q37876334Potential relevance of Chlamydia pneumoniae surface proteins to an effective vaccine
Q37872473Preclinical models for Chlamydia pneumoniae and cardiovascular disease: hypercholesterolemic mice.
Q91240713Prediction of Chlamydia pneumoniae protein localization in host mitochondria and cytoplasm and possible involvements in lung cancer etiology: a computational approach
Q37873504Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells
Q37866465Preeclampsia and Chlamydia pneumoniae: is there a link?
Q36758395Preliminary data on Chlamydia pneumoniae seroprevalence in HIV-1 infected children.
Q37877055Preliminary study on Chlamydia pneumoniae pneumonia
Q37841506Preparation and evaluation of monoclonal antibodies against chlamydial protease-like activity factor to detect Chlamydia pneumoniae antigen in early pediatric pneumonia
Q37874596Preparation of Chlamydia pneumoniae in roller bottles with high IFUs
Q37861493Presence and severity of Chlamydia pneumoniae and Cytomegalovirus infection in coronary plaques are associated with acute coronary syndromes
Q37863575Presence of Chlamydia pneumoniae DNA in the artery wall--biomarker of coronary artery disease
Q37874186Presence of Chlamydia pneumoniae DNA in the cerebral spinal fluid is a common phenomenon in a variety of neurological diseases and not restricted to multiple sclerosis
Q37874464Presence of Chlamydia pneumoniae antibodies in patients with ischemic heart disease and acute myocardial infarct
Q37871162Presence of Chlamydia pneumoniae in abdominal aortic aneurysms is not associated with increased activity of matrix metalloproteinases
Q34205431Presence of Chlamydia pneumoniae in human symptomatic and asymptomatic carotid atherosclerotic plaque
Q37864067Presence of Chlamydia pneumoniae in patients with and without atherosclerosis.
Q37866202Presence of Chlamydia pneumoniae in the carotid artery
Q43431365Presence of Chlamydia pneumoniae strain TWAR in bronchial secretions collected from HIV-positive and negative patients: preliminary data.
Q37864786Prevalence and clinical features of Chlamydia pneumoniae pneumonia at Srinagarind Hospital, Khon Kaen, Thailand
Q37866904Prevalence and incidence of Chlamydia pneumoniae antibodies among the healthy elderly and patients with chronic obstructive pulmonary diseases.
Q33788646Prevalence and persistence of Chlamydia pneumoniae antibodies in healthy laboratory personnel in Finland
Q37863038Prevalence and persistence of antibodies to herpes viruses, Chlamydia pneumoniae and Helicobacter pylori in Alaskan Eskimos: the GOCADAN Study
Q37868263Prevalence of <i>Chlamydia pneumoniae</i> in Japanese Rural Districts; Association of Smoking and Physical Activity awith <i>Chlamydia pneumoniae</i> Seropositivity
Q43421284Prevalence of Chlamydia pneumoniae IgG antibodies in patients with coronary artery disease: a report from an Indian population
Q58289831Prevalence of Chlamydia pneumoniae Infection in Atherosclerotic Plaques of Corpses Referred to Iranian Legal Medicine Organization, Tehran
Q33998574Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae immunoglobulin G and A antibodies in a healthy Finnish population as analyzed by quantitative enzyme immunoassays
Q37854561Prevalence of Chlamydia pneumoniae and Mycoplasma pneumoniae in different forms of coronary disease.
Q37893843Prevalence of Chlamydia pneumoniae antibodies in Hungary
Q37248184Prevalence of Chlamydia pneumoniae antibodies in patients with acute respiratory infections in Israel
Q43436258Prevalence of Chlamydia pneumoniae in Japan
Q37888837Prevalence of Chlamydia pneumoniae in acute lower respiratory infection in the pediatric population in Japan.
Q37873675Prevalence of Chlamydia pneumoniae in acute respiratory tract infection and detection of anti-Chlamydia pneumoniae-specific IgE in Japanese children with reactive airway disease
Q37882735Prevalence of Chlamydia pneumoniae in healthy children and in children with respiratory tract infections
Q43423000Prevalence of Chlamydia pneumoniae in nonrheumatic stenotic aortic valves
Q37872992Prevalence of Chlamydia pneumoniae in peripheral blood mononuclear cells in Italian patients with acute ischaemic heart disease.
Q37878905Prevalence of Chlamydia pneumoniae in respiratory infections in children: an ambulatory diagnostic problem
Q37869378Prevalence of Chlamydia pneumoniae in the atherosclerotic plaque of patients with unstable angina and its relation with serology
Q37895249Prevalence of Chlamydia pneumoniae infection among pneumonias in a sample of Spanish hospital population
Q37868738Prevalence of Chlamydia pneumoniae infection in Thai children with community-acquired pneumonia
Q37867125Prevalence of Chlamydia pneumoniae infection in squamous cell carcinoma of the head and neck
Q37880214Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey
Q91394513Prevalence of Chlamydia psittaci, Chlamydia pneumoniae, and Chlamydia trachomatis Determined by Molecular Testing in Ocular Adnexa Lymphoma Specimens
Q37884853Prevalence of Chlamydia trachomatis, Chlamydia psittaci and Chlamydia pneumoniae antibodies in blood donors and attendees of STD clinics
Q37391436Prevalence of Helicobacter pylori, cytomegalovirus, and Chlamydia pneumoniae immunoglobulin seropositivity in coronary artery disease patients and normal individuals in North Indian population
Q37876688Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community acquired pneumonia
Q37865747Prevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in pneumonia patients in four major hospitals in Trinidad
Q127748617Prevalence of Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumophila in LRTI Patients in a Tertiary Care Center, Karimnagar
Q37859222Prevalence of active infection with Chlamydia pneumoniae and human cytomegalovirus in patients with type II diabetes mellitus
Q43425464Prevalence of anti-Chlamydia pneumoniae and anti-Helicobacter pylori antibodies in subjects with acute myocardial infarction
Q37878594Prevalence of anti-Chlamydia pneumoniae antibodies in preadolescent children in Congo
Q37895455Prevalence of antibodies to Chlamydia pneumoniae (strain TWAR) and other Chlamydia in Japan
Q37890676Prevalence of antibodies to Chlamydia pneumoniae TWAR in a group of German medical students
Q43433288Prevalence of antibodies to Chlamydia pneumoniae in Slovenia.
Q37892833Prevalence of antibodies to Chlamydia pneumoniae in a Belgian population
Q37896623Prevalence of antibodies to Chlamydia pneumoniae in a pediatric hospital population in Belgium
Q35586164Prevalence of antibodies to Chlamydia pneumoniae in an Israeli population without clinical evidence of respiratory infection
Q37233458Prevalence of antibody to Chlamydia pneumoniae TWAR in japan.
Q37871009Prevalence of antibody to Chlamydia pneumoniae in residents of Japan, the Solomon Islands, and Nepal.
Q37874230Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults
Q37887150Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: assessment by polymerase chain reaction-enzyme immunoassay and culture
Q37872923Prevalence of chlamydia pneumoniae antibodies in patients with coronary heart disease
Q37883379Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough
Q43434779Prevalence of specific antibodies to Chlamydia pneumoniae (TWAR) in Swedish orienteers
Q33688588Prevalence of specific antibodies to Chlamydia pneumoniae in Korea
Q37888150Prevalence of specific antibodies to Chlamydia pneumoniae in children with acute respiratory infections
Q37866868Prevalence of viable Chlamydia pneumoniae in peripheral blood mononuclear cells of healthy blood donors
Q37859629Prevalence, genetic conservation and transmissibility of the Chlamydia pneumoniae bacteriophage (phiCpn1).
Q37871372Prevalence, rate of persistence and respiratory tract symptoms of Chlamydia pneumoniae infection in 1211 kindergarten and school age children
Q37873036Prevention of coronary heart disease through treatment of infection with Chlamydia pneumoniae? Estimation of possible effectiveness and costs.
Q43429547Previous cytomegalovirus or Chlamydia pneumoniae infection and risk of restenosis after percutaneous transluminal coronary angioplasty
Q37874580Previous exposure to Chlamydia pneumoniae, Helicobacter pylori and other infections in Canadian patients with ischemic heart disease.
Q37864816Previous infection with Chlamydia pneumoniae and long-term prognosis in patients with acute coronary syndrome with non-ST segment elevation
Q37867201Primary biliary cirrhosis: an infectious disease caused by Chlamydia pneumoniae?
Q37876537Prior cytomegalovirus, Chlamydia pneumoniae or Helicobacter pylori infection and the risk of restenosis after percutaneous transluminal coronary angioplasty
Q37861865Prior exposure to infection with Chlamydia pneumoniae can influence the T-cell-mediated response to Chlamydia trachomatis
Q43421621Problem of Chlamydia pneumoniae serology today
Q37856842Production and application of Chlamydia pneumoniae-specific monoclonal antibody
Q34995600Production of Chlamydia pneumoniae proteins in Bacillus subtilis and their use in characterizing immune responses in the experimental infection model
Q37876556Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae
Q37866199Prognostic value of antibodies anti-Chlamydia pneumoniae in ischemic heart disease
Q37867739Progression of early carotid atherosclerosis is only temporarily reduced after antibiotic treatment of Chlamydia pneumoniae seropositivity
Q37865453Progression of peripheral arterial occlusive disease is associated with Chlamydia pneumoniae seropositivity and can be inhibited by antibiotic treatment
Q37871352Proinflammatory cytokines, antibodies to Chlamydia pneumoniae and age-associated diseases in Danish centenarians: is there a link?
Q52596124Proliferative stimulation of the vascular Endothelin-1 axis in vitro and ex vivo by infection with Chlamydia pneumoniae.
Q37869056Prolonged febrile syndrome and Chlamydia pneumoniae infection
Q37878526Prolonged respiratory failure in chlamydia pneumoniae pneumonia
Q33901750Promoting effect of Chlamydia pneumoniae infection on human laryngeal carcinoma HEp-2 cell adhesion and migration
Q30453259Properties of the glucose-6-phosphate transporter from Chlamydia pneumoniae (HPTcp) and the glucose-6-phosphate sensor from Escherichia coli (UhpC).
Q37869279Prospective study of Chlamydia pneumoniae IgG and IgA seropositivity and risk of incident ischemic stroke.
Q37878896Prospective study of Chlamydia pneumoniae IgG seropositivity and risks of future myocardial infarction
Q37876806Protective DNA immunization against Chlamydia pneumoniae
Q33756547Protective effects of sparfloxacin in experimental pneumonia caused by Chlamydia pneumoniae in leukopenic mice
Q37862010Protein expression profiles of Chlamydia pneumoniae in models of persistence versus those of heat shock stress response
Q37858663Proteolytic cleavage of the Chlamydia pneumoniae major outer membrane protein in the absence of Pmp10.
Q37870594Proteome analysis of Chlamydia pneumoniae
Q30669016Proteome analysis of the Chlamydia pneumoniae elementary body
Q33388890Proteomic analysis of Chlamydia pneumoniae-infected HL cells reveals extensive degradation of cytoskeletal proteins
Q31056127Proteomic analysis of differentially expressed Chlamydia pneumoniae genes during persistent infection of HEp-2 cells
Q37873916Provocation of experimental aortic inflammation and dilatation by inflammatory mediators and Chlamydia pneumoniae
Q37877156Pyoderma gangrenosum and Chlamydia pneumoniae infection in a diabetic man: pathogenic role or coincidence?
Q37851387Quantification and location of Chlamydia pneumoniae-specific antigen in the walls of abdominal aortic aneurysms
Q37853835Quantification of Chlamydia pneumoniae in cultured human macrophages and HL cells: comparison of real-time PCR, immunofluorescence and ELISA methods
Q37871871Quantitative detection of respiratory Chlamydia pneumoniae infection by real-time PCR.
Q37860138RNase HII from Chlamydia pneumoniae discriminates mismatches incorporation into DNA-rN1-DNA/DNA duplexes
Q37883934Rabbit model for Chlamydia pneumoniae infection
Q37888375Radiographic appearance of Chlamydia pneumoniae (TWAR strain) respiratory infections. CBPIS Study Group. Community-based Pneumonia Incidence Study
Q37878769Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection: The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamyd
Q33598968Rapamycin can inhibit the development of Chlamydia pneumoniae, which might partly contribute to the prevention of in-stent restenosis
Q37870150Rapid and standardized detection of Chlamydia pneumoniae using LightCycler real-time fluorescence PCR.
Q37871981Rapid detection of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells of coronary artery disease patients by real-time fluorescence PCR.
Q37880695Rapid detection of Chlamydia pneumoniae by PCR-enzyme immunoassay.
Q37882746Rapid diagnosis of respiratory Chlamydia pneumoniae infection by nested touchdown polymerase chain reaction compared with culture and antigen detection by EIA.
Q37863080Rapidly progressive glomerulonephritis in a patient with Chlamydia pneumoniae infection: a possibility of superantigenic mechanism of its pathogenesis.
Q43424592Re: Chlamydia pneumoniae does not influence atherosclerotic plaque behavior in patients with established carotid artery stenosis
Q37861896Reaching out for the causative agent in inflammatory bowel disease: is there evidence for Chlamydia pneumoniae as a pathogenic factor?
Q35231913Reactions of polyclonal and neutralizing anti-p54 monoclonal antibodies with an isolated, species-specific 54-kilodalton protein of Chlamydia pneumoniae
Q35486096Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment.
Q37886683Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone
Q43432666Reactive arthritis ascribed to Chlamydia pneumoniae. Report of a case
Q37890930Reactivity of Chlamydia pneumoniae strains in the IDEIA CHLAMYDIA test kit designed for detection of Chlamydia trachomatis
Q35789698Real-time PCR for Chlamydia pneumoniae utilizing the Roche Lightcycler and a 16S rRNA gene target
Q37851037Recent Chlamydia pneumoniae infection is highly associated with active ankylosing spondylitis in a Chinese cohort
Q37844406Recent advances in technologies for developing drugs against Chlamydia pneumoniae.
Q37895348Recovery of Chlamydia pneumoniae and Chlamydia trachomatis in a patient with recurrent tonsillitis, bronchitis and otitis media with effusion
Q37893027Recovery ofChlamydia pneumoniae, in six patients with otitis media with effusion
Q37869761Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice
Q37861658Recurrent optic neuritis associated with Chlamydia pneumoniae infection of the central nervous system
Q37872604Recurrent pneumonia due to persistent Chlamydia pneumoniae infection.
Q43421538Red wine, resveratrol, Chlamydia pneumoniae and the French connection
Q37870886Reduced progression of early carotid atherosclerosis after antibiotic treatment and Chlamydia pneumoniae seropositivity
Q37893913Regional differences of Chlamydia pneumoniae as causative agent of pneumonia in Sweden
Q37876677Regulation and role of IFN-gamma in the innate resistance to infection with Chlamydia pneumoniae
Q37874299Regulation by IFN-beta of inducible nitric oxide synthase and interleukin-12/p40 in murine macrophages cultured in the presence of Chlamydia pneumoniae antigens
Q37883734Reinfection with Chlamydia pneumoniae may induce isolated and systemic vasculitis in small and large vessels.
Q37872185Relation between Chlamydia pneumoniae infection and acute attack of asthma
Q37878316Relation between direct detection of Chlamydia pneumoniae DNA in human coronary arteries at postmortem examination and histological severity (Stary grading) of associated atherosclerotic plaque
Q37873120Relation of Chlamydia pneumoniae infection in Taiwan to angiographically demonstrated coronary artery disease and to the presence of acute myocardial infarction or unstable angina pectoris.
Q37865613Relation of Chlamydia pneumoniae infection to documented coronary artery disease in Shiraz, Southern Iran
Q37878617Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study
Q37866859Relation of secretory phospholipase A(2) and high-sensitivity C-reactive protein to Chlamydia pneumoniae infection in acute coronary syndromes
Q37868337Relationship between Chlamydia pneumoniae and classical risk factors of coronary heart disease
Q34503313Relationship between Chlamydia pneumoniae infection, inflammatory markers, and coronary heart diseases.
Q37866358Relationship between dyslipidemia, C-reactive protein and serological evidence of Chlamydia pneumoniae in Turkish patients with coronary artery diseases
Q37873938Relationship of Chlamydia pneumoniae infection to severity of coronary atherosclerosis in patients with chronic coronary artery disease and with normal coronary arteries
Q37876300Relationship of Chlamydia pneumoniae infection to severity of human coronary atherosclerosis
Q37848300Relationship of cytomegalovirus, Chlamydia pneumoniae and herpes simplex virus type 2 infections with preeclampsia
Q127324000Relative frequency of Chlamydia pneumoniae in patients with respiratory infections using the PCR and ELISA methods in Ahvaz, Iran
Q43434587Relevance of Chlamydia pneumoniae in community-acquired respiratory infections
Q35118114Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents
Q37854798Relevance of the genetic polymorphism of NOD1 in Chlamydia pneumoniae seropositive stroke patients.
Q37870755Reliability of nested PCR for detection of Chlamydia pneumoniae DNA in atheromas: results from a multicenter study applying standardized protocols
Q43422110Reliability of nested PCR for the detection of Chlamydia pneumoniae in carotid artery atherosclerosis
Q37889465Remarkable sequence relatedness in the DNA encoding the major outer membrane protein of Chlamydia psittaci (koala type I) and Chlamydia pneumoniae
Q37866188Repetitive measurements of Chlamydia pneumoniae DNA in peripheral blood mononuclear cells in healthy control subjects and dialysis patients: a prospective study
Q37874322Replicate PCR testing and probit analysis for detection and quantitation of Chlamydia pneumoniae in clinical specimens
Q35488540Replication of Chlamydia pneumoniae in vitro in human macrophages, endothelial cells, and aortic artery smooth muscle cells
Q37876249Requirement for NF-kappaB in transcriptional activation of monocyte chemotactic protein 1 by Chlamydia pneumoniae in human endothelial cells
Q37862545Respiratory infection caused by Chlamydia pneumoniae
Q37888234Respiratory infection with Chlamydia pneumoniae in middle-aged and older adult outpatients
Q37871214Respiratory symptoms, asthma, atopy and Chlamydia pneumoniae IgG antibodies in a general population sample of young adults
Q37895268Respiratory tract diseases due to Chlamydia pneumoniae
Q124967643Respiratory tract diseases due to Chlamydia pneumoniae.
Q37883746Respiratory tract infection due to Chlamydia pneumoniae in military personnel.
Q37877330Respiratory tract infections triggering bronchial asthma attacks--with special reference to the involvement of Chlamydia pneumoniae
Q91453136Response to "Chronic cerebrospinal venous insufficiency, chlamydia and multiple sclerosis": CCSVI, Chlamydia pneumoniae and multiple sclerosis clarification
Q37854535Restriction of Chlamydia pneumoniae replication in human dendritic cell by activation of indoleamine 2,3-dioxygenase
Q37846267Resveratrol in Chlamydia pneumoniae-induced foam cell formation and interleukin-17A synthesis
Q36732330Retinoic acid inhibits the infectivity and growth of Chlamydia pneumoniae in epithelial and endothelial cells through different receptors.
Q37009782Retinoic acid prevents Chlamydia pneumoniae-induced foam cell development in a mouse model of atherosclerosis
Q37887861Reversible acute renal failure associated with Chlamydia pneumoniae infection
Q34698619Review of evidence for a connection between Chlamydia pneumoniae and atherosclerotic disease
Q37856254Rifalazil retains activity against rifampin-resistant mutants of Chlamydia pneumoniae
Q37876549Risk factors for coronary heart disease and persistent infection with Chlamydia pneumoniae or cytomegalovirus: a population-based study.
Q37884439Roentgenographic findings of pneumonia caused by Chlamydia pneumoniae. A comparison with streptococcus pneumonia
Q37840740Role of Chlamydia pneumoniae and Helicobacteria pylori in the development of tympanosclerosis
Q37868255Role of Chlamydia pneumoniae and Mycoplasma pneumoniae as Causative Agents of Community-Acquired Pneumonia in Hospitalised Children and Adolescents
Q37852585Role of Chlamydia pneumoniae and Mycoplasma pneumoniae infections in the course of asthma
Q37895576Role of Chlamydia pneumoniae in acute chest syndrome of sickle cell disease
Q37883614Role of Chlamydia pneumoniae in asthmatic disease in children
Q37108634Role of Chlamydia pneumoniae in atherosclerosis
Q37836906Role of Chlamydia pneumoniae in community-acquired pneumonia in hospitalized Jordanian adults
Q37869600Role of Chlamydia pneumoniae in the etiology of atherosclerosis
Q37877163Role of Chlamydia pneumoniae in the pathogenesis of coronary disease
Q37835252Role of Chlamydia pneumoniae in the pathogenesis of hypertrophy and adenoid tissue inflammation in children
Q43415878Role of Chlamydia pneumoniae infection in asthma in Northeast of Iran
Q37851077Role of Chlamydia pneumoniae, helicobacter pylori and cytomegalovirus in coronary artery disease.
Q37869530Role of Chlamydia pneumoniae‐infected macrophages in atherosclerosis developments of the carotid artery
Q37860213Role of IRAK4 and IRF3 in the control of intracellular infection with Chlamydia pneumoniae
Q37870576Role of IgG-seropositivity to Chlamydia pneumoniae in early thrombotic events after coronary stent placement
Q37874412Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections
Q37862475Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired pneumonia in Istanbul, Turkey
Q77216405Role of chlamydia pneumoniae (TWAR) in IgA nephropathy
Q37871262Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae
Q37878887Role of innate and adaptive immunity in the outcome of primary infection with Chlamydia pneumoniae, as analyzed in genetically modified mice.
Q34590364Role of persistent infection in the control and severity of asthma: focus on Chlamydia pneumoniae
Q37871273Role of viral infections and Chlamydia pneumoniae and Mycoplasma pneumoniae infections in asthma in infants and young children. Epidemiologic study of 118 children
Q34004010Roles of interleukin-12 and gamma interferon in murine Chlamydia pneumoniae infection
Q54309872Roquefort cheese proteins inhibit Chlamydia pneumoniae propagation and LPS-induced leukocyte migration.
Q37871978Roxithromycin in prevention of acute coronary syndrome associated with Chlamydia pneumoniae infection: a randomized placebo controlled trial
Q37871843Roxithromycin treatment prevents progression of peripheral arterial occlusive disease in Chlamydia pneumoniae seropositive men: a randomized, double-blind, placebo-controlled trial
Q37860426Rupture of the atherosclerotic plaque: is Chlamydia pneumoniae a possible agent?
Q37857906SOCS-1 protects against Chlamydia pneumoniae-induced lethal inflammation but hampers effective bacterial clearance.
Q37838989SPECIFIC SERUM IMMUNOGLOBULIN G AGAINST CHLAMYDIA PNEUMONIAE IN HEALTHY CHILDREN AND ADULTS IN SOUTH-EAST OF IRAN.
Q37862244STAT1 regulates IFN-alpha beta- and IFN-gamma-dependent control of infection with Chlamydia pneumoniae by nonhemopoietic cells.
Q37877691Safety and effect on anti-Chlamydia pneumoniae antibody titres of a 1 month course of daily azithromycin in adults with coronary artery disease
Q37887299Sample preparation for Chlamydia pneumoniae PCR.
Q35096446Scc1 (CP0432) and Scc4 (CP0033) function as a type III secretion chaperone for CopN of Chlamydia pneumoniae
Q37889144Screening for antibody to Chlamydia pneumoniae by the complement fixation test
Q37874714Search for Chlamydia pneumoniae genes and their expression in atherosclerotic plaques of carotid arteries.
Q37848975Searching for Helicobacter pylori and Chlamydia pneumoniae in primary endodontic infections.
Q37865351Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease
Q33762181Secondary prevention trials for coronary artery disease with antibiotic treatment for Chlamydia pneumoniae: design issues
Q37864878Secretion of Cpn0796 from Chlamydia pneumoniae into the host cell cytoplasm by an autotransporter mechanism
Q31907026Secretion of predicted Inc proteins of Chlamydia pneumoniae by a heterologous type III machinery
Q37857356Selective cyclooxygenase inhibitors prevent the growth of Chlamydia pneumoniae in HL cells
Q37863962Self-limiting pneumonia due to Chlamydia pneumoniae
Q36961827Sequence analysis of the gene encoding the Chlamydia pneumoniae DnaK protein homolog
Q37894914Sequence analysis of the major outer membrane protein gene of Chlamydia pneumoniae
Q43413121Sequencing of Chlamydia pneumoniae in coronary artery disease patients attending tertiary hospital in India
Q37865878Serine-to-asparagine substitution in the GyrA gene leads to quinolone resistance in moxifloxacin-exposed Chlamydia pneumoniae
Q37853757Serodiagnosis of Chlamydia pneumoniae infection using three inclusion membrane proteins.
Q37889634Serodiagnosis of Chlamydia trachomatis and Chlamydia pneumoniae. Evaluation comparing 2 methods: microimmunofluorescence and ELISA. A study of 216 Congolese sera
Q37888229Seroepidemiologic study of Chlamydia pneumoniae and other chlamydial species in a hyperendemic area for trachoma in the Sudan
Q37879495Seroepidemiological evidence for an association between Chlamydia pneumoniae and atherosclerosis
Q37863014Seroepidemiological studies of Chlamydia pneumoniae infections in 1-36 months old children with respiratory tract infections and other diseases in Poland.
Q43424116Seroepidemiology in Chlamydia pneumoniae-- atherosclerosis association
Q37892533Seroepidemiology of Chlamydia pneumoniae TWAR infection in Seattle families, 1966-1979
Q35585961Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000.
Q126791029Seroepidemiology of chlamydia pneumoniae infections in the city of Utrecht, the Netherlands
Q37875823Serologic and histopathologic study of Chlamydia pneumoniae infection in atherosclerosis: a possible pathogenetic mechanism of atherosclerosis induced by Chlamydia pneumoniae
Q37866810Serologic evidence of Chlamydia pneumoniae infection as a long-term predictor of cardiovascular death in renal transplant recipients.
Q37876906Serologic markers for Chlamydia pneumoniae in asthma
Q43433982Serologic tests for Chlamydia pneumoniae
Q44059118Serological Analysis and Drug Resistance of Chlamydia pneumoniae and Mycoplasma pneumoniae in 4500 Healthy Subjects in Shenzhen, China.
Q37869645Serological Association Between Chlamydia pneumoniae Infection and Age-Related Macular Degeneration
Q37859518Serological Evidence of Chronic Chlamydia pneumoniae Infection in Coronary Artery Disease
Q37875894Serological analysis of specific IgA to Chlamydia pneumoniae: increased sensitivity of IgA antibody detection using prolonged incubation and high antigen concentration
Q37861895Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease
Q27006867Serological association of Chlamydia pneumoniae infection with age-related macular degeneration: a systematic review and meta-analysis
Q37873980Serological cross-reaction among Bartonella henselae, Chlamydia pneumoniae and Coxiella burnetii by indirect fluorescence antibody method
Q37781228Serological diagnosis of Chlamydia pneumoniae infection: limitations and perspectives.
Q37877275Serological evidence of Chlamydia pneumoniae lipopolysaccharide antibodies in atherosclerosis of various vascular regions
Q37883417Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer
Q37876946Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma
Q37849329Serological findings of Chlamydial pneumoniae in the Czech Republic--control group of patients examined in the study: Chlamydia pneumoniae in the aetiology of keratoconjunctivitis sicca
Q37872711Serological markers of Chlamydia pneumoniae infection in men and women and subsequent coronary events; the Scottish Heart Health Study Cohort
Q37868948Serological markers of Chlamydia pneumoniae, cytomegalovirus and Helicobacter pylori infection in diabetic and non-diabetic patients with unstable angina pectoris.
Q37858396Serological markers of chronic Chlamydia pneumoniae and cytomegalovirus (CMV) infection in patients with peripheral occlusive artery disease--an initial report
Q37132394Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques.
Q37884209Serological response to Chlamydia pneumoniae in patients with sarcoidosis
Q37184543Serological response to Chlamydia pneumoniae infection
Q37876727Serological screening examinations of atypical pathogens (Mycoplasma pneumoniae, Chlamydia pneumoniae) in respiratory tract infection
Q37861143Serology of Chlamydia pneumoniae in patients with chronic cough
Q129144231Seropositivity Rates of Mycoplasma pneumoniae and Chlamydia pneumoniae in Cases with Community-Acquired Childhood Pneumonia
Q37876599Seropositivity against Chlamydia pneumoniae in patients with coronary atherosclerosis
Q37862797Seropositivity for Chlamydia pneumoniae in patients with primary biliary cirrhosis
Q43421467Seropositivity of Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in a South Indian population.
Q37863096Seropositivity to Chlamydia pneumoniae is associated with risk of first ischemic stroke
Q43419456Seropositivity to Chlamydia pneumoniae or Helicobacter pylori and coronary artery disease
Q37877198Seropositivity to chlamydial lipopolysaccharide and Chlamydia pneumoniae, systemic inflammation and stable coronary artery disease: negative results of a case-control study
Q37876969Seroprevalence of Chlamydia pneumoniae antibodies in a young adult population sample living in Verona. European Community Respiratory Health Survey (ECRHS) Verona
Q37853986Seroprevalence of Chlamydia pneumoniae antibodies in stroke in young.
Q37878194Seroprevalence of Chlamydia pneumoniae in Chile
Q37891923Seroprevalence of Chlamydia pneumoniae in Taiwan
Q37860260Seroprevalence of Chlamydia pneumoniae in asthmatic children from Northern India
Q43435230Seroprevalence of Chlamydia pneumoniae in the normal population
Q37868059Seroprevalence of Chlamydia pneumoniae infection in Taiwan
Q37874882Seroprevalence of Chlamydia pneumoniae infection in Thailand.
Q37893633Seroprevalence of Chlamydia pneumoniae infections in otolaryngeal diseases
Q57253017Seroprevalence of Helicobacter pylori and Chlamydia pneumoniae among Patients with Coronary Artery Diseases at Mansoura University Hospital, Egypt
Q37870815Seroprevalence of IgG antibodies against Chlamydia pneumoniae in Chinese, Malays and Asian Indians in Singapore
Q37863546Seroprevalence of IgG antibodies to Chlamydia pneumoniae and Helicobacter pylori among coronary heart disease patients and normal individuals in South Indian population
Q33599500Seroprevalence of Mycoplasma pneumoniae and Chlamydia pneumoniae in stable asthma and chronic obstructive pulmonary disease
Q37876475Seroprevalence of antibodies to Chlamydia pneumoniae in elderly people: a two-decade longitudinal and cohort difference study
Q37870192Seroprevalence of antibodies to Chlamydia pneumoniae in women with preeclampsia
Q43422044Seroprevalence of antibodies to chlamydia pneumoniae in women with preeclampsia
Q37871695Seroprevalence of chronic Chlamydia pneumoniae infection in patients affected by chronic stable asthma
Q37863634Serum IgG and IgA antibodies to Chlamydia pneumoniae and severity of emphysema
Q37867220Serum antibodies against Chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms
Q37885579Serum gamma-interferon in patients with pneumonia caused by Chlamydia pneumoniae
Q37855525Serum levels of antibodies to Chlamydia pneumoniae and human HSP60 in giant cell arteritis patients
Q37865564Serum lipid profiles poorly correlate with Chlamydia pneumoniae, Helicobacter pylori, and cytomegalovirus seropositivity in prospectively followed-up healthy children
Q37868195Severe Chlamydia pneumoniae infection in a patient with mild neutropenia during treatment of Hodgkin's disease
Q33982905Severe Chlamydia pneumoniae infection in patients with neutropenia: case reports and literature review
Q37866174Severe chlamydia pneumoniae pneumonia requiring mechanical ventilation and steroid therapy in an elderly patient
Q37869236Severe community-acquired pneumonia with acute hypoxemic respiratory failure due to primary infection with Chlamydia pneumoniae in a previously healthy adult
Q37882885Severe community-acquired pneumonia, shock and multiorgan dysfunction syndrome caused by Chlamydia pneumoniae
Q37885786Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae
Q37877234Severe meningoencephalitis: an unusual manifestation of Chlamydia pneumoniae infection
Q37881612Severe pneumonia caused by Chlamydia pneumoniae in a patient treated with steroids for bronchial asthma
Q37123769Severity of allergic airway disease due to house dust mite allergen is not increased after clinical recovery of lung infection with Chlamydia pneumoniae in mice.
Q37858208Severity of carotid atherosclerosis unrelated to Chlamydia pneumoniae infection in acute ischemic stroke patients: a clinicopathological study
Q37844983Shear Stress Enhances Chemokine Secretion from Chlamydia pneumoniae-infected Monocytes
Q37843237Shear stress upregulates IL-1β secretion by Chlamydia pneumoniae- infected monocytes
Q37878639Signal transduction pathways activated in endothelial cells following infection with Chlamydia pneumoniae.
Q43432055Significance of Chlamydia pneumoniae (TWAR) in atherosclerotic lesions
Q37865400Signs of active infection with Chlamydia pneumoniae in patients with coronary heart disease
Q37864413Silencing or permanent activation: host-cell responses in models of persistent Chlamydia pneumoniae infection
Q36973222Similarity of Chlamydia pneumoniae strains in the variable domain IV region of the major outer membrane protein gene
Q37876764Simplified preparation of human arterial sections for PCR analysis of Chlamydia pneumoniae and human DNA
Q37878900Single channel analysis of recombinant major outer membrane protein porins from Chlamydia psittaci and Chlamydia pneumoniae
Q37862359Single-nucleotide-polymorphism-specific PCR for quantification and discrimination of Chlamydia pneumoniae genotypes by use of a "locked" nucleic acid
Q37860515Small molecule inhibitors of type III secretion in Yersinia block the Chlamydia pneumoniae infection cycle
Q37866388Smoking increases the risk of coronary artery disease in Chinese with Chlamydia pneumoniae infection
Q37892687Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association
Q24797351Smoking, season, and detection of Chlamydia pneumoniae DNA in clinically stable COPD patients
Q37888681Species-specific monoclonal antibodies against Chlamydia pneumoniae
Q37876372Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma
Q35764383Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis
Q37892198Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infections
Q37874605Sphingomyelin trafficking in Chlamydia pneumoniae-infected cells.
Q37886696Spontaneous Cure of Pneumonia Caused by Chlamydia pneumoniae
Q37890387Spontaneous cure of acute bronchitis caused by Chlamydia pneumoniae in a 15-year-old boy.
Q37893998Spread of subclinical Chlamydia pneumoniae infection in a closed community
Q34312881Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada).
Q37853780Stevens-Johnson syndrome/erythema multiforme major and Chlamydia pneumoniae infection in young patients
Q35558055Strong correlation between Helicobacter pylori seropositivity and Chlamydia pneumoniae IgG concentrations
Q43414066Strong correlation in the serum levels of IgM rheumatoid factor and IgM anti-Chlamydia pneumoniae antibody
Q36975448Structural and antigenic analysis of Chlamydia pneumoniae
Q28732757Structural characterization of a novel Chlamydia pneumoniae type III secretion-associated protein, Cpn0803
Q37896267Studies on Chlamydia pneumoniae, strain TWAR infection. 2. Seroepidemiology of TWAR on healthy controls and patients with acute respiratory infections
Q37897302Studies on Chlamydia pneumoniae, strain TWAR, infection. I. Experimental infection of C. pneumoniae in mice and serum antibodies against TWAR by MFA
Q37871867Submitral annular aneurysm, postpartum cardiomyopathy, and anti-Chlamydia pneumoniae antibodies in Niamey (Niger)
Q37888330Successful culture of Chlamydia pneumoniae in 2 asymptomatic patients
Q37862635Successful removal of Chlamydia pneumoniae from plateletpheresis products collected using automated leukoreduction hemapheresis techniques
Q43431545Sudden cardiac death in young athletes: orienteering on Chlamydia pneumoniae?
Q24816884Sudden psychotic episode probably due to meningoencephalitis and Chlamydia pneumoniae acute infection
Q100942032Super-Resolution Fluorescence Microscopy Reveals Clustering Behaviour of Chlamydia pneumoniae's Major Outer Membrane Protein
Q37846456Supra-additive expression of interleukin-6, interleukin-8 and basic fibroblast growth factor in vascular smooth muscle cells following coinfection with Chlamydia pneumoniae and cytomegalovirus as a novel link between infection and atherosclerosis
Q37887457Survival of Chlamydia pneumoniae following contact with various surfaces
Q37873270Survival of Chlamydia pneumoniae-infected Mono Mac 6 cells is dependent on NF-kappaB binding activity
Q37888689Susceptibilities to clarithromycin and erythromycin of isolates of Chlamydia pneumoniae from children with pneumonia
Q37883672Susceptibility of Chlamydia pneumoniae to azithromycin and doxycycline: methodological aspects on the determination of minimal inhibitory and minimal bactericidal concentrations
Q43432916Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection
Q37858280Susceptibility of human monocyte-macrophages to Chlamydia pneumoniae infection in vitro is highly variable and associated with levels of soluble CD14 and C. pneumoniae IgA and human HSP-IgG antibodies in serum.
Q37874367Sweet's syndrome and Chlamydia pneumoniae infection.
Q37840819Synergistic Costimulatory Effect of Chlamydia pneumoniae with Carbon Nanoparticles on NLRP3 Inflammasome-Mediated Interleukin-1β Secretion in Macrophages
Q37869454Synergistic Effect of Persistent Chlamydia pneumoniae Infection, Autoimmunity, and Inflammation on Coronary Risk
Q37861538Systemic and mucosal antibody response in experimental Chlamydia pneumoniae infection of mice.
Q37887366Systemic dissemination of Chlamydia pneumoniae following intranasal inoculation in mice
Q37871681Systemic inflammation, Chlamydia pneumoniae DNA in circulating leukocytes and coronary atherosclerosis
Q35922115Systems Biology Approaches for the Prediction of Possible Role of Chlamydia pneumoniae Proteins in the Etiology of Lung Cancer
Q37877466Sézary T-cell activating factor is a Chlamydia pneumoniae-associated protein.
Q126658004T cell lines and clones from unstable human atherosclerotic plaques respond to chlamydia pneumoniae
Q37196471TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis
Q93206750TLR2/CXCR4 co-association facilitates Chlamydia pneumoniae infection-induced atherosclerosis
Q37568474Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice
Q37841231Temperature and host cell-dependent changes in virulence of Chlamydia pneumoniae CWL029 in an optimized mouse infection model.
Q34935390Temporal Expression of Type III Secretion Genes of Chlamydia pneumoniae
Q34601757Temporal arteritis and Chlamydia pneumoniae: failure to detect the organism by polymerase chain reaction in ninety cases and ninety controls
Q74254691Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen
Q37875269Temporal arteritis associated with Chlamydia pneumoniae DNA detected in an artery specimen.
Q36950013Temporal delay of peak T-cell immunity determines Chlamydia pneumoniae pulmonary disease in mice
Q102978124The Association Between Mycoplasma pneumoniae and Chlamydia pneumoniae, a Life-Threatening Condition in Small Children-A Case Report and a Review of the Literature
Q37835815The Chlamydia pneumoniae Adhesin Pmp21 Forms Oligomers with Adhesive Properties
Q35633956The Chlamydia pneumoniae Inclusion Membrane Protein Cpn1027 Interacts with Host Cell Wnt Signaling Pathway Regulator Cytoplasmic Activation/Proliferation-Associated Protein 2 (Caprin2).
Q49268348The Chlamydia pneumoniae Tarp Ortholog CPn0572 Stabilizes Host F-Actin by Displacement of Cofilin
Q27334989The Chlamydia pneumoniae invasin protein Pmp21 recruits the EGF receptor for host cell entry
Q37863637The Chlamydia pneumoniae type III secretion-related lcrH gene clusters are developmentally expressed operons
Q37886395The CrP operon of Chlamydia psittaci and Chlamydia pneumoniae
Q37886297The Etiology of Community-Acquired Pneumonia among Hospitalized Patients during a Chlamydia pneumoniae Epidemic in Finland
Q57285394The Genetic Transformation of Chlamydia pneumoniae
Q128079263The Impact of Chlamydia Pneumoniae Infection on the Immune Status of Children
Q93002037The Important Role of Dendritic Cell (DC) in iNKT-Mediated Modulation of NK Cell Function in Chlamydia pneumoniae Lung Infection
Q37864227The Relationship between chlamydia trachomatis and chlamydia pneumoniae as the cause of neonatal conjunctivitis (ophthalmia neonatorum).
Q37868392The Role of Chlamydia pneumoniae Infection in Children With Chronic Sinusitis
Q35928664The Type III Secretion System-Related CPn0809 from Chlamydia pneumoniae
Q34140532The acute phase reactant response to respiratory infection with Chlamydia pneumoniae: implications for the pathogenesis of atherosclerosis
Q37873971The adventitia of atherosclerotic coronary arteries frequently contains Chlamydia pneumoniae
Q37854139The association between Chlamydia pneumoniae DNA in arherosclerotic plaque and major risk factors in patients undergoing coronary artery bypass grafting
Q34088551The association between Chlamydia pneumoniae and metabolic syndrome in Taiwanese adults
Q37858277The association between past Chlamydia pneumoniae infection and markers of chronic inflammation in obese women
Q44059163The association between serological features of chronic Chlamydia pneumoniae infection and markers of systemic inflammation and nutrition in COPD patients
Q37881687The association between serum sialic acid and asymptomatic carotid atherosclerosis is not related to antibodies to herpes type viruses or Chlamydia pneumoniae. The Atherosclerosis Risk in Communities (ARIC) Study Investigators
Q37856609The association of C (-260)-->T polymorphism in CD14 promoter and Chlamydia pneumoniae infection in ischemic stroke patients
Q37888656The association of Chlamydia pneumoniae infection and reactive airway disease in children
Q37851226The association of body mass index, waist and hip circumference, and waist-hip ratio with Chlamydia pneumoniae IgG antibodies and high-sensitive C-reactive protein at 31 years of age in Northern Finland Birth Cohort 1966.
Q37860798The association of carotid plaque inflammation and Chlamydia pneumoniae infection with cerebrovascular symptomatology.
Q61798413The association of mannose binding lectin genotype and immune response to Chlamydia pneumoniae: The Strong Heart Study
Q24673197The association of metabolic syndrome and Chlamydia pneumoniae, Helicobacter pylori, cytomegalovirus, and herpes simplex virus type 1: the Persian Gulf Healthy Heart Study
Q37870997The association of seropositivity to Helicobacter pylori, Chlamydia pneumoniae, and cytomegalovirus with risk of cardiovascular disease: a prospective study
Q33843538The atherogenic effects of chlamydia are dependent on serum cholesterol and specific to Chlamydia pneumoniae
Q37852294The clinical and morphological features of Chlamydia pneumoniae-induced chorioretinitis in an experiment
Q37867236The detection of Chlamydia pneumoniae in aneurysm of abdominal aorta and in normal aortic wall of organ donors
Q37871621The detection of Chlamydia pneumoniae in atherosclerotic plaques of Australian subjects
Q37868399The development of asthma in children infected with Chlamydia pneumoniae is dependent on the modifying effect of mannose-binding lectin.
Q37859023The development of asthma in wheezing infants with Chlamydia pneumoniae infection
Q37847297The dynamics of detection of antibodies class G against Chlamydia pneumoniae and Chlamydia psittaci in blood serum of patients of different age groups
Q37857559The effect of Chlamydia pneumoniae on the expression of peroxisome proliferator-activated receptor-gamma in vascular smooth muscle cells
Q37881386The effect of prolonged doxycycline therapy on Chlamydia pneumoniae serological markers, coronary heart disease risk factors and forearm basal nitric oxide production
Q37869647The effect of viable Chlamydia pneumoniae on serum cytokines and adhesion molecules in hemodialysis patients
Q90736099The endogenous antiseptic N-chlorotaurine irreversibly inactivates Chlamydia pneumoniae and Chlamydia trachomatis
Q36506125The epidemic cycle of Chlamydia pneumoniae infection in eastern Finland, 1972-1987.
Q35820707The epidemiology and significance of Chlamydia pneumoniae
Q37856476The essential role of the CopN protein in Chlamydia pneumoniae intracellular growth
Q37872119The evolving relationship between Chlamydia pneumoniae and atherosclerosis.
Q24795016The expression, processing and localization of polymorphic membrane proteins in Chlamydia pneumoniae strain CWL029
Q101469980The global prevalence of Chlamydia pneumoniae, Helicobacter pylori, Cytomegalovirus and Herpes simplex virus in patients with coronary artery disease: A systematic review and meta-analysis
Q37852535The implication of Chlamydia pneumoniae in damage to human aortic endotheliocytes in atherosclerosis
Q43420849The in vitro activity of a new fluoroquinolone, ABT-492, against recent clinical isolates of Chlamydia pneumoniae
Q37895406The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR)
Q37895842The in-vitro antibiotic susceptibility of Chlamydia pneumoniae
Q33559443The incidence of Chlamydia pneumoniae lower respiratory tract infections among university students in northern California
Q37655083The inflammatory aspects of Chlamydia pneumoniae-induced brain infection.
Q37868324The influence of Chlamydia pneumoniae infection on acute coronary syndromes
Q37862621The inhibitory effect of antihyperlipidemic drugs on the growth of Chlamydia pneumoniae in vitro
Q37864470The load of Chlamydia pneumoniae in the Alzheimer's brain varies with APOE genotype
Q37876392The microimmunofluorescence test for Chlamydia pneumoniae infection: technique and interpretation
Q37890807The morphology of Chlamydia pneumoniae
Q37884214The nPCR detection of Chlamydia pneumoniae and Chlamydia trachomatis in children hospitalized for bronchiolitis
Q37837847The novel chlamydial adhesin CPn0473 mediates the lipid raft-dependent uptake of Chlamydia pneumoniae
Q37896091The nucleotide sequence of the 60 kDa cysteine rich outer membrane protein of Chlamydia pneumoniae strain IOL-207.
Q37867714The occurrence of Chlamydia pneumoniae, Mycoplasma pneumoniae, and herpesviruses in otitis media with effusion
Q43416608The ongoing debate over the association between Chlamydia pneumoniae infection and coronary artery disease: antibiotic dilemma
Q37869346The pathogenesis of Chlamydia pneumoniae-type pneumonitis in mice.
Q43425861The pathology of Chlamydia pneumoniae lesions in humans and animal models
Q37861669The possible association of Chlamydia pneumoniae infection with nasal polyps
Q74197029The potential etiologic role of Chlamydia pneumoniae in atherosclerosis. Proceedings of a meeting. Seattle, Washington, USA. 22-25 September 1999
Q37877801The presence of Chlamydia pneumoniae in atherosclerotic plaques--a report of three cases of ischaemic heart disease
Q37874213The presence of anti-Chlamydia pneumoniae antibodies in peripheral vascular and neurological disorders
Q37841749The presence of some cytokines and Chlamydia pneumoniae in the atherosclerotic carotid plaque in patients with carotid artery stenosis
Q37893513The prevalence and regional distribution of antibodies against Chlamydia pneumoniae (strain TWAR) in Finland in 1958
Q37877687The prevalence of Chlamydia pneumoniae antibodies in Thai patients with coronary artery disease.
Q37879200The prevalence of Chlamydia pneumoniae in atherosclerotic and nonatherosclerotic blood vessels of patients attending for redo and first time coronary artery bypass graft surgery
Q43424431The prevalence of Chlamydia pneumoniae in respiratory infections in the lower respiratory tracts in children under two
Q37836053The prevalence of Chlamydia pneumoniae in the aortic wall and in peripheral blood of patients scheduled for coronary artery bypass grafting
Q37889630The prevalence of anti-Chlamydia trachomatis and anti-Chlamydia pneumoniae antibodies in Brazzaville
Q37879934The prevalence of chronic Chlamydia pneumoniae infection as detected by polymerase chain reaction in pharyngeal samples from patients with ischaemic heart disease
Q37876824The proatherogenic properties of lipoprotein(a) may be enhanced through the formation of circulating immune complexes containing Chlamydia pneumoniae-specific IgG antibodies.
Q37877179The progression of lower limb atherosclerosis is associated with IgA antibodies against Chlamydia pneumoniae
Q37274217The prospective association of Chlamydia pneumoniae and four other pathogens with development of coronary artery calcium: the multi-ethnic study of atherosclerosis (MESA).
Q42390881The relation between Chlamydia pneumoniae and atherosclerosis
Q37872328The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm
Q37876114The relation between Chlamydia pneumoniae infection and abdominal aortic aneurysm: case-control study
Q37874658The relation between carotid ultrasound changes and seropositivity to Chlamydia pneumoniae in patients with acute stroke
Q37872878The relationship between Chlamydia pneumoniae and atherosclerosis
Q37883789The relationship between Chlamydia pneumoniae and atherosclerotic lesions of the aorta
Q100696461The relationship between Chlamydia pneumoniae infection and CD4/CD8 ratio, lymphocyte subsets in middle-aged and elderly individuals
Q37866409The relationship between Chlamydia pneumoniae infection and primary biliary cirrhosis
Q43421710The relationship between Chlamydia pneumoniae seropositivity and peripheral vascular diseases, acute myocardial infarction and late-onset asthma
Q37849268The relationship between seropositivity against Chlamydia pneumoniae and stroke and its subtypes in a Latvian population
Q37867778The reproducibility of an enzyme-linked immunosorbent assay for detection of Chlamydia pneumoniae-specific antibodies
Q37876793The resistance of human monocyte-derived macrophages to Chlamydia pneumoniae infection is enhanced by interferon-gamma
Q37862246The role of Chlamydia pneumoniae in acute respiratory tract infections in young children in The Gambia, West Africa
Q37875691The role of Chlamydia pneumoniae in atherogenesis
Q43428087The role of Chlamydia pneumoniae in atherosclerosis
Q33934178The role of Chlamydia pneumoniae in atherosclerosis--recent evidence from animal models
Q33817488The role of Chlamydia pneumoniae in cardiovascular disease
Q37873386The role of Chlamydia pneumoniae in etiology of acute bronchitis in children
Q37866349The role of Chlamydia pneumoniae in human aortic disease-a hypothesis revisited
Q43419200The role of Chlamydia pneumoniae in multiple sclerosis: real or fictitious?
Q37889412The role of Chlamydia pneumoniae in severe acute tonsillitis.
Q37860157The role of Chlamydia pneumoniae in the etiology of acne rosacea: response to the use of oral azithromycin.
Q37843000The role of Chlamydia pneumoniae in the etiology of keratoconjunctivitis sicca (KCS).
Q37864473The role of Chlamydia pneumoniae in the pathogenesis of abdominal aortic aneurysm
Q43428884The role of Chlamydia pneumoniae in the pathogenesis of atherosclerosis
Q37870107The role of Chlamydia pneumoniae infection in the pathology of respiratory organs
Q37870210The role of atypical pathogen: Mycoplasma pneumoniae and Chlamydia pneumoniae in the acute respiratory infection in childhood
Q37880009The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in respiratory infection
Q37876418The role of chlamydia pneumoniae in atherosclerosis - recent evidence from animal models: response
Q37842253The role of endoplasmic reticulum-related BiP/GRP78 in interferon gamma-induced persistent Chlamydia pneumoniae infection
Q37859699The role of endothelial dysfunction and Chlamydia pneumoniae infection in patients with ischemic stroke
Q37862874The significance of Chlamydia pneumoniae in selected neurologic disorders
Q37873368The significance of Chlamydia pneumoniae in symptomatic carotid stenosis
Q37230432The species specificity of the microimmunofluorescence antibody test and comparisons with a time resolved fluoroscopic immunoassay for measuring IgG antibodies against Chlamydia pneumoniae
Q27333845The sst1 resistance locus regulates evasion of type I interferon signaling by Chlamydia pneumoniae as a disease tolerance mechanism
Q37877192The studying of Chlamydia pneumoniae in atherosclerosis
Q90918083The therapeutic role of inhibition of miR-328 on pulmonary carcinoma induced by chlamydia pneumoniae through targeting histone H2AX
Q27825840The transcriptional landscape of Chlamydia pneumoniae
Q30885714The ultrastructure of a new species of Chlamydia--Chlamydia pneumoniae
Q37876877Therapeutic effect of clarithromycin for respiratory-tract infections in children caused by Chlamydia pneumoniae. Research Group of Sapporo for Pediatric Chlamydial Infections
Q30682022Time-dependent expression and processing of a hypothetical protein of possible importance for regulation of the Chlamydia pneumoniae developmental cycle
Q37835597To study the association between anti-Chlamydia pneumoniae antibodies (IgG), anti-Mycoplasma pneumoniae antibodies (IgG) and coronary artery disease (CAD).
Q37863624Tobacco smoke induces a persistent, but recoverable state in Chlamydia pneumoniae infection of human endothelial cells
Q37863888Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells
Q37854329Toll-like receptor-4 (TLR4) mediates human beta-defensin-2 (HBD-2) induction in response to Chlamydia pneumoniae in mononuclear cells.
Q34077643Toll-like receptors 2 and 4 regulate the frequency of IFNγ-producing CD4+ T-cells during pulmonary infection with Chlamydia pneumoniae
Q37864028Total hip arthroplasty infection with Chlamydia pneumoniae and Mycobacterium chelonae.
Q37885691Towards Chlamydia Pneumoniae vaccination
Q36673413Transcription factor complex AP-1 mediates inflammation initiated by Chlamydia pneumoniae infection.
Q37838929Transforming activities of Chlamydia pneumoniae in human mesothelial cells
Q37890551Transmission of Chlamydia pneumoniae
Q37895809Transmission of Chlamydia pneumoniae in young children in a Japanese family
Q37865867Transmission of Chlamydia pneumoniae infection from blood monocytes to vascular cells in a novel transendothelial migration model
Q37886846Transport and storage conditions for cultural recovery of Chlamydia pneumoniae
Q43423013Treating Chlamydia pneumoniae in patients with early atherosclerosis
Q43426684Treatment of Chlamydia pneumoniae
Q34974820Treatment of Chlamydia pneumoniae infection and chronic obstructive pulmonary disease
Q34295748Treatment of Chlamydia pneumoniae infection in adult asthma: a before-after trial
Q37873906Treatment of Chlamydia pneumoniae infection with roxithromycin and effect on neointima proliferation after coronary stent placement (ISAR-3): a randomised, double-blind, placebo-controlled trial
Q37878785Treatment of Helicobacter pylori and Chlamydia pneumoniae infections decreases fibrinogen plasma level in patients with ischemic heart disease
Q37867216Treatment of acute Chlamydia pneumoniae infection with telithromycin in C57BL/6J mice
Q37873600Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae
Q37881246Tricuspid endocarditis caused by Chlamydia pneumoniae. Apropos of a case
Q33431609Trophoblast infection with Chlamydia pneumoniae and adverse pregnancy outcomes associated with placental dysfunction
Q37199823Tryptophan Codon-Dependent Transcription in Chlamydia pneumoniae during Gamma Interferon-Mediated Tryptophan Limitation
Q33769133Tumor necrosis factor alpha plays a role in the acceleration of atherosclerosis by Chlamydia pneumoniae in mice
Q57187454Tumor necrosis factor receptor superfamily members 1a and 1b contribute to exacerbation of atherosclerosis by Chlamydia pneumoniae in mice
Q37850119Two cases of erythema exsudativum multiforme associated with Chlamydia pneumoniae infection
Q37889579Two family outbreaks of Chlamydia pneumoniae infection
Q37872509Typing strains of Chlamydia pneumoniae by amplified fragment length polymorphism typing
Q37879427Ultrastructural Analysis of Chlamydia Pneumoniae in the Alzheimer's Brain
Q34004081Ultrastructural analysis of developmental events in Chlamydia pneumoniae-infected cells
Q37888544Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice
Q37873353Ultrastructural study of Chlamydia pneumoniae in a continuous-infection model
Q37894232Ultrastructure of Chlamydia pneumoniae in cell culture
Q33320687Under the microscope: focus on Chlamydia pneumoniae infection and multiple sclerosis
Q37875278Unstable atherosclerotic plaques contain T-cells that respond to Chlamydia pneumoniae
Q37860674Up-regulation of host cell genes during interferon-gamma-induced persistent Chlamydia pneumoniae infection in HL cells
Q37870410Upregulation of extracellular matrix metalloproteinase inducer (EMMPRIN) and gelatinases in human atherosclerosis infected with Chlamydia pneumoniae: the potential role of Chlamydia pneumoniae infection in the progression of atherosclerosis
Q37892713Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae
Q37182583Use of HL cells for improved isolation and passage of Chlamydia pneumoniae
Q37876328Use of a mouse lung challenge model to identify antigens protective against Chlamydia pneumoniae lung infection
Q33672291Use of lambda phage DNA as a hybrid internal control in a PCR-enzyme immunoassay to detect Chlamydia pneumoniae
Q37867461Use of quantitative and objective enzyme immunoassays to investigate the possible association between Chlamydia pneumoniae and Mycoplasma pneumoniae antibodies and asthma
Q37863292Usefulness of sparfloxacin against Chlamydia pneumoniae infection in patients with bronchial asthma
Q43431172Uveitis and joint pain without pulmonary involvement disclosing Chlamydia pneumoniae infection
Q73382390Vaccination against infections by Chlamydia pneumoniae
Q43426598Validation of the use of an ELISA test in the detection of Chlamydia pneumoniae antibodies
Q37877532Value of animal models for Chlamydia pneumoniae-related atherosclerosis
Q37878273Vascular surgical society of great britain and ireland: immunoglobulin A antibodies against chlamydia pneumoniae are associated with expansion of small abdominal aortic aneurysms and declining ankle blood pressure
Q37876304What is needed to prove that Chlamydia pneumoniae does, or does not, play an etiologic role in atherosclerosis?
Q37865213Why Chlamydia pneumoniae is associated with asthma and other chronic conditions? Suggestions from a survey in unselected 9 yr old schoolchildren
Q43414862Why first degree relatives of coronary artery disease patient's have Chlamydia pneumoniae infection
Q37882965Widely used, commercially available Chlamydia pneumoniae antigen contaminated with mycoplasma
Q128852287Yersinia enterocolitica and Chlamydia pneumoniae possible triggering agents of Guillain-Barre syndrome: a case report
Q37844072Zoledronic acid affects the cytotoxic effects of Chlamydia pneumoniae and the modulation of cytokine production in human osteosarcoma cells
Q44025531[Chlamydia pneumoniae and atherosclerosis]
Q77317950[Chlamydia pneumoniae pneumonia]
Q36763581[Chlamydia pneumoniae]
Q43436048[Chlamydia pneumoniae]
Q37872743[Clinical significance of interaction between Chlamydia infection (Chlamydia pneumoniae) and free radical processes during ischemic heart disease]
Q74406210[Diseases from Chlamydia psittaci and Chlamydia pneumoniae]
Q74374927[Influence of Chlamydia pneumoniae and cytomegalovirus infections on prevalence and the course of coronary artery disease]
Q74194114[Is Chlamydia pneumoniae infection the risk factor of unstable angina pectoris?]
Q84407997[Morphological factors of productive and persistent developmental cycles of Chlamydia pneumoniae in human coronary and aortic endothelium]
Q74505785[Presence of Chlamydia pneumoniae antibodies in patients with ischemic heart disease and acute myocardial infarct]
Q75186812[The response to the letter of Dr. Jerzy Durkalec regarding literature review by Przemyslaw Kotyla, Bogna Sliwińska-Kotyla and Eugeniusz J. Kucharz "The Significance of Chlamydia pneumoniae Infection in the Development of Sclerosis]
Q73250338[The role of Chlamydia pneumoniae infection in the development of atherosclerosis in humans]
Q91905173[Viral identification, Chlamydia pneumoniae and Mycoplasma pneumoniae during asthma exacerbation: comparative epidemiology between infants and children.]
Q37874954cDNA array analysis of altered gene expression in human endothelial cells in response to Chlamydia pneumoniae infection
Q129424231chlamydia pneumoniae unfection in - patients with community acquired pneumonia in Iraq
Q126338711Infections respiratoires à Chlamydia pneumoniae, sur 5 ans, au centre hospitalier d'Aix (1991–1995)